ATP-binding cassette transporters of Paracoccidiodes brasiliensis by Gray, Christopher H
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
UNIVERSITY
of
GLASGOW
ATP-binding cassette transporters of 
Paracoccidiodes brasiliensis
By
Christopher H Gray B.Sc (Hons)
A thesis presented for the degree of Doctor of Philosophy
in
The Faculty of Science at the University of Glasgow
Institute of Biomedical and Life Sciences 
Division of Infection & Immunity 
University of Glasgow
Glasgow G21 8QQ April 2001
ProQuest Number: 10662718
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uesL
ProQuest 10662718
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
The author was a recipient of an Institute of Biomedical and Life Sciences studentship. 
Except where stated all results described in this thesis were obtained by the author’s 
own efforts.
'  9^  /^ /11T  "
Christopher H Gray 20th April 2001
[G tA scsovT *iwjvrasitY
Acknowledgem ents
I wish to give special thanks to Dr. Adrian R Walmsley for his supervision, support 
and encouragement throughout this project and for the proof reading of this thesis.
I would also like to thank the Institute of Biomedical & Life at the University of 
Glasgow for the provision of the funds that sustained me throughout the project.
This work would not have been possible without the extended assistance I received 
from members of the group. Particular thanks go to Dr. M. Ines Borges-Walmsley for 
knowledge, advice and assistance. Dr. Borges-Walmsley also prepared all the nucleic 
acid materials supplied for this study. I would also like to make special mention of Dr. 
Paul Blackburn who has been resolute in his support, although his poor emu spotting 
skills almost brought the whole endeavour to an end.
To the members of the Division of Infection and Immunity South Laboratory I extend 
my warmest appreciation. They are recognised for their enthusiasm and 
friendship....and for putting up with my exclusive brand of “wit”.
Thanks also go to Caroline for listening to my moans when things were bad and for 
keeping my feet on the ground when things were good. I would like to apologise for 
all those Saturday afternoons when we “just popped into the lab for 10 minutes” and 
stayed for 2 hours.
This thesis is dedicated to my Mum and Dad whose selfless and unfailing support has 
allowed me to get to this point. I extend to them my greatest appreciation and love. 
Without them none of this would have been possible. I would also thank Simon, 
Jennifer and Connor for their encouragement and understanding.
Summary
ATP-binding cassette (ABC) transporters represent one of the largest recognised 
superfamilies of proteins. They are ubiquitous in nature and have been implicated in a 
wide range of physiological functions, including multi-drug resistance (MDR). All of 
these transporters are structurally related, with active transport complexes exhibiting the 
minimal complement of twelve transmembrane helices and two nucleotide-binding 
domains. Despite the structural similarity, the range of functions performed by these 
proteins is variable. In many cases the substrate range is equally diverse with the 
proteins displaying the capacity to translocate substrates which appear structurally 
unrelated. This intensifies the problem of MDR where a number of classes of drug are 
susceptible to efflux.
A number of ABC transporters have been identified in fungi including Saccharomyces 
cerevisiae and Candida albicans. An increasing wealth of information is emerging for a 
few of these transporters. The current knowledge on the various characteristics of the 
S.cerevisiae transporter PDR5 approaches that relating to P-glycoprotein (Pgp) of 
mammalian cells. The ABC transporter CDRI from Candida albicans has been shown 
to confer clinical drug resistance in a number of disease cases.
Paracoccidiodes brasiliensis is a thermally dimorphic human pathogen that is exclusive 
to South America. Inhalation is the route of infection with disease progression 
originating in the lungs and progressing to other parts of the body. 
Paracoccidiodiomycosis is the most prevalent systemic mycosis in Latin America. 
Exposure to the organism is most common in rural workers, particularly those involved 
in deforestation. Disease progression occurs when the host is immunocompromised 
and tends to follow and extended period of latency which can last over ten years. 
Outgrowth of the organism is dependent on a morphological transition from the 
mycelial to the yeast form of the organism. This transition is inhibited by the female 
hormone oestrogen resulting in the clinical syndrome displaying a bias towards males. 
The drug of choice is ketoconazole, a member of the azole family of anti-fungal agents. 
Azoles act on an intermediate enzyme in the ergosterol biosynthesis pathway, lanosterol 
demethylase, resulting in the perturbation of cell membrane integrity. Resistance to 
azole drugs can occur in two ways. A mutation in lanosterol demethylase can alter the 
drug-binding site so that the target is not recognised. Alternatively, the intracellular 
concentration of azole can be reduced by the ABC transporter mediated active efflux of 
the drug.
The remit of this thesis was to screen the genome of P,brasiliensis for loci encoding 
ABC transporters. Particular interest would be paid to proteins that may be involved 
with drug resistance. Initially a strategy employed by other investigators was 
employed. Two degenerate oligonucleotides (MDRI and MDR2), designed on the 
basis of conserved motifs from the nucleotide binding domains of a number of ABC 
transporters were used in PCR. A single amplicon was obtained which showed 
homology to other sequences coding for nucleotide-binding domains. This amplicon 
was used to screen a lambda genomic library and a single phage was isolated. This 
phage clone contains part of a gene with displayed considerable identity to an ABC half­
transporter from Aspergillus fumigatus. The complete sequence of the gene was then 
obtained using genome walking SSP-PCR. The gene, p ftl ,  spans 2627bp and is 
interrupted by 2 introns of 68bp and 77bp.
A similar approach was employed in a search for additional genes. The amino acid 
sequences from a number of PDR5-like fungal ABC transporters were aligned. This 
allowed the identification of conserved motifs that were specific to these fungal 
proteins. Application of these primers allowed the amplification of a second amplicon. 
The sequence of this amplicon displayed considerable homology to the fungal 
transporter genes. This fragment was proposed to belong to a second P.brasiliensis 
gene, pft2. Screening of the lambda phage genomic library allowed the isolation of a 
single clone. Subeloning of fragments from this phage clone allowed the greater part of 
this gene sequence to be determined.
RT-PCR based transcript analysis of these genes proved that both were expressed and 
spliced by P.brasiliensis. The expression of p ftl occurred only on stimulation with an 
azole drug. This result represents the first evidence linking a fungal half-transporter 
with drug resistance. Further analysis of the p ftl  transcript revealed that the mRNA 
was shorter than expected at the 5’ end. 5’RACE RT-PCR suggested that a second 
ATG codon was the true translational start and not the ATG suggested by the genomic 
sequence. The acquisition of cDNA allowed progression to recombinant protein 
expression. All further experiments concentrate on p ftl, as half-transporters represent a 
more novel and less characterised system.
A number of constructs were created in pET21b. The objective was to produce a 
soluble nucleotide-binding domain of Pftl. Subcellular localisation of the resultant 
proteins caused a number of problems. Larger constructs appeared to partition to the 
membrane which would complicate purifieation procedures. The level of expression of 
smaller portions of the NBD was very high and the protein persisted mainly as 
insoluble inclusion bodies. Despite these problems, a 28.0kDa NBD was selected for
purification using nickel affinity chromatography. This pure protein, termed 
PftlNBDTW, was then applied to fluorescence based experiments. Measurement of 
tiyptophan fluorescence and fluorescence energy transfer to ligands allowed the 
demonstration of binding of both ATP and ketoconazole to the NBD, Stopped flow 
analysis allowed the visualisation of the transient kinetics of ATP binding. Further 
experiments, examining the steady-state binding of ketoconazole and ATP indicated that 
the NBD had a high affinity for ketoconazole.
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Chapter 1 
General Introduction
Paracoccidiodes brasiliensis is a pathogenic fungus and the etiological agent of 
paracoccidiodiomycosis (PCM). PCM is the most prevelant systemic mycosis in Latin 
America. Disease is observed in discreet pockets within an area that is restricted to the 
regions between Mexico and northern Argentina. Even within these limits not every 
country reports disease. Approximately 80% of cases are recorded in Brazil, where 
PCM is a significant clinical problem. The majority of cases are clustered in areas of 
tropical and humid forest, the suspected environmental niche of P.brasiliensis. A  
number of patients are individuals involved in the deforestation industry. The disease 
manifests initially as a respiratory infection causing pulmonary lesions. This typically 
follows an extended period of latency (up to 15 years) where the organism remains 
dormant in the lower lung. Outgrowth often occurs when the host becomes immuno­
compromised and, if untreated, can spread to other organs causing lesions in the skin, 
adrenal glands, mucous membranes and lymph nodes (Brummer et al., 1993).
As with so many pathogens restricted to the developing world, the characterisation of 
P.brasiliensis is poor in comparison with pathogens causing disease in the developed 
world. This is particularly true with respect to studies involving current applications of 
molecular biology, biochemistry and immunobiology. However, the increasing profile 
of the South American scientific community, coupled with an increased interest in 
tropical disease in centres of the West has led to an elevation in the frequency of papers 
relating to this organism in recent years. Sequences derived from P.brasiliensis have 
been submitted to sequence databases. The total number of distinct genes represented 
in these data is 13, and the number will continue to increase (Source; NCBI Genbank 
database (www.ncbi.nih.nlm.gov)).
Within the field of medical mycology, an area which receives intense interest is the 
phenomenon of multi-drug resistance. Indeed resistance to the popular azole drugs has 
already been demonstrated in the important pathogen, Candida albicans. (Hitchcock, 
1993; Miyazaki et al., 1998; Prasad et al., 1995). Such drug resistance is often 
mediated by the active efflux of the cytotoxic drug from the microbial cell by membrane 
transport proteins. These can belong to either the major facilitator superfamily or the 
ATP-binding cassette transporter (ABC transporter) superfamily. ABC tranporters are 
ATP hydrolysing, energy dependant influx or efflux systems. They are universal and 
are described in organisms from bacteria to man (Higgins, 1992). In Saccharomyces
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cerevisiae there are 31 genes coding for proteins of this type (Decottignies & Goffeau,
1999). The biological function of ABC transporters is wide and varied but popular 
themes of research often focus on processes such as antigen presentation (Karttunen et 
aL, 1999), solute and nutrient uptake (Hung et al., 1998) and multidrug resistance 
(Higgins, 1995; Tobin et al., 1997; Van Veen et al., 1996). It is accepted that ABC 
transporters perform a wide range of additional and often essential tasks contributing to 
cellular homeostasis. Prior to the studies reported in the following chapters of this 
thesis, no ABC transporters had been described in P.brasiliensis.
1.1  Paracoccidiodes brasiliensis
1 . 1 .1  Morphology of P.brasiliensis
P.brasiliensis is a thermally dimorphic saprobic fungus which exists in a mycelial form 
at environmental temperatures (26°C) and in a yeast form at temperatures consistent 
with internalisation in the mammalian host (37°C) (Braibant et aL, 1996; Brummer et 
a l, 1993). (This is an inverted arrangement to the dimorphism exhibited by C.albicans 
where mycelial growth is associated with the infectious form (Balan et al., 1997)). The 
organism was first cultured by Lutz in 1908 and reported in the Brazilian scientific 
literature (Lutz, 1908). Disease in man is invariably associated with the yeast form of 
the organism. Very often the clinical diagnosis of PCM involves the microscopic 
observation of the distinct “pilots wheel” morphology of this yeast form, where a 
mother cell is surrounded by a number of peripheral daughter cells (Hadad et al., 
1992). Under conditions of nutritional stress mycelia will transform and release 
propagules as either conidia or chlamydospores (Brummer et al., 1993). It is suspected 
that contraction of the disease involves inhalation of propagules produced by the 
organism when exposed to sub-optimal conditions in the environment. The process of 
morphological transition and the biochemical distinctiveness of each form is the subject 
of ongoing research. Targeting a certain morphology or by inhibiting the 
morphological switching from non-pathogenic to pathogenic forms could prove a useful 
point of intervention for chemotherapeutics. This will only be achieved following a 
comprehensive understanding the molecular biology and biochemistry of this microbe.
Scientific investigations relating to the nature of P.brasiliensis began in earnest in the 
mid-1970s, with South American investigators performing rudimentary microbiological 
studies on this novel fungus. For example, the simple analysis of growth curves of
Chapter 1
mycelial and yeast forms of the organism in trypticase soy broth proved worthy of 
publication, indicating the level of knowledge pertaining to this organism at that time 
(Arango & Restrepo, 1976). This is not to say that this rudimentary type of 
investigation desisted as knowledge progressed. For the last 25 years investigators 
have continued to perform very simple techniques to tiy and unravel some of the 
fundamental questions which persist about P.brasiliensis. For example, the outgrowth 
of the mycelial form on incubation in sterile distilled water demonstrated that 
intracellular storage compounds, in particular lipid vacuoles and glycogen deposits, 
allowed the continued development of the mycelia for over 6 months (De Bedout et al., 
1986). Such elementary observations are important, conveying the resilience of the 
organism and confirming it’s ability to survive and increase in numbers in a hostile 
environmental niche. Later elementary studies have attempted to refine the laboratory 
handling of the organism with simple reports of differing culture dynamics on various 
media (Borba et al., 1999).
There are considered to be three main morphologies of P.brasiliensis. The amount of 
information relating to each of these forms is variable but studies focus on either the 
mycelial form, the propagule form or the yeast form. Each of these is intricately 
associated with the ecology of the organism in its survival in the humid forest 
environment through to the lungs of an infected individual. The mycelial form of the 
pathogen is poorly described in comparison to the yeast or propagules. This is may be 
due to the fact that this phase is not thought to be directly associated with disease in any 
way. Only on sporulation will the organism be inhaled. In addition to the 
aforementioned studies relating to mycelial resilience there have been reports concerned 
with metabolism in this form. For example, the activity of cytosolic neutral 
proteinases, is much higher in mycelia than yeast. Inhibitor experiments implicated 
serine-, cysteine- and metallo-proteases in particular (San-Blas et al., 1998).
The majority of information available concerning the life-cycle of P.brasiliensis relates 
to the yeast form or to the morphological transition from mycelia or propagule to yeast. 
The result of a temperature shift from 26°C to 37*^ C can be observed in F ig I.l. The 
entire transition process occurs over a period of approximately 15 days. During the 
transformation there is a cessation of respiratory function and oxidative phosphorylation 
that re-establishes in the presence of cysteine and the arrival at the yeast form (Medoff et 
al., 1987). A number of researchers have performed preliminary analyses of the 
biochemistry underlying the transition event. San-Blas and San-Blas (1986) noted a 
shift in the chemical linkage of the glucan molecules of the cell wall with the yeast wall
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F i g  1.1
(A dapted from  (Da Silva et al., 1999)) The tem perature induced m orphological transition o f  P. brasiliensis. 
A: M ycelia at 26°C B: T ransitional cells at 36"C for II days,
C : T ransitional cells 36"C for 15 days D: Yeast cells at 37"C
exhibiting a-glucan linkages while the myceial cell wall is predominantly (3-glucan. 
Presumably this denotes the differential expression or activation of a-glucan synthases 
and P-glucan synthases during the phase transition. Indeed a p-glucan synthase from 
P.brasiliensis has recently been cloned and sequenced (Pereira et al., 2000).
The composition of the lipid component of the cell surface also varies during the 
transition. The study of the glycosphingolipid repertoire of fungi receives attention 
because the structure and biosynthesis of these components differs from those in 
mammalian cells, thus providing a potentially useful drug target. The mycelial form of 
P.brasiliensis exhibits a 1:1 ratio of p-glucopyranolsylceramides to (£)-A 3-unsaturated 
fatty acids. The yeast form presents only 15% of the glycosphingolipid component as 
the (£)-A 3-unsaturated fatty acid (Toledo et al., 1999).
At a more general level, discrepancies in both qualitative and quantitative profiles of 
protein expression have been noted between the two forms. Da Silva et al. (1994) 
record the differential synthesis of a number of stage specific proteins during the
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mycelium to yeast shift. Most of these proteins were denoted only by merit of their 
difference in size while a 70 kDa protein, found only in the yeast form, was shown to 
react with the monoclonal rat anti-Hsp70 antibody. (The molecular biology associated 
by this differential expression has since been elucidated and will be discussed later.) 
This partly concurred with the investigations of Goldani et al. (1994) where a number 
of proteins were shown to be expressed or repressed in response to temperature stress 
on both yeast and mycelia. Similarly, the N-termini of two differentially expressed 
proteins were sequenced by automated protein sequencing, one specific to the mycelial 
form and one to the yeast. BLAST analysis of the peptide sequences so obtained 
demonstrated a mycelial enolase while the protein of the yeast was most probably an 
allergen protein (Cunha et al., 1999). While it was suggested that this demonstrated 
differential gene expression no physiological significance was inferred.
Other metabolic functions have also been investigated with a differential profile of 
polyamine synthesis observed on transition. This occurs as a consequence of a 
modulation in ornithine decarboxylase activity which has been shown to be important in 
a number of fungal transition systems. In particular this ornithine decarboxlase activity 
has been mapped to the onset of the budding process rather than throughout the entire 
transition (San-Blas etal., 1997).
It is worth noting here that specific observations of differential protein expression in a 
particular strain of P.brasiliensis does not infer that this will be the case for all isolates. 
Protein expression profiles in both mycelia and yeasts of different isolates demonstrates 
that heterogeneous protein synthesis can be observed. This is particularly true of the 
mycelial form (Salem-Izacc et al., 1997). The issue is further complicated by the 
apparently unpredictable nature of P.brasiliensis expression profiles. An analysis of 
antigen batches, both inter- and intra-strain, showed that there is considerable instability 
in the synthesis of antigens even by the same isolate under tightly controlled incubation 
conditions (Franco et al., 1996). If this observation of antigenic moieties is mirrored 
by other protein molecules then an accurate determination of the proteome of the 
organism at any given time could prove complicated.
It is most likely that the mechanics of the transition process will resemble those 
observed in other fungi and involve kinase dependant cell signalling mechanisms. In 
particular, it is likely that P.brasiliensis possesses a MAP (mitogen activated protein) 
kinase cascade and a cAMP kinase cascade similar to those observed in related species. 
This subject, in the context of pathogenic fungi, has been reviewed recently by Borges- 
Walmsley and Walmsley (2000). An initial indication that this is indeed the case comes 
from the isolation and sequencing of a ra.y-like gene from a cDNA clone derived from
Chapter 1
the yeast form of P.brasiliensis (Borges-Walmsley, unpublished data). The influence 
of increased intracellular cAMP levels has been shown to stabilise the proliferation of 
the yeast form. It has been postulated that the induction of expression of the Hsp70 
stabilises components of the cAMP signalling pathway in the face of temperature stress 
thus supporting the biochemistry of the transition process (Borges-Walmsley and 
Walmsley, 2000).
The yeast cells of P.brasiliensis have been shown to be quite metabolically active, 
despite the apparent fastidious nature of the organism on in vitro culture. Among the 
numerous enzymatic processes assessed in active yeast cells has been the measurement 
of phosphatase, esterase, dehydrogenase, and triphospatase activities. A comparison of 
cellular organisation between a number of isolates shows little variation in 
ultrastructure. A thin but dense cell wall composed of two sublayers encloses a three 
layered plasma membrane with extensive invaginations. Within the cells, mitochondria 
are profuse while endoplasmic reticulum tends to be poorly represented. Cells also 
present a number of vacuoles and multiple nuclei. Additional studies have shown that a 
number of lipid droplets appear within the cells and that there is a wide distribution in 
the size range of the oval elongated yeast when grown on plates (Brummer et al., 
1990).
Diagnosis of an active population of P.brasiliensis in infection has often relied on the 
microscopic observation of the “pilots wheel” appearance of cells, with a central mother 
cell possessing a number of associated peripheral daughter cells. A direct immediate 
diagnosis is difficult using this technique if the microbial load of the infection is low or 
sampling is difficult. In cases where numbers are low, diagnosis is complicated by the 
slow growth of the organism with cream coloured yeast colonies requiring 10 to 15 
days of incubation.
As previously mentioned, nutritional stress can lead to the formation of conidia or 
spores. It has been suggested that the response resulting in the formation of conidia is 
specific to mycelial cells under nutritional or water stress (San-Blas, 1986). The 
beginning of the formation of conidia is a commitment that invariably results in the 
collapse of the hyphae and the persistence of the propagule. Investigations of this form 
demonstrate that these cells are also receptive to thermal dimorphism and reversion to 
either mycelial or yeast form is determined by the temperature applied. At 37^C , either 
on plates or in vivo (in mice), the conidia revert to the yeast form. Microscopic 
observations see the uni-nucleated conidial cell change to the multi-nucleated yeast 
which is vimlent and produces a pulmonary fibrosis in mice that equates to the same 
sequelae observed in humans (McEwan etal., 1987).
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The conidia are rather small, 3.5 to 5.0pm, which may explain why the organism can 
penetrate to the alveolus on inhalation thus further implicating conidia in the infection 
process. The intracellular organisation is little different from any eukaiyotic cell with all 
major organelles present and correct within the protective environment of a thick spore 
wall. Nutrient stores are present, for example large lipid bodies are readily visible in 
the cytoplasm (Brummer et aL, 1990).
The other important propagule is the chlamydospore that forms in response to low 
oxygen tension and poor nutrient availability. Under certain culture conditions this can 
also reform the parent phase of growth. Like the yeast form, cells possess multiple 
nuclei and a high density of mitochondria meaning that further development may be 
possible (Franco et al., 1989). Alternatively, this increase in mitochondria may be an 
oxygen scavenging response. Like the mycelial phase, this form of the organism is not 
extensively characterised.
1 . 1 .2  Paracoccidiodiomycosis; disease and infection
PCM can occur in two forms, the severe and rare “acute”, or “subacute”, juvenile form 
or the chronic adult form. Both disease scenarios are associated with extensive 
sequelae, mediated by systemic infections, including lesions and an abnormality in the 
cell-mediated immune response. Infection can occur many years prior to the onset of 
clinical symptoms, disease occurring only on the outgrowth of active yeast cells. 
Disease onset usually coincides with a period of immuno-compromisation (a dramatic 
PCM has been found associated with HIV (Miranda Aires et aL, 1997)). A failure to 
administer therapy once PCM is recognised usually precedes mortality (Brummer, et aL, 
1990).
The juvenile disease is the harshest of the two forms. It accounts for 3-5% of recorded 
cases and the progression of the disease is relatively rapid (weeks to months) as the 
disease is disseminated by the reticuloendothelial system. The prognosis for diseased 
children and young adults is poor (Tapia et aL, 1991). In contrast to the adult form the 
lungs do not appear to be the primary focus for the disease, although the organism can 
be detected in pulmonary exudate.
The adult form of the disease accounts for more than 90% of all patients. In this case 
the lungs are certainly the site of initial infection. Chest X-rays reveal lesions in the 
lower lung that can be extensive even while the initial clinical symptoms are mild 
(Campos etal., 1991). Indeed some cases of PCM are only identified when the patient
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reports with symptoms in a second organ while the pulmonary lesions are silent 
(Brummer, et aL, 1990). PCM is associated with a concurrent episode of tuberculosis 
in 10% of cases (Angulo-Artega & Pollack, 1972). Most of the patients are adult males. 
This may be due to the link between the deforestation industry and the contraction of the 
disease. However, an extensive case exists demonstrating that oestrogens in the female 
actually inhibit the conversion from propagules to yeast cells. The bias against disease 
in females and the effects of the female hormone status have been shown at the 
biochemical level (Feldman et aL, 1983; Loose et aL, 1983) and in vivo in model 
systems (Aristizabal et aL, 1998).
The actual method of disease contraction is still poorly understood. There is certainly no 
evidence for person to person transmission. It is widely suspected that an individual 
acquires the organism through inhalation of material from the environment. Where this 
environmental niche actually lies, at local or geographical scale, is not clear. The disease 
is definitely associated with tropical, humid, forested areas in South America. Any 
cases outside South America can generally be traced back to the endemic area, with the 
suspected contraction occurring on a visit by the patient often many years before 
(Brummer, et aL, 1993). Even within Brazil the contraction of disease in individuals 
can be correlated with visits to areas considered favourable to the survival of 
P.brasiliensis. For example, all 36 cases of juvenile PCM reported in the state of Rio de 
Janeiro between 1981 and 1996 were linked with children who had visited a nearby area 
of abundant watercourses and rainforest (Goncalves et aL, 1998).
Studies on the distribution of disease are geographically dispersed. The incidence of 
exposure and disease in Northwest Argentina has been studied and presented in a series 
of papers. The lower age limit for the immune response to paracoccidiodin in a skin 
hypersensitivity test appeared to be two years old but the numbers of children displaying 
this sensitivity were low (5 out of 344 children tested) (Mangiaterra et aL, 1996). The 
sequential assessment of paracoccidiodiomycosis, or exposure to P.brasiliensis, in the 
individual regions of Northwest Argentina suggests that 10% of individuals are 
seropositive in this area (Van Gelderen, et aL, 1999; Van Gelderen & Duran, 1995). In 
certain areas of Brazil as much as 80% of the population is thought to have been 
exposed (Brummer, et a l, 1993).
The association of disease with certain environmental features has led to the concept of 
“reservarea” (Goncalves, et a l, 1998). Whether it is the fauna, flora or soil that 
harbours the organism is unclear and in the dynamic ecology of the forest it is difficult to 
dissect. P.brasiliensis has been linked to animals. It has been suggested that freshwater 
fish and amphibians represent a significant enzootic reservoir for the fungus. Spread
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from this pool could be exacerbated by the excretions of birds which feed on such fish 
(Conti Diaz & Rilla, 1989). Strong evidence links the armadillo {Dasypus 
novemcinctus) to the survival of the organism in the forest. Organisms can be isolated 
from the internal organs of such animals in the area of endemicity. This has been 
confirmed in a number of ways including immunological reactions with anti-gp43 
antibody (a P.brasiliensis specific antigen) (Vidal et al., 1995) and PCR (random 
amplified polymorphic DNA analysis) (Sano et al., 1998). It would appear that the 
growth of P.brasiliensis in armadillos is quite common. The fungus was cultured from 
the organs of three out of nine armadillos captured in the area of Botucatu, Brazil 
(Bagagli et al., 1998). Additionally, armadillos have been captured that possesses 
pulmonary lesions consistent with elinical PCM (Vergara & Martinez, 1998).
As an extension of the armadillo concept, it has been proposed that the soil can also act 
as a habitat for P.brasiliensis cells. Indeed the co-isolation of the fungus from soil and 
armadillos in the south-eastern area of Brazil has been reported (Silva-Vergara et al.,
2000). There are numerous examples of cases where P.brasiliensis has been isolated 
from soil samples. The screening of 887 soil samples from Botacatu resulted in the 
isolation of five strains of the organism, including three from armadillo holes 
(Montenegro et al., 1996). Similarly a strain was isolated from soil around a coffee 
plantation in Ibia, South Brazil, and it was proposed that the organism was associated 
with the coffee industry (Silva-Vergara et a i, 1998). Many of these reports are greeted 
with scepticism however as the confirmatory tests employed are not always conclusive 
and the reproducibility of these isolations is often impossible (Franco et al., 2000). 
Nevertheless, the confusing issue of the precise reservarea of P.brasiliensis and the 
route of infection remains unconfirmed. This is further complicated by the appearance 
of the organism in samples from sources as diverse as Antarctic penguin faeces and dog 
food (Sandhu et al., 1997)
1 . 1 .3  Molecular studies of P.brasiliensis
An increase in the application of current molecular techniques in the study of 
P.brasiliensis has coincided with its elevated profile within the scientific community. 
While the genomes of important Western pathogens are being sequenced, most of the 
key genes encoding virulence factors and antigens of P.brasiliensis remain 
undiscovered. A number of researchers in South America, the USA and in the UK are 
taking steps to remedy this situation. The sequencing of the genome of P.brasiliensis 
may be some time away but the isolation and characterisation of novel and important 
genetic determinants from this organism is underway. In addition, the application of
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molecular biology in the study of the ecology of this organism, as well as the field of 
diagnosis, has allowed rapid progress and shows great promise for data gathering and 
practical application.
At the time of writing there are 89 submissions to Genbank which report sequences 
derived from P.brasiliensis. The majority of these sequences (52 of the 89) are multiple 
submissions reporting the sequence of one particular gene {gp43) from a number of 
individual strains. The group with secondary prominence relates not to protein encoding 
sequences but to rRNA genes and DNA sequences that have been used as genetic 
markers. The actual number of distinct, protein encoding genes is 13. Most of these 
genes are not the subject of publications and there is no biochemical data relating to their 
putative protein products. Those that have been investigated to some degree are 
discussed below.
As with so much of the biology of P.brasiliensis, recent molecular publications continue 
to deal with fundamental questions. Even the size of the genome and the chromosomal 
complement of the organism has been hard to pin down. The first analysis was 
performed in 1998 where 4 chromosomal bands were recognised on pulse field gel 
electrophoresis. These bands, ranging from 2.0 to lO.OMbp, give a genome size of 
30Mbp. This is consistent with the genome size and chromosome numbers of 
Neurospora crassa and Coccidiodes immitis. Microfluorimetry of DAPI stained yeast 
nuclei suggested a nuclear DNA content of approximately 60Mbp implying a diploid 
genome. Hybridisation of chromoblots with selected gene probes gave the interesting 
result that the laminin binding protein gene, gp43, was positioned on different 
chromosomes in two separate isolates (Nogueira Cano et al., 1998). This intra-species 
variation was reinforced by a later electrophoretic karyotype study of environmental and 
clinical isolates. In all five environmental isolates and four clinical isolates tested, five 
chromosomal bands were observed. Four of these were common but the environmental 
isolates had a fifth chromosome of 7.2Mbp rather than the 8.8Mbp of the clinical strains 
(Montoya et al., 1999). It is possible that the apparent discrepancy in the number of 
chromosomes reported in these two papers can be explained by differences in the 
electrophoresis technique used. It seems certain though that some sort of deletion and 
rearrangement occurs among isolates resulting in a change in the map of the genome. 
Chromosomes appear variable in size and the location of any one gene on any one 
chromosome seems variable also. This may have important ramifications in the event 
that the genome of this organism is sequenced.
The molecular cloning of genes from P.brasiliensis remains reportable. Included in 
sequence reports have been the sequences of cell wall synthesis genes including the
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chitin synthases (CHSl to CHS5) (Nino-Vega et a i, 1998; Nino-Vega et al., 2000) and 
a putative (3-glucan synthase (Pereira, et ai, 2000). Analysis of the mRNA levels of aU 
five of the chitin synthase genes during the morphologieal transition illustrated that 
CHS3 was not expressed at any detectable level at any point. The other 4 were peculiar 
to the mycelial form reflecting the prominent chitin component of the mycelial cell wall 
(Nino-Vega, et al., 2000). Such studies are of particular importance because it is in 
areas such as cell wall biosynthesis that we will find new drug targets and points of 
therapeutic intervention. Indeed testament to the importance of cell wall biosynthesis in 
fungal drug targeting is the almost exclusive attention that this area receives from current 
drug regimes (Georgopapadakou, 1998; Vanden Bossche et al., 1998).
An hsp70 gene, translated only by the yeast form of the organism, is reported by Da 
Silva et al (1999). This study delves deeper than the gene sequence and notes a putative 
novel mechanism of regulation of expression of the Hsp70 protein. It would appear that 
the expression of this gene is constitutive and transcripts are observed in both mycelia 
and yeast forms. However, it is only in the yeast form that the two introns are spliced 
allowing successful translation of the transcript. This ties in well with the previously 
mentioned study where an Hsp70 protein was differentially expressed in the yeast form 
only (Da Silva, et al., 1994).
Two genes have been cloned that encode the 27kDa (McEwan et al., 1996) and 43kDa 
(Cisalpino et al., 1996) antigenic proteins. The study of gp43 in particular has 
generated a wealth of research relating to the immunobiology of PCM (discussed in 
section 1.4). The gp43 gene was isolated from a lambda DNA library using short DNA 
hybridisation probes deduced from the protein on N-terminal sequencing. The isolated 
clone demonstrated a 1329bp ORE interrupted by one 78bp intron which coded for the 
416 amino acid protein that is the immuno-dominant antigen of P.brasiliensis. The 
27kDa antigenic protein was isolated on screening a lambda display library with 
P.brasiliensis antisera. The isolated clone possessed a Ikb cDNA insert which appeared 
to code for a 259 amino acid protein.
Diagnosis of P.brasilisensis by culture from clinical samples requires an extensive 
incubation of around 2 weeks before an accurate observation can be made by 
microscopy (Hadad, et a l, 1992). There has been considerable interest in the 
application of diagnostic PCR or nucleic acid hybridisation techniques based on newly 
discovered gene sequences. Such tests serve not only to identify P.brasiliensis in a 
rapid and more definitive manner but also to aid distinction from other pathogenic and 
closely related organisms like Paracoccidiodes loboi or Paracoccidiodes cerebiformis. 
The specificity and effectiveness of hybridisation to the 28S ribosomal RNA has been
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demonstrated (Sandhu, et al., 1997). The sequencing of 800bp of the 5’ terminus of the 
P.brasiliensis 28S rRNA gene identified a 14bp motif that was specific for the species. 
This probe was shown to hybridise to all 7 isolates of the organism investigated, which 
ranged from clinical isolates to samples from soil and penguin faeces. Hybridisation to 
an extensive panel of other fungi were negative confirming specificity. This probe was 
later used in a more clinically relevant method, by in situ hybridisation in tissue samples. 
The 14bp probe and it’s complementary sequence resulted in the labelling of 2-3% of the 
total cells present in the material (in comparison to analysis with Gridley stain) (De Brito 
et al., 1999). This rather disappointing level suggests that this technique may not be 
suitable from routine use in the diagnostic lab.
The more sensitive application of PCR has proved more promising. PCR approaches 
include the amplification of sequences of particular genes and the use of random 
amplification polymorphisms to determine a characteristic amplicon signature for the 
organism. The application of these techniques has contributed to both clinical and 
environmental studies. A potentially global PCR target is the Internal Transcribed 
Spacer (ITS) genes which contribute to the 5.8S rRNA. The amplification of a 418bp 
product from this locus has resulted in identical outputs from 29 strains from diverse 
sources (Imai et al., 2000). A similar result was reported by targeting sequences from 
both the 5.8S and 28S rRNA sequences (Motoyama et al., 2000).
The sequence of the gp43 gene allowed the design of primers which detected as little as 
10 cells per ml of sputum (Gomes et al., 2000). This was extended in a nested PCR 
method to correctly identify 21 of 23 culture positive infected BALB/c mice where as 
little as 0.5fg of P.brasiliensis DNA was present in the samples. This technique was 
specific for this fungus and failed to detect Histoplasma capsulatum in other mice 
(Bialek et al., 2000). An equally promising ratio of positive results was reported in 
which PCR (with lOpg of template per sample) detected five of five positive blood 
samples while culture only suggested that two were positive. In this case the sequence 
of a previously identified PCR fragment was used that has not yet been attributed to any 
open reading frame (Goldani & Sugar, 1998).
Random amplified polymorphic DNA analysis has been used to group different clinical 
isolates of P.brasiliensis. The grouping suggested by the amplicon patterns mirrored the 
grouping made on the basis of virulence. In this case two groups were identified with a 
suggested genetic relatedness of only 17% (Molinari-Madlum et al., 1999). 
Comparative analysis of amplicons between human and armadillo isolates has suggested 
a link in transmission to man from the armadillo. Three major clusters were observed in 
the RAPD analysis. Cluster II was exclusive to the armadillo but cluster I and III
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patterns were observed in both human and animal isolates. This suggests that humans 
may contract the organism in exposure to the armadillo environment (Sano, et al.,
1998). Discrimination of isolates on a geographical basis by RAPD illustrated that a 
single primer was sufficient to divide isolates into five groups. Each of these groups 
related to the area where the strain was isolated with Venezuelan, Brazilian, Peruvian, 
Colombian and Argentinean strains all providing a different polymorphism (Calcagno et 
al., 1998).
It is evident that the further application of molecular techniques in the study of 
paracoccidiodiomycosis will continue to provide new information. The culmination of 
these studies will hopefully be the sequencing of the P.brasiliensis genome. The degree 
of relatedness of genes between P.brasiliensis and those of other well characterised 
fungal pathogens means that information derived from the genome sequence would be 
immediately useful. The extensive biochemical data available for important fungal 
proteins could be suggestive of a phenotype for many of the genes discovered in this 
venture. It should be noted that the apparent heterogeneity in the overall structure of the 
genome among P.brasiliensis isolates may complicate this matter. Until the genome is 
sequenced the classical approaches to gene identification and characterisation will remain 
important.
1 .1 .4  The immunobiology and gp43 of paracoccidiodiomycosis
Studies of the mammalian immune response to paracoccidiodiomycosis focuses on two 
main areas. Firstly, the influence of immuno-effector molecules and immune cell 
functions have been addressed. However, the bulk of information relates to a single 
protein, the immuno-dominant antigen of P.brasiliensis, gp43. The literature dealing 
with gp43 represents the most comprehensive area of research relating to this organism.
The gp43 was first recognised in 1986 when the major antigenic exocellular components 
of the yeast form were identified after immuno-preciptitation with human antisera. The 
component that appeared to have the major antigenicity was purified and included a 
43kDa protein glycoconjugate (Puccia et al., 1986). This protein was digested by 
proteolysis and N-terminally sequenced. The sequence allowed the design of degenerate 
oligonucleotide probes. Screening of a lambda library using these probes resulted in the 
isolation of a 1329bp ORF, interrupted by two introns, encoding a 416 amino acid 
protein with a deduced molecular mass of 45,947Da (Cisalpino, et a i,  1996). A 43kDa 
component was found in circulating immune complexes (CICs) from the sera of PCM 
patients, probably representing the gp43 of P.brasiliensis (Unterkircher et al., 1996).
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The T-cell epitope, which induces a Th-1 response in BALB/c mice, has been mapped to 
a 15 amino acid motif with the essential core of “HTLAIR”. This region, denoted as 
PIO, is suffieient to induce a significant immune response that is comparable to that 
observed with gp43 (Taborda et al., 1998).
As with so many of the proteins of P.brasiliensis, there is variation in the patterns of 
expression between isolates. The phase-specific expression of gp43 in yeast cells alone 
has been observed in some strains while a constitutive expression in both major forms is 
true for others (Mattar-Filho et al., 1997). Polymorphisms of gp43 in individual 
isolates have been noted on the basis of differing isoelectric points. These 
polymorphisms arise from substitution sites within the 578-1166bp region of the gene. 
This is not the region containing the epitope highlighted in PIO and should not effect the 
antigenicity (Morais et al., 2000). This means that vaccination with gp43 may still be an 
appropriate endeavour. Related to this notion is the partially successful application of 
purified gp43 as a paracoccidiodin in a delayed hypersensitivity test to assess the anti- 
P.brasiliensis immune status of animals and patients. In PCM patients the detection rate 
of the immune response was 48%, compared to the 28% success when using the 
traditional Fava Netto antigen (AgFN) (Saraiva et al., 1996). Even more encouraging 
are the results of a DNA vaccination trial in BALB/c mice where the intramuscular and 
intradermal injection of a plasmid encoding the gp43 gene resulted in a characteristic T~ 
CD4(+) Thl response and a decrease in both the number of cells in the lungs and the 
extent of the dissemination of disease (Pinto et al., 2(X)0).
In addition to its immuno-stimulatory properties, a role for gp43 as an important 
virulence factor is emerging. The progression of most invasive microbial disease relies 
on an initial process of adhesion to the surfaces of mammalian cells. The notion of 
micro-organisms binding to extracellular matrix components is well established for 
many bacterial and fungal pathogens. It was discovered that a monoclonal antibody 
raised against the laminin-binding protein of Staphylococcus aureas binds to gp43 
(Vicentini et al., 1994). It would appear that gp43 is present not only as exoantigens but 
also on the cell surface. Electron microscopy of strains expressing gp43 on the cell 
surface shows binding of the cells to coated epithelial cell layers (Lopes et al., 1994). 
Recently a model system, using Vero cells, has demonstrated that permanent attachment 
is observed after 30 minutes but this attachment is inhibited on addition of anti-gp43 
antisera (Hanna et al., 2000). This correlates with in vivo observations as the binding 
of free laminin to gp43 on the P.brasiliensis yeast cell surface, prior to injection into 
hamster testicles, greatly enhances virulence (Vicentini, et al., 1994). The progression 
from protein production, cellular display and secretion has been monitored by immuno- 
electron microscopy. The gp43 is directed to the plasma membrane inside large dense
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core vesicles. On fusion with the plasma membrane the gp43 extrudes into the cell wall 
and the immuno-reactive epitope is displayed on the cell surface. The gp43 is eventually 
released from the eell as membrane free material at scattered locations (Straus et al.,
1996). As well as adhesion to tissues, the intracellular parasitic nature of P.brasiliensis 
will require an initial attachment to macrophages. Anti-gp43 antibodies have a 
competitive effect on P.brasiliensis association to macrophages and consequent 
phagocytosis (Almeida etal., 1998).
The development of a murine model of paracoccidiodiomycosis has assisted in the 
reinforcement of many of the postulations made on the basis of biochemical and 
epidemiological data. The first demonstration that PCM arises from the inhalation of 
conidia was performed in BALB/c mice. The intranasal introduction of 10® viable 
conidia cells into healthy animals was sufficient to induce symptoms of disease. 
Transformation to yeast commenced after 12 hours in the animal model with budding 
after 18 hours. Histology demonstrated a sequential recmitment of leukocytes to the 
alveolar cavity. The preliminary response saw the localisation of PMNs with 
lymphocytes, macrophages and plasmocytes appearing after 6 days (McEwan, et al., 
1987).
Much of the work performed since has attempted to dissect the dynamics of the cellular 
response and the involvement of certain immuno-modulators in the process. This has 
included systems using either gp43 or whole organisms. The presentation of purified 
gp43 to two isogenic mouse strains has demonstrated that the cellular response mounted 
against the antigen determines the degree of susceptibility of the individual to infection. 
In the resistant A/Sn mouse strain the antigen is processed and presented by 
macrophages. This induces a largely Thl lymphokine response which correlates with 
the resilience against infection. Conversely, the susceptible BIO.A mice use B cells as 
the main antigen-presenting cell, mounting a Th2 response. Thus, the nature of the 
APC component of the immune response would seem critical in determining whether the 
disease progresses (De Almeida et al., 1998). The same comparative experimental 
system has been used to demonstrate that a decrease in CD8(+) cells allows a rapid and 
dramatic progression of fungal dissemination to the major organs (Cano et al., 2000).
The clearance of fungal cells by PMNs is important and the fungicidal activities of such 
murine cells has been measured in vitro. The efficacy of PMNs in killing yeast cells 
would seem to vary according to fungal strains. The extent of fungal killing is enhanced 
by Interferon-y (IFN-y) (Kurita et al., 1999; Kurita et al., 1999) and granulocyte- 
macrophage colony-stimulating factor (GM-CSF) (Kurita et al., 2000). The importance 
of IFN-y has been shown in vivo. The depletion of IFN-y in the mouse lung using
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monoclonal anti-IFN-y antibodies increased the susceptibility of both A/Sn and BIO.A 
mice. The normally defined focal lesions of PCM were transformed into coalescent 
granulomata that destroyed the fabric of the lung (Cano et a i, 1998).
Finally, as suggested by the epidemiology studies of PCM, the female hormone status 
appears to convey protection from disease progression. A comparative study of the 
susceptibility of male BALB/c mice and female BALB/c mice at various stages of the 
oestrus cycle demonstrated that the lowest rates of disease were observed in oestrus 
female mice that presented high levels of blood oestrogen (Sano et al., 1992). The 
previous observation that oestrogen’s inhibit the mycelium to yeast transition in vitro 
(Restrepo et al., 1984) also holds true in vivo allowing early low level infection to clear 
in females (Aristizabal, et a l, 1998).
In conclusion, Paracoccidiodes brasiliensis represents an important pathogen in South 
America. While the volume of published data relating to this organism is increasing the 
answers to several fundamental questions persist. It will be vital to address these and 
further issues if a comprehensive program of disease control is to be established. In so 
doing an often fatal disease could be circumvented and the wealth of data relating to the 
medical control of fungal pathogenesis could be enriched.
1.2  ATP-Binding Cassette Transporters
The relationship between a cell and the surrounding milieu requires dynamic but 
selective interactions. Processes at the cell boundary convey the ability to take up 
essential nutrients and expel toxic and/or waste products. This is universally achieved 
by membrane transport proteins incorporated within the lipid membrane barrier that 
defines the cell.
It is now recognised that such transport proteins can be limited to a number of families 
(Quentin & Fichant, 2(X)0). Members of a given family show a degree of structural and 
functional relatedness, even though they can be widely distributed among prokaryotes, 
simple eukaryotes and higher eukaryotes. Despite a wide diversity in transport 
function, the relatedness of proteins within a family suggests a common evolutionary 
origin. The largest of these families, which is currently the focus of intense research 
interest, is the ATP-binding cassette (ABC) superfamily (also called the traffic 
ATPases). These proteins convey an energy dependent active transport process, by 
which substances can cross the cell membrane on the hydrolysis of ATP (Higgins,
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1992). They have been noted not only on cell surfaces but also on the membranes of 
organelles (Allikmets etaL, 1999; Csere et a i, 1998; Leighton & Schatz, 1995). Many 
experiments have demonstrated that deletion of these transport proteins has a pleiotropic 
effect on cell function. Numerous ABC transporters display the ability to translocate a 
number of apparently unrelated substrates, with multidrug resistance associated 
transporters providing a prime example (Golin et al., 2000; Van Helvoort et al., 1996).
The first ABC transport proteins were found in bacteria in the 1970s, although they 
were not denoted as ABC transporters at this time. The histidine periplasmic permease 
system, HisJQMP, of Salmonella typhimurium was first isolated by Ames (Ames, 
1972), whose laboratory continues to pioneer advances in the study of this complex. 
This permease, and the maltose transport system, MalEFGK, of Escherichia coli 
(Davidson & Niki ado, 1991) marked the beginning of the gradual discovery of the 
family. Almost 30 years later, the number of ABC transporters known is extensive and 
these molecules represent the largest accepted superfamily of homologous proteins. 
Research in this area remains broad but a few individual transporters have become 
representative of the ABC system due to the extent of the data relating to their function 
and/or their medical importance. The original pioneering system, the S.typhimurium 
histidine permease, remains prominent with the first X-ray crystal structure of an ABC 
transporter component coming from HisP (Hung, et al., 1998). At a similar time the 
crystal structure of ATPase of RbsA was solved (Armstrong, 1998). The crystal 
structure of the ATPase subunit of the E.coli arsenite transporter, ArsA, has also been 
solved providing a structural insight into the detailed data concerning the mechanism of 
metalloid binding and ATP hydrolysis (Zhou et al., 2000). Also, the homodimeric 
MalK of Thermococcus litoralis, has been solved to 1.9Â resolution (Deideriches, et 
a l,  2 0 0 0 )
Yeast transporters are often used as model systems for eukaryotic transport processes. 
Notable proteins include the STE6  a-pheromone transporter, involved in mating of 
S.cerevisiae (Kuchler e ta l ,  1989). The PDR5 drug transporter represents the pivotal 
component in a network of proteins relating to drug transport in yeast, including ABC 
transporters and transcription factors (Balzi & Goffeau, 1995). The PDR5 drug 
transporter of S.cerevisiae is the fungal equivalent of mammalian P-glycoprotein in the 
respect that it now represents the archetypal transporter in fungal studies. A number of 
other ABC transporters have been found to convey a drug resistant phenotype in 
pathogenic fungi. Two ABC protein drug resistance determinants, CDRl and CDR2, 
are now recognised in C.albicans (Balan, et a l, 1997; Franz et a l ,  1998; Hernaez et 
al., 1998; Sanglard et al., 1997). Three ABC transporters have been described in 
Aspergillus nidulans (AtrA, AtrB & AtrC (Angermayr et a l ,  1999; Del Sorbo et a l .
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1997)). Thomewell et a l  and Tobin et al. have successfully identified MDR 
transporters in Cryptococcus neoformans (Thomewell et al., 1997), Aspergillus 
fumigatus and Aspergillus flavus (Tobin, et al., 1997) using degenerate 
oligonucleotides for PCR. In mammalian cells the medically important mdrl gene 
product, P-glycoprotein (Pgp), and the cystic fibrosis associated CFTR transporter 
contribute heavily to the literature (Higgins, 1992).
Recently, the rate at which new ABC transporters have been reported is comparatively 
high and a further understanding of both stmcture and function promises scope for 
applied biology. Genome sequencing projects have allowed the assembly of 
comprehensive inventories of ABC transporters for certain organisms. For instance the 
current accepted figure for Saccharomyces cerevisiae, the first eukaryote for which the 
genome was complete, is 31 (Decottignies and Goffeau, 1999). The ABC transporter 
complements for S.cerevisiae and other organisms are further classified into a number 
of distinct subfamilies. While all of the proteins involved use ATP hydrolysis to pass a 
solute through the membrane, sequence comparisons show an underlying subdivision 
of relatedness within the family. With the draft of the human genome sequence now 
complete the putative inventory of human ABC transporters will surely be assembled. 
Indeed Klein et al. present a pre-emptive inventory in their recent review (Klein et al., 
1999). This review perhaps demonstrates that a large number of novel sequences of 
human ABC transporters remain to be mined from the human genome sequence. The 
authors note that only 30 human ABC proteins are represented by full sequences in 
databases. If S.cerevisiae has 31 genes then it is probable that the human complement 
will be much larger. Even within the 30 available we can see a much greater diversity 
in the array of subfamilies in comparison with yeast. Broccardo et al. (Broccardo et 
al., 1999) note that ABC transporters tend to represent 2-5% of all ORFs in the 
genomes that have already been sequenced. Given that the human genome appears to 
possess around 30,000 genes we can expect in excess of 1000 ABC transporters if this 
trend holds true.
Due to a frequent bias in the literature, any given transporter is often associated with a 
single phenotype, e.g. Pgp is a drug transporter. This practice is perhaps misleading as 
many of these molecules display pleiotropic function. The YRSl transporter of 
S.cerevisiae, which transports reveromycin, also allows tolerance to a broad range of 
organic anions not used as drugs (Cui et al., 1996) and the mammalian P-glycoprotein 
has been implicated in the disposition of cholesterol suggesting a role in membrane 
biosynthesis (Wang et al., 2000). It is thus possible that the phenomenon of multidrug 
resistance has appeared due to fortuitous substrate tolerance by existing transporters 
acting in normal physiological processes. Also any given function of these proteins is
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often performed by additional transporters within the cell, ABC or otherwise. Thus, 
the cellular transporter arsenal is a complex system of both pleiotropy and pluralism that 
often complicates in vivo analysis. In lower organisms this can be partially 
circumvented. For instance Goffeau has created a multiple deletion mutant of 
S.cerevisiae which lacks all known drug transporters and associated transcription 
factors (unpublished data). Thus, candidate drug resistance mechanisms can be studied 
more accurately in this system. However, a similar approach in a mammalian cell line 
is not possible.
Biochemical studies have provided much information about the function of each subunit 
of ABC transporters and, to a lesser extent, the nature of the interactions between them. 
As the wealth of functional information is now complemented by crystal structures we 
may hope to understand these interactions in more detail.
1.2 .1  The structural organisation of ABC transport proteins
All known ABC transport proteins are composed in a modular manner consisting of an 
arrangement of nucleotide-binding domains (NBDs) and membrane spanning domains 
(MSDs) (Fig 1.2). It is generally accepted that there are four domains present in the 
functional transporter, two nucleotide-binding and two membrane spanning. The 
membrane spanning portions are highly hydrophobic and most often portrayed as six 
transmembrane helices. The two hydrophobic subunits form a “two-times-six” 
arrangement, thought to provide a pathway through which the substrate (or allocrite) 
can be transported. The other two domains are peripherally located on the cytoplasmic 
face of the membrane hydrolysing ATP and coupling the resultant energy to the 
transport process (Higgins, 1992).
Some ABC transporters possess additional domains to the four that form the core of the 
complex. The ATP-binding domain of the bacterial maltose transporter has a C 
terminal extension that possesses an enzymatic activity totally unrelated to the transport 
process. The mammalian CFTR chloride ion channel possesses an additional domain, 
the R domain, which plays a regulatory role (based on phosphorylation) but has no 
apparent function in the transport process per se. This motif lies between the first 
nucleotide-binding domain (NBDl) and the second membrane spanning domain 
(MSD2). This gives CFTR an overall MSD1-NBD1-R-MSD2-NBD2 topography 
(Klein, et al., 1999). A similar organisation exists in the emergent ABCA subfamily 
where the R domain is proposed to form an additional membrane associated region 
(Broccardo, etal., 1999).
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Fi g  1.2
The general m odular structure o f  ABC transporters. It is thought all transporters require 2 NBDs and 2 M SDs 
to function. A num ber o f  transport system s require assoc iations between separate p ro teins the co m p le te  
com plex. This can include heterodim eric or hom odim eric arrangem ents o f half transporte rs. In bacteria the  
functional transporter can include up to four separate proteins (H iggins, 1992).
The distinctive MRP (multidrug resistance protein) family, related to CFTR, illustrates a 
set of proteins which appear to be extensions of a Pgp-like organisation. The most 
important of these is M RPl, identified by Cole and Deele in 1992 (Cole et al., 1992). 
There now 5 other assured members of the family (MRP2-6). M RPl, 2, 3 and 6 have 
a similar structure with a large C-terminal extension providing 5 additional 
transmembrane helices. MRP4 and MRP5 restrict themselves to only 12 helices but 
have an N-terminal cytoplasmic loop as the extension. As well as having a role in the 
extrusion of cytotoxic drugs these proteins have a particular affinity for glutathione 
conjugated substances and have been shown to participate in organic anion balance and 
to transport immune effector molecules like leukotriene C4 (Borst et al., 1999).
The logistics of expression of ABC proteins is found to be variable. The expression of 
the domains can occur as separate polypeptides or as fused combinations of subunits.
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Almost all possible combinations of subunits have been reported. Generally, all 
eukaryotic ABC transporters show some fusion of subunits. Either the entire 
transporter is expressed as a single polypeptide or a half transporter is produced having 
one NBD and one MSD usually with six helices. It is thought that these half­
transporters dimerise in a homologous or heterologous unit (Michaelis & Berkower,
1995).
In bacteria almost every conceivable combination can be found. The oligopeptide 
permease of S.typhimurium is expressed in four separate protein modules 
(MSD;MSD;NBD;NBD). In the E.coli ribose transporter the NBDs are fused giving 
(MSD;MSD;NBD2) while the iron hydroxamate transporter has fused MSDs 
(MSD2;NBD;NBD) (Young & Holland, 1999). The LmrA transporter of Lactococcus 
lactis is a dimer of (NBDiMSD)^ (Van Veen, et a l, 1996). Many ATP dependant 
uptake systems of Gram negative bacteria have the additional requirement of a 
periplasmic binding protein (Linton & Higgins, 1998). Solutes can enter the 
periplasmic space through a non-specific uptake mechanism, e.g. by porin. This solute 
is then bound by a soluble periplasmic protein which directs the molecule to the correct 
transporter. The S.typhimurium uptake system is typical of this type with the 
periplasmic binding protein, HisJ, binding to the heterodimeric MSDs, HisQ & HisM. 
The histidine uptake is then performed on hydrolysis of ATP by the homodimeric HisP 
(Nikaido et al., 1997).
Regardless of the organisation of expression, four modular units must be present in the 
functional end product. A number of experiments have been reported whereby the 
expression of normally fused polypeptides has been altered so as to cause them to be 
expressed as single units. It is found that these manipulated strains continue to produce 
functional transporters even though the organisation of expression has been changed. 
Berkower et al. (Berkower & Michaelis, 1991) used the STE6 a-factor transporter to 
illustrate this property. This protein is normally expressed as a single four subunit 
transporter. The experiment demonstrated that, if the protein was expressed as two half 
molecules, the a-pheromone continued to be transported as normal. In a later paper it 
was demonstrated, by immuno-precipitation techniques, that the two half molecules 
interacted physically, supporting the idea that such proteins spontaneously associate in 
vivo (Berkower et al., 1996). It is probable that the fusion of subunits into larger 
arrangements has occurred over time as the single units were constantly co-expressed 
on the same operon. The above experiment demonstrates that the physical mechanism 
of protein-protein association persists even now the polypeptides are fused. As 
previously mentioned, no transporter has been found which functions with only two 
domains. For the moment, it is accepted that this form is the minimal requirement for
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function. This does not rule out the notion of ABC transport processes occurring in 
larger, more complex arrays of subunits.
The necessity for two MSDs is apparent, with both domains contributing to the 
structure of the channel or pore. The requirement for two NBDs is perhaps less 
obvious. What is the significance and functional necessity for the duplication of the 
energy generating subunit of the transporter? The significance of this arrangement is 
contentious with investigators reporting different conclusions from different systems.
1 . 2 .2  The Nucleotide-Binding Domain (NBD)
The provision of energy, which allows the transport of solutes against a concentration 
gradient, is achieved by ATP hydrolysis. The nucleotide-binding domains of ABC 
transporters, which possess this enzymatic activity, tend to be the most conserved 
modules of the complex. Typically values of 30% to 50% identity are observed 
depending on the proteins compared. The typical location for the nucleotide-binding 
domain is the cytosolic face of the cell membrane in peripheral association with the 
bilayer (Jones & George, 1999)
Each NBD is approximately 200 residues in length, possessing two highly conserved 
Walker A and Walker B sequence motifs (Michaelis and Berkower, 1995). These 
sequences are common to, and characteristic of, ATP-binding proteins. The Walker A 
motif is generally presented as being of sequence “GxxGxKS/T” where x is any amino 
acid. This is a general sequence and should not be considered as completely stringent 
for all proteins. The region is also known as the phosphate (P-) loop as it forms a 
direct contact with the a, (3 and y phosphates of ATP (Schneider & Hunke, 1998), and 
is a common motif in a number of ATP and GTP binding proteins, not just ABC 
transporters. The P-loop is also conserved in ATP synthases, the myosin head piece, 
many kinases including adenylate kinase, RecA protein, the ras oncogene product p21 
and the heterodimeric G proteins (Saraste et al., 1990). It should be noted that other 
proteins which have an ATP/GTP-binding capacity do so without a P-loop structure.
The Walker B site is less conserved with the consensus sequence of “Rx (g_gj(f)(t)(t)(})D” 
where ( j )  is any hydrophobic residue. The conserved aspartic acid residue is thought to 
interact with the magnesium of the Mg^^ATP complex (Michaelis and Berkower, 1995). 
In the native protein the Walker A site and the Walker B site are orientated so as to form 
a nucleotide-binding fold. The A site interacts with the phosphates while the B site 
stabilises the association by interaction with the Mg '^  ^ ion of the complex. While a 
lysine plays the critical role in the Walker A site an aspartate residue is central to the
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function of the Walker B motif. These residues, and others important in ATP binding, 
will be discussed below in the context of the crystal stmcture.
Between the two Walker sites lies a helical domain which is followed by a third 
conserved motif known as the “signature sequence”, or linker peptide, of the general 
sequence “LSGGQK/R/QR”. Some non-ABC transporter proteins also exhibit this 
sequence, such as the UvrA of E.coli and the EF-3 elongation factor of yeast (Higgins, 
1992). A fourth region within the NBD is the “centre region” which tends to be 
conserved among subsets of ABC proteins and hosts the CFTR phenylalanine mutation 
(AF508) that is most commonly associated with cystic fibrosis. Also, towards the 
carboxy terminus, after the Walker B site, lies a switch domain with the consensus 
XpH. While there is no clear appreciation of the functional significance of these regions 
they have proved useful for identifying other members of the family (Schneider and 
Hunke, 1998).
In early studies of the energy dependent transport functions it was not clear that ATP 
was the actual energy source. In 1974, Berger and Heppel (Bergher & Heppel, 1974) 
stated that ATP was the energy source for the transport of glutamine and several other 
amino acids by shock sensitive bacterial permeases. The key to this conclusion was 
that a loss of transport function occurred on mutation of the FgF^ATPase or dismption 
of the electron transport chain by arsenate. This apparently clear cut result was 
conflicted however by later studies of glutamine transport in other labs. Membrane 
potential (Plate, 1979), direct electron transport and the use of acetylphosphate (Hunt & 
Hong, 1983) as a source of chemical energy were proposed.
As research progressed, the use of additional uncouplers allowed a better definition and 
it again became clear that ATP was in fact the energy source. Dean et al. (Dean et al., 
1990) successfully studied the maltose transporter of E.coli in membrane vesicles using 
a number of chemical agents to disrupt or enhance particular physiological conditions in 
the model. They found that transport was always observed in the presence of a 
concentration of ATP or a functional ATP generating capacity. Experiments like this, 
coupled with the extensive characterisation of a nucleotide-binding site in the transport 
protein lead to confidence in ATP as the true energy source.
The elucidation of the structure and function of NBDs is best illustrated using current 
examples of well characterised systems, in particular the two solved structures of 
bacterial NBDs. These two proteins, as well as the NBDs of MDRl P-glycoprotein are 
currently the front runners in this field.
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ArsA is the ATP hydrolysing component of the E.coli ArsA/B heavy metal transporter. 
This protein complex is responsible for the active efflux of the toxic trivalent metalloid 
anions arsenite (As(III)) and antimonite (Sb(III)). The arsA gene encodes a 583 residue 
protein which exhibits two nucleotide binding folds termed A l and A2 and is thus 
equivalent to a fused dimer of NBDs. The hydrolysis of ATP by these domains is 
stimulated directly by the presence of arsenite or antimonite providing a system of 
positive regulation of nucleotide hydrolysis in the presence of the allocrite (Rosen et al., 
1999). It is, in part, the ArsA component of this transport complex that is beginning to 
unveil the necessity for two nucleotide-binding domains in the functional architecture.
The two ATP binding sites appear to interact (Li et al., 1996). This was first indicated 
when a mutant was generated that was sensitive to arsenite. This mutation is 
constituted by the substitution of Gly^ ® to Cys. A screen for silencer mutations which 
would restore the phenotype to this strain generated a second mutant where Ala^ "^  ^ was 
altered to valine. This suggests a physical interaction between these two residues which 
are located in the proximity of the A l and A2 NBDs respectively. Further substitutions 
in the area of Ala^ "^ "^  demonstrated that larger residues further increased the affinity for 
both antimonite and ATP illustrating the potential for physical interaction between the 
two nucleotide-binding lobes.
As well as the affinity for ATP, the ArsA binds the metalloid ions resulting in an 
allosteric activation of ATP hydrolysis. Antimonite is especially potent in this case with 
a concentration dependant induction of hydrolysis of between 10 and 20 fold. The 
binding site for antimonite was mapped by mutation of the four cysteine residues of 
ArsA. ArsA appeared to co-ordinate the Sb(III) ion within a pyramidal array of 
cysteines 113, 172 and 422. Mutation of any one of these residues substantially 
decreased the affinity for the metalloid. The feasibility of this conformation was further 
enforced when the distance between the thiol groups of the respective cysteines was 
mapped. Using the homobifunctional thiol linker dibromobimane the distance between 
the cysteine residues was proven to be 6Â (Bhattachaijee & Rosen, 1996), a distance 
consistent with the crystal structure of arsenite and antimonite bound to small molecule 
dithiols. The lengths of the As(III)-S Sb(III)-S bonds are 2.23Â and 2.45Â 
respectively. An inter-cysteine gap of 6Â allows the ion to be perfectly co-ordinated.
The interaction between the allosteric and catalytic sites of ArsA has been proposed to 
occur in the following way. The two NBDs within ArsA are independent with respect 
to mobility and are only connected by a 25 residue flexible linker region. In order for 
the aforementioned interaction to occur some sort of spatial constraint must force the 
two sites into close proximity. The co-ordination of the metalloid anion within the three
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cysteines pulls the two lobes of the ArsA protein together to achieve this (Rosen, et a l, 
1999). This is perhaps an over simplification however. The contribution of ATP to 
conformational change cannot be ignored. By monitoring changes in intrinsic 
tryptophan fluorescence it has been shown that the presence of MgATP is sufficient to 
induce a change in conformation. This is thought to be associated with the hydrolysis 
process as it is not observed with MgADP or with non-hydrolysable ATP analogues 
(Zhou & Rosen, 1997).
Fluorescence based techniques, including the measurement of variations in intrinsic 
tryptophan fluorescence, have been used to great effect in the dissection of the catalytic 
process of ArsA. Walmsley et al, have published detailed kinetic mechanisms for the 
hydrolysis of ATP. In so doing a more detailed scheme of the transient dynamics of 
conformational change has been assembled. For instance the rate-limiting step in the 
catalysis is a conformational change that occurs after hydrolysis and MgADP release. It 
is this conformational change that returns the molecule to the original state allowing it 
then to receive another MgATP. It is further proposed that the presence of the allosteric 
activator increases the rate of this conformational change thus increasing the rate of 
catalysis. The experimental evidence for this process is extensive and complex and is 
presented elsewhere (Walmsley et aL, 1999; Walmsley et a i, 2000).
Much of the biochemical observations of the mechanism of ArsA have now been 
explained on the publication of the 3D crystal structure of the entire protein, with bound 
MgADP and Sb(III), at 2.3Â resolution (Zhou, et a i, 2000). The homology in amino 
acid sequence between the two domains is reflected in the structure. Each NBD is "L" 
shaped with each arm extensively a-helical in composition. The binding site for the 
antimonite is distinct to that of MgADP, lying in the upper half of the protein, close to 
the linker peptide. There appears to be three clustered Sb(III) ions in ArsA. Both the 
ATP/ADP binding sites were occupied and positioned in close proximity in the lower 
half (see Figl.3). The two P-loops are only 8Â apart at the closest point. As 
suggested by the earlier experiments, each nucleotide-binding site involves residues 
from the other domain. A l relies on local residues for interactions with the a-and p- 
phosphates and Mg^^ of the ADP. However, two threonine residues (Thr501 and 
Thr502) of A2 are involved, Thr50I hydrogen bonding with a hydroxyl group of the 
ribose structure and Thr502 with the p-phosphate. The A2 binding site is similar to the 
A l in that it also relies on some input from Al residues. In this case the proximity of 
the interacting A l residues is less pronounced with Ser210 positioned 6Â away from 
the p-phosphate. This is thought to give the A2 binding site an open conformation 
allowing easier access for the nucleotide than A l. This supports earlier biochemical
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suggestions that A l has a high affinity site with a low turnover while the affinity of the 
A2 P-loop is lower and more processive (Kaur, 1999).
The metalloid binding site does arise from the co-ordination of the anion by a number of 
cysteine residues, but not in the way previously suspected. Rather than a single metal 
ion co-ordinated by 3 Cys residues, 3 metal ions appear to be present, each anchored by 
2 residues only. Indeed, one of the metal ions has no Cys associated, interacting with 
H148 and S420. The second Sb(III) involves C l 13 and C422 and the third C172 and 
H453. Thus the metal binding site of ArsA requires residues from both A l and A2 and 
is not entirely cysteine dependant as first thought.
The allosteric activation of the ArsA ATPase activity on metal binding requires a signal 
transduction mechanism. The metal and ATP binding sites are too far removed to 
warrant any direct interaction. The crystal structure suggests an internal signal 
transduction adapter for each ATP binding site. At the upper, metal ends of the 
transduction paths are the histidines H148 and H453. Each serves A l and A2 
respectively. A stretch of 7 residues connects the ATP binding site to the metalloid 
binding site (D142/447TAPTGH, . The D142 and D447 residues co-ordinate with
the Mg^ "^  ion via a water molecule and it is proposed that, when MgATP is bound, this 
interaction (prompted by metalloid binding) will induce ATP hydrolysis.
The Salmonella typhimurium histidine transporter represents not only the first ABC 
transporter to be identified but also the first transporter for which a component has been 
solved structurally. The histidine permease was first noted in 1970 (Ames & Lever, 
1970) simply as a protein related to histidine acquisition. On the discovery of 
associated membrane components (Ames & Nikaido, 1978) the His transporter 
complex proved to be an ABC transporter belonging to the Gram negative bacterial 
periplasmic permeases. This group of proteins is now very well characterised. The 
currently accepted organisation for the histidine permease is that of an oligomer 
composed of four separate subunits making up a functional ABC transporter. A 
heterodimer of two membrane spanning domains (HisQ and HisM) is coupled to a 
homodimer of the nucleotide binding domain, HisP, this providing the organisation of 
HisQM?2 (Kerppola et al., 1991). The biology of the HisP component has been the 
focus of research in recent years and a wealth of information has emerged. This has 
been complemented by the elucidation of the 3D crystal structure of the protein in 1998 
(Hung, et a l, 1998)
The study of the biochemistry of HisP was made increasingly possible by the 
purification of recombinant soluble HisP. The production of this protein in this way
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had proved very problematic previously because of its tendency to be insoluble on over­
expression. Indeed even in the aforementioned crystallography publication the pure 
recombinant HisP displayed a tendency to aggregate in solution even in the presence of 
detergents and could be partially stabilised using high concentrations of ATP and 
glycerol (Nikaido, et al., 1997). The recombinant HisP displayed a high intrinsic rate 
of cation-dependant ATP hydrolysis, implicating the membrane HisQM components in 
a negative regulatory role. The HisP preparation appeared to be in a dynamic 
equilibrium between dimer and monomer states with the distribution between the two 
states being concentration dependant.
The ATPase activity of HisP in the context of an intact permease has been investigated 
(Liu et al., 1997). The ATPase activity of the complex under various conditions was 
examined using a Mg^^ permeabilised proteoliposome system. It was found that a 
degree of co-operativity existed between all components and a high elevation in the rate 
of ATP hydrolysis was observed in the presence of a ligand coupled HisJ protein. HisJ 
is the periplasmic binding protein that directs the substrate to the permease across the 
periplasmic space. It had been proposed that the binding of this molecule to the 
permease complex would induce hydrolysis and this was indeed the case. This 
induction was specific to liganded HisJ as free histidine or unliganded HisJ had no 
effect when used alone or in competition assays with liganded HisJ.
Thus a picture begins to emerge regarding the regulation of NBD mediated ATP 
hydrolysis in relation to the membrane components of the permease and the presentation 
of the ligand. Free HisP displays a high level of ATPase activity even in the absence of 
liganded HisJ. This is not the case in the HisQMP^ complex where ATP hydrolysis is 
inhibited except on association with liganded HisJ. The structural organisation of the 
entire complex is unknown so the spatial organisation of the components cannot be 
surmised. It has been proposed that the HisP dimer emerges through the HisQM 
component to display motifs on the periplasmic face of the plasma membrane (Baichwal 
et al., 1993). Some have suggested the HisQM dimer is not only a regulator of ATP 
hydrolysis but is also protective, shielding the hydrophilic HisP from the lipid 
environment. Supporting evidence for this is the fact that the ATPase activity of HisP 
is inhibited in the presence of most phospholipids (Liu & Ames, 1998).
The relationship between substrate presentation and ATP hydrolysis has been 
reinforced by recent work involving the maltose ABC transporter of E.coli. The 
inhibition of maltose transport by vanadate occurs on the trapping of an ADP molecule 
in one of the nucleotide-binding folds. Vanadate does so by mimicking the transition 
state of the y-phosphate of ATP during hydrolysis. The consequence of this trapping is
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a high affinity association between the periplasmic maltose-binding protein (MBP) and 
the transporter and the loss of maltose affinity by the MBP (Chen, et al., 2001). It 
would appear that the periplasmic binding protein is not merely a delivery system. It 
also stabilises an ATP hydrolysis transition state stimulating ATP hydrolysis.
As previously mentioned the crystal stmcture of HisP has been solved. This high 
resolution stmcture (1.5Â) shows the protein to be “L” shaped, having two thick arms 
(ARM I and ARM II) (Figl.3). ARM I is predominantly p sheet with the nucleotide 
binding fold positioned at the bottom. A detailed analysis of the nucleotide-binding fold 
allowed the elucidation of the role of particular residues in hydrogen bond formation 
and water molecules co-ordination in the stabilisation of the ATP molecule. This P- 
loop region wraps around the p phosphate of the ATP to form extensive hydrogen 
bonds between the main chain nitrogens and the oxygens of the phosphates. A lesser 
degree of association is observed for the a  and y phosphates. The stmcture had no 
included cation as the presence of Mg^ '*' promotes catalysis of the ATP which would 
thus negate the possibility of acquiring the structure. The residues implicated in the 
ATP interaction in the crystal stmcture concur with previous point mutants that were 
unable to bind ATP.
The second arm is mainly a-helices and contains the conserved “LSGQQQRV” 
signature motif and is proposed to interact with the HisQM membrane component. The 
role of the signature motif remains unclear but mutation in this region greatly reduces 
the processivity of the permease. It may be involved in the signalling of liganded HisJ 
binding to the outer face of the transporter. A number of other ARM II residues, 
outside of this region, have been mutated and these mutants release HisP from the 
negative control of HisQM, so the regulation cannot be due solely to the signature 
motif. Alternatively, this motif may be cmcial for HisP folding.
In keeping with previous studies on soluble HisP, the majority of protein present in the 
crystalline form was monomeric. Dimeric forms were found and a presentation of this 
organisation can be seen in Figl.3. Interaction between the two domains occurs at a 
region of surface hydrophobicity, via the anti-parallel (3-sheet on the outer face of ARM 
I. The negatively charged Asp 11 is stabilised in some way but it is not clear whether 
this is through protonation or binding of a metal ion. Nevertheless, this represents an 
energetically unfavourable status and it is likely that the dimer is further stabilised on 
interaction with the HisQM dimer.
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Sb(lll) site
A1NBS A2NBS
B
ARM II
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F ig  1.3
The structures o f the A TP hydro lysing  dom ains o f  ArsA (A) and HisP (B). Taken from (Zhou, et a i ,  2 0 0 0 ) 
and (Hung, et a i ,  1998) respectively. H isP is show n in the dim eric form.
The crystal structure strongly supports the idea of dimérisation that has long been 
suspected for HisP. In keeping with findings for ArsA, it would appear that the two 
NBDs in the HisPj complex interact to promote hydrolysis of ATP. Nikiado and Ames 
recently demonstrated that only one functional NBD was necessary to fuel the 
translocation process and that the second NBD served to activate this hydrolysis by 
interacting with the hydrolysing fold (Nikaido & Ames, 1999). This role would appear 
interchangeable within the dimer as the system with only one functional hydrolysing 
domain catalysed at half the rate observed for the wild type complex.
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The majority of information regarding the NBDs of eukaryotic transporters concerns 
MDR P-glycoproteins. The MDRl protein was associated with a drug resistant 
phenotype when it was seen to be over-expressed in drug resistant human cell lines 
(Juliano & Ling, 1976). The ATPase activity of MDR 1 was predicted later on the basis 
of homology with the NBDs of bacterial permeases and the realisation that there is a 
predicted P-loop in the amino acid sequence (Chen et al., 1986). A number of similar 
genes have been found in humans and other mammals including mice. The MDRl is 
expressed as an entire transporter with two NBDs, each NBD possessing one ATP 
binding fold (Higgins, 1992).
The recombinant expression of the N-terminal NBD (395-581) of murine MDRl 
allowed the calculation of a millimolar for ATP and demonstrated a functional 
ATPase activity. This affinity was enhanced to micromolar concentrations when the 
binding study used the ATP analogue 2',3'-0-(2,4,6-trinotrophenyl) (Dayan et at.,
1996). The stoichiometiy of substrate transport versus ATP hydrolysis was initially 
measured at a near 1:1 ration of drug to ATP. The uptake of a ^^Rb^-valinomycin 
complex into vesicles indicated between 0.5 and 0.8 molecules of drug per ATP 
hydrolysed allowing the accumulation of ^^Rb  ^to intra-vesicle concentrations of 8mM 
(Eytan et a i,  1996). As we shall see later, this would appear to be an underestimation 
in the light of more detailed kinetic analysis.
The use of fluorescence based spectroscopic techniques in ligand binding assays is 
made possible using fluorescent substrate analogues of ATP, such as MANT-ATP/ADP 
or TNP-ATP/ADP. These molecules a low level of fluorescence in free solution but 
when bound, and shielded from the quenching effect of bombarding water molecules, 
will give a greater, measurable fluorescence output. Experiments have been performed 
using a GST-MDRl (NBD2) fusion protein, produced in E.coli, which bound both 
TNP-ATP and TNP-ADP. The resultant blue shift reported the incorporation of the 
substrate into a hydrophobic environment. Affinities for the ATP and ADP analogues 
were calculated at 1.8pM and 2.3pM respectively. As with 2 ',3 '-0 -(2 ,4 ,6 - 
trinotrophenyl), the affinities of the analogues are considerably higher than for ATP or 
ADP (Sharom et al., 1998).
The elucidation of the catalytic mechanism of ATP hydrolysis by P-glycoprotein has 
been a complex endeavour. Misleading deductions such as the variable estimations of 
ATP hydrolysis to drug transport stoichiometry, have hampered the rate of progress. 
The issue has been further complicated by the implications of substrate and modulator 
interactions which appear to alter the rates of catalysis. Sauna and Ambudkar have 
recently published two papers that go some way towards claiifying the issue. A more
30
Chapter 1
definitive dissection of the catalytic events on substrate translocation indicates that two 
ATP molecules are required for the translocation of a single substrate molecule (Sauna 
& Ambudkar, 2000). The dynamics of the ATP interactions and the sterical 
consequences of hydrolysis would appear to answer the question of communication 
between nucleotide-binding sites and substrate-binding sites. In their recent work these 
authors use both radio-labelled ATP and the Pgp substrate lodoazidoprazosin (lAAP) to 
track events at both sites. The catalytic cycle that leads to substrate translocation is very 
interesting. Initially, recruitment of an ATP molecule to either of the two NBDs is 
random. The binding of the ATP at one site prohibits nucleotide binding at the second 
site but greatly increases the affinity for the drug substrate. ATP hydrolysis of this 
initial bound molecule results in the release of a phosphate and the drug on 
translocation. This in turn conveys a greater affinity to the second NBD for ATP. The 
ensuing second ATP hydrolysis event serves not to transport drug but to reset the Pgp 
into a conformation that restores its high affinity for substrate (Sauna & Ambudkar, 
2001). This raises two interesting points. Firstly, ATP hydrolysis does not strictly 
“energise” drug transport but rather imposes an intra-molecular communication that 
mediates the degree of affinity at the drug-binding site. Thus we have a dynamic 
release and capture mechanism. Secondly, it would appear that every other hydrolysis 
event does not result in substrate transport but in a re-setting of the conformation of the 
transporter.
The previous work indicates that communication between the two NBDs is essential. 
We have noted from the crystal structure of ArsA that amino acids from both NBDs 
play a role in each NBD. The likelihood for a similar strategy in P-glycoprotein is high. 
The spatial proximity of the two NBDs was recently demonstrated by disulphide cross- 
linking. Several mutations in the Walker A sites of both NBDs were generated 
resulting in the substitution of wild-type residues for cysteine. Following oxidative 
cross linking of the mutant Pgp two mutant forms were found to cross link; 
G427C(NBD1)/Cys-1074(NBD2) and L439C(NBD1)/Cysl074. The latter mutant 
retained significant drug stimulated ATPase activity and was studied further. It was 
discovered that cross linking of this form could be inhibited by MgATP suggesting an 
alternate “open” conformation in the presence of ATP and a closed conformation in the 
absence of nucleotide (Loo & Clarke, 2000).
As suggested above, the binding of additional molecules to NBDs can alter the rate of 
ATP hydrolysis, extent of nucleotide-binding or indeed the affinity or accessibility for 
transported substrate. While ATP hydrolysis results in substrate transport, the presence 
of a transported molecule, or a modulator with similai' structure, can alter the rate of 
ATP hydrolysis. This has been demonstrated for a number of molecules. Initially it
31
Chapter 1
was shown that the addition of the anti-cancer drug verapamil dramatically increases the 
rate of ATP hydrolysis. The phenomenon of drug stimulated ATPase activity for Pgp 
is now well documented (Loo and Clarke, 2000). Additional modulators, such as 
flavonoid compounds have been shown to interact with the C-terminal NBD of murine 
Pgp affecting reducing the binding of nucleotide (MANT-ATP) and steroid molecules 
(Consiel et al., 1998). Steroid molecules can be transported by M drl depending on 
their size. Indeed larger steroids, such as antiprogestin RU 486, aie used to combat 
Pgp mediated drug efflux. This lead to the conclusion that flavonoids overlap distinct 
ATP and steroid binding sites. This has been demonstrated not only for M drl but also 
the major drug transporter of S.cerevisiae, Pdr5 (Conseil etal., 2000). In this case the 
binding of nucleotide is less affected but drug-binding (rhodamine 123) was severely 
perturbed. The binding of daunomycin to an ABC transporter of Leishmania tropica 
has been shown to by reduced by modulation by t derivatives of the flavonolignan 
silybin (Perez-Victoria, et a i, 2001)
1 . 2 .3  The Membrane Spanning Domain (MSD)
Information on the membrane spanning modules of ABC transporters is far less than 
that for NBDs. The main reason for this is the difficulty in producing functional 
recombinant protein for biochemical study. Investigators must proceed through a 
lengthy and rigorous program of purification, solubilisation and reconstitution of 
membrane proteins stabilised in membrane or detergent environments. The yields of 
these proteins are usually far less than those obtained with the soluble cytoplasmic 
domains. As discussed below, this has hampered progress in this area but has not 
ruled it out completely.
Early predictions of protein structure gave rise to the “two-times-six” helix paradigm. 
That is, the majority of transporters will possess two domains each composed of six 
membrane spanning a-helices with the C- and N-termini on the cytoplasmic face of the 
membrane. This results in three extracellular and two intracellular loops (see Fig 1.2) 
(Higgins, 1992). This notion was supported by the binding of epitope specific 
antibodies to the outer face of P-glycoprotein. These epitopes lie on the glycosylated 
sites on predicted extracellular loops (Zhang & Ling, 1991). However, even in the 
early stages of research in this area a few anomalies were noted. MalF of the bacterial 
maltose transporter has two additional N-terminal helices but these can be deleted 
without loss of function. On the other hand the HisQ and HisM proteins have only five 
helices each (Higgins et al., 1982). As we shall see the “two-times-six” paradigm is 
now only considered a basic and general guide as most well studied proteins show 
some degree of departure from this organisation.
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In contrast to the NBD, conservation of sequence amongst MSDs is not notable. 
Homologues between species are often highly conserved but comparisons between 
MSDs of different proteins shows considerable diversity. In some cases, where the 
membrane component of the transporter is a heterodimer such as in the HisQ/HisM 
complex, each distinct half relates well to the other suggesting a possible gene 
duplication (Higgins et al., 1982). Given that ABC transporters are thought to have a 
common evolutionary origin, it is probable that the functional role of the MSD can be 
satisfied by a number of amino acid compositions. It may be that gross structural 
properties play a more important role than any local specifics relating to amino acid side 
chains. The constraints on mutation would therefore be lessened. The formation of an 
MSD pathway is generally considered to require the circular organisation of 12 
amphipathic helices. This could be provided by several sequences.
A conserved motif has been noted in the MSDs of some ABC transporters including 
the bacterial periplasmic permeases. This region spans at least 20 residues, is of the
sequence “EAA—G--------- I-LP”, and is located on the cytoplasmic face of the
membrane. Mutating this EAA region in MalF and MalG has different effects on the 
activity of the maltose permease. While there is inequality in the roles of the sequence 
in both proteins, the simultaneous mutation of both totally perturbs function (Mourez et 
al., 1997). The structure of HisP suggests that the signature motif of the NBD is 
involved in communication with the MSD, It is possible that it is the EAA motif that 
interacts in this case. This is supported by the fact that mutations in the putative helical 
domain of the MalK ATPase can suppress the mutant MalF/MalG phenotypes. The 
physical interaction between the MalK helix and MalF and MalG has been demonstrated 
in proteolysis protection experiments. Trypsin digests of free MalK demonstrates a 
trypsin digest site in this helix. The addition of MalG and MalF in inverted membrane 
vesicles protects this particular protease site from digestion (Mourez et al., 1998). It is 
possible that the communication from one MSD affects only one NBD fold. The limited 
detrimental effect of mutating one of the two EAA’s mirrors the limited effect of 
mutating one of the ATPase folds of HisP where the ATPase activity is reduced to half 
the maximal rate (Nikaido and Ames, 1999).
The simplest conception of the MSD is that of a pore or channel for substrate transit. 
The transport of hydrophilic moieties across the lipid barrier fits well with this notion. 
Indeed studies of the CFTR channel have contributed in supporting this idea. The 
channel of this protein was probed by cysteine scanning mutagenesis. The 24 residues 
of the sixth TM were mutated individually and in turn to cysteine and the accessibility of 
these residues assessed. The addition of the hydrophilic compound sulphydryl
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methanethiosulphonate (MTS) compounds would modify exposed cystiene sulphydryl 
groups and reduce chloride ion conductance. The mutation of 11 of the 24 residues 
reduced the function of the transporters in Xenopus oocytes indicating that these 
residues were exposed on the pore lining surface of the channel. By varying the size of 
the MTS molecule it was calculated that the diameter of the pore was at least 6Â to the 
depth of Gln353 which is predicted to be the deepest of the positively modified residues 
(Cheung & Akabas, 1996). A broader view of important residues in the CFTR channel 
implicates prolines as key components but not necessarily as pore lining residues. The 
mutation of the 4 prolines in the CFTR MSD resulted in a reduction in the concentration 
of mature protein produced in HeLa cells. The conductance of any single channel was 
also affected with each mutant showing a reduced figure in comparison with the wild 
type protein. Different amino acids introduced at Pro^  ^had varying effects with glycine 
producing a minimal alteration while lysine and alanine induced very significant 
reductions in conductance . It would thus appear that these four proline residues play 
an important role in the stabilisation of the functional architecture of the pore although 
their precise orientation within that pore is unknown.
In many ABC transporter mediated processes it is hydrophobic substrates that are 
transported rather than hydrophilic. In these cases the simple notion of amphipathic 
helices providing a central hydrophilic core is not so appropriate. MDR in cancer cells 
requires the efflux of hydrophobic drugs such as vinca-alkaloids while antifungal 
resistance in pathogenic yeasts requires the transport of compounds such as azoles. 
Intestinal tract bacteria like E.coli encounter and efflux toxic bile salts and fatty acids. 
How are these transported through a hydrophilic channel? It has been suggested that 
the lipophilic nature of these compounds and their accumulation in the membrane allow 
some transporters to act as “hydrophobic vacuum cleaners”. In this model the 
transporter would sequester the substrate peripherally from the inner leaflet of the lipid 
bilayer and into the pore for translocation (Bolhuis et al., 1997). However, this only 
satisfies part of the problem, substrate acquisition. What about the interior of the pore? 
The suggestion that ABC transporters including MDR I are involved in membrane 
physiology may hold the key. Pgp has been suggested to be a membrane flippase, 
transferring phosphotidyl choline from the inner to the outer leaflet of the bilayer 
(Higgins & Gottesman, 1992). It has been postulated that the pathway of drug efflux is 
similar and that the pore does not really exist but the substrate passed on the side of the 
MSD within the lipid bilayer. The recruitment from the membrane is supported by the 
observation that the MSDs of P-glycoprotein can bind drugs in the absence of the 
ATPase. Deletion construct analysis showed that when the two MSDs were fused and 
expressed alone in HEK239 cells they interacted with verapimil, vinblastine, caspiacin 
and cyclosporin A (Loo & Clarke, 1999).
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More detailed biochemical investigations required in the over-expression and 
purification of Pgp. This was first reported by Dong et al. (1996), who purified P- 
glycoprotein from overproducing cell lines, retaining 70% of the starting material at 
99% purity. This was achieved by extracting the protein from cells in SDS followed by 
buffer exchange into a dodecyl-maltoside containing buffer. This detergent solubilised 
protein was then reconstituted into lipid bilayers and was shown to possess an ATPase 
activity that was enhanced by verapimil and other drugs. A later adaptation of this 
procedure has permitted structural analysis by electron microscopy. It is now certain 
that a central pore exists in Pgp as image analysis has allowed the low resolution 
structure (2.5nm) to be visualised. The protein is a cylinder, lOnm in diameter, with a 
large central aqueous pore or pit (about 5nm in diameter) that is closed on the 
cytoplasmic face of the membrane. The depth of the protein is approximately 8nm, 
twice that of the lipid bilayer. While the cytoplasmic face is closed there is an opening 
on the side of the pore which allows access to the lipid bilayer supporting the flippase 
model (Rosenberg et al., 1997).
In keeping with the ongoing controversy regarding the translocation strategy, the 
topography of the twelve transmembrane spans is also in question. Early work on the 
topography of these segments was achieved using fused reporter molecules to putative 
loops of the MSD. Geller et al. (1996) used topogenic reporters to study the topology 
of the N-terminal half of yeast STE6 in both E.coli and S.cerevisiae. In this technique 
the STE6 gene segment was fused to either alkaline phosphatase (in E.coli) or invertase 
(in S.cerevisiae). Alkaline phosphatase is active only when extracellular and invertase 
is heavily glycosylated when expressed extracellularly. Only this glycosylated form 
allows growth of the yeast on sucrose. This extracellular/ intracellular distinction 
makes these proteins ideal for topology studies. The result of this study was proposed 
as proof that the N-terminal MSD of the STE6 gene did contain a typical six helix 
organisation when expressed in the yeast or in recombinant E.coli. The use of a similai' 
approach with Tapi, fused to a p-galactosidase reporters, illustrated the unconventional 
arrangement of 8 membrane spanning segments with large loops that would be exposed 
on the lumen face of the endoplasmic reticulum (Gileadi & Higgins, 1997). This was 
later confirmed using immunological techniques allocating 8 TMs to TAPI and 7 to 
TAP2. In addition this study has proposed a three domain organisation for each TAP 
molecule with an MSD and cytoplasmic peptide-binding domain and a NBD (Vos et al.,
1999).
The early experiments may have provided an over simplistic view of the assembly and 
orientation of MSD components. The most common models involve simple mirror
35
Chapter 1
symmeti-y of each set of six spanning segments. This gives a head-head/tail-tail 
orientation. In other words TMI of the first MSD module is positioned close to TM l of 
the second. Some recent papers continue to report biochemical data supporting this 
organisation. In the TAP1/TAP2 heterodimer complex, TM6 of TAP is stabilised and 
anchored in the membrane through the influence of the teiminal TMs (TM4 +TM5) of 
TAP2. It is proposed that this interaction will require local interaction between these C- 
terminal MSD components thus supporting tail-tail interactions (Vos et al., 2000). This 
is corroborated by cysteine cross-linking experiments with Pgp in which cysteines 
introduced to TM6 cross-link with T M l2 (Loo and Clarke, 2000). This work focused 
on the fact that this cross-linking inhibits the ATPase activity implicating TM6 and 
TM12 in intra-molecular communication with the NBDs. It would appear that the 
cross-linking status of certain residues along the TMs was dependant on the occupation 
of the NBD by ATP suggesting that the two TMs move on hydrolysis. This cross- 
linking supports the head-head model.
A recent challenging review by Jones and George (Jones & George, 2000) presents a 
radically alternative model for MSD organisation in light of current advances that casts 
confusion on the results of the cross linking data. The essential point to the challenge 
of the head-head organisation is that the general round pore structure seems impossible 
in this model. If we accept that the overall stmcture of each MSD domain is similar 
then a head-head/tail tail channel would be shaped “((“ rather than the required “O”. 
The authors point out that the images of P-glycoprotein from the EM study clearly show 
an “O” pore. This can only be achieved with rotational head-tail/head-tail symmetry 
with TMl being located beside TM l2 and TM6 beside TM7. This would appear to 
contradict the cross-linking data. In response this apparent inconsistency a third 
symmetry form has been proposed, that of a “cyclone” pore. In this case the two MSD 
domains are opposed as in the mirror symmetry model but mis-aligned so that the pore 
arises only from TM4-6 and TMlO-12 (Loo & Clarke, 2000). While this brings the 
TM6  and TM l2 closer together it is questionable if it is close enough to reconcile the 
cross-linking data. Additionally, it seems unlikely that the substantial pore observed in 
Pgp could be formed by only 6 participating TMs.
The aforementioned radical topology of Jones and George relinquishes all notion of the 
two-times-six paradigm and forward the possibility that the TMs of ABC transporters 
are not truly a-helices. In this model the transporter has two pores in a double (3-barrel 
organisation, each formed by the individual 6TMs of each MSD domain This dual 
channel model has some similarity to the outer membrane porins of Gram negative 
bacteria. The authors liken this stmcture to a “two stroke two-cylinder combustion 
engine”.
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1 . 2 .4  The fungal ATP-binding cassette transporters
ABC transporters are universal and a number of key physiological process in fungi rely 
on the activities of this class of protein. S.cerevisiae, the first eukaryote for which the 
genome was entirely sequenced, has 31 genes encoding ABC transporters. (Bauer et 
a i,  1999; Decottignies and Goffeau, 1999). Screening and gene cloning experiments 
on other fungi has resulted in the identification of homologues throughout the genera. 
The best characterised of these systems tend to be those associated with multidrug 
resistance but other major functions include heavy metal resistance, organelle function 
and biosynthesis, protein synthesis and pheromone secretion. Many of these 
transporters display a considerable homology to those involved in human disease. The 
opportunity to use this convenient organism and its transporters as model systems for 
higher eukaryote processes has been embraced.
The ABC transporters of fungi have been characterised into a series of subfamilies 
based on sequence homology. The majority of transporters are grouped in the MDR 
and PDR subfamilies. MDR subfamily members display a considerable homology to 
mammalian Pgp while the PDR (Pleiotropic Drug Resistance) group are more 
distinctive as fungal proteins. Interestingly, it is the PDR subfamily rather than the 
MDR that is responsible for the bulk of drug resistance in S.cerevisiae (Balzi and 
Goffeau, 1995) and C.albicans (Cowen et al., 2000). Other transporters belong to the 
MRP, ALDp, YEFl and RLI subfamilies as described below (Bauer, et ai, 1999).
In S.cerevisiae there are four members of the MDR subfamily. The most studied by far 
is STE6 , the transporter responsible for the excretion of a-factor pheromone from 
haploid MATa cells. On screening mating deficient mutants, a strain was observed that 
produce pro-a-factor and mature a-factor intracellularly. This strain was termed ste6 
and the mutated gene was cloned and sequenced. It was found to encode a 1290 
residue polypeptide (STE6) with considerable homology to P-glycoprotein (Kuchler, et 
al., 1989). The protein is arranged in an MSDI-NBD1-MSD2-NBD2 manner constant 
with this homology.
Recently a 1323 amino acid homologue (HST6 ) was cloned during a ste6A 
complementation study using an expression library derived from C.albicans. It would 
appear that C.albicans uses a very similar mechanism for pheromone release. As with 
STE6 , HST6 was expressed only in haploid cells of S.cerevisiae as the promoter 
element that facilitates repression of these genes in the diploid yeast is present. 
However, the gene is constitutively expressed to a high level in all forms of C.albicans
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cells suggesting that the function of this protein may be different or that it has attained a 
more pleiotropic role in the pathogenic fungus (Raymond et al., 1998).
The other characterised member of the MDR subfamily is ATM l, until recently 
S.cerevisiae’s only known mitochondrial ABC transporter. This is a half transporter 
that appears to be responsible for the export of Fe-S proteins from the mitochondrial 
matrix, including cytochromes. An atmlA  strain lacks all of the major cytochromes and 
accumulates high levels of free iron. Additionally, this strain is unable to use non- 
fermentable carbon sources. This protein has a human homologue, hABC7, that 
appears to mediate the X-linked disease sideroblastic anemia with spinocerebellar ataxia 
(Bauer, et al., 1999).
Two other half transporters are also grouped with the MDR class, MDLl and MDL2 
(SSHl). The genes for these were isolated and cloned in 1994 following the 
application of degenerate PCR primers designed to target conserved sequences in genes 
of this type. Deletion mutants of both mdll and mdl2 showed no reduction in growth 
so these genes are not essential for viability (Dean et al., 1994). A number of 
investigators carried out follow up experiments in attempts to ascribe function to these 
proteins but could not progress (Susan Michaelis; personal communication). Very 
recently, in closing stages of the writing of this thesis, MDLl was shown to be 
responsible for the transport of oligopeptides from the yeast mitochondrion. It would 
appear that the cleavage of proteins by the mitochondrial m-AAA protease provides 
substrate for a 200kDa complex including MDLI. This complex can transport the 
oligopeptides through the mitochondrial inner membrane. The transport function 
MDL2 was also found to be evident in the membranes of mirochondria but was part of 
a larger independent 300kDa complex. Deletion analysis demonstrated that the MDL2 
function was different than that for MDLI and it would appear that MDL2 does not 
facilitate oligopeptide transport (Young et al., 2001).
The PDR subfamily is the most studied in fungi. These proteins are involved in drug 
resistance and cellular detoxification and are the most numerous in the yeast genome. 
In addition to ABC transporters, the PDR network now has a number of associated 
regulatory proteins that control the expression of the ABC proteins. This important 
class will be discussed below in more detail along with fungal drug resistance.
Of the 7 proteins that appear to belong to the MRP subfamily, only two have been 
characterised to any degree, YCFl and YRSl (Yorl). Initial indications that MRP like 
proteins could be found in yeast was the detection of the transport of glutathione 
conjugated substrates into the secretory vesicles of a secretion deficient strain. The
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protein responsible was found to be YCFl, a 1515 residue MRPl homologue. YCFl 
also has a weak homology to CFTR as it possesses a rudimentary R domain. It would 
appear that YCFl transports not only organic glutathione conjugates into the vacuole 
but also glutathione associated toxic metal compounds. It has been shown that this 
protein is responsible for the sequestration of divalent cadmium, arsenite, antimonite 
and arsenate ions conveying heavy metal resistance to yeast. YRSl, or YORl, was 
cloned in a complemetation study in a reveromycin sensitive strain. The yrslA  
knockout strain showed increased sensitivity to this cell cycle arresting drug. Screening 
a number of anions revealed that YRSl shared Y C Fl’s ability to transport cadmium. 
Additionally, YRSl can translocate a wide number of organic anions containing a 
carboxyl group (Cui, et a l, 1996). A third protein, BATl, has also been identified that 
is competent in the transport of bile acids. This can not be the true physiological role in 
yeast cells but it does introduce BATl as a candidate for studying homologues involved 
in bile acid transport in mammals (Bauer, et a i, 1999). The remaining 4 ORFs have 
not been characterised and are represented only by submissions to the sequence 
database. Two of these ORFs (YLL015w (Z73120) and YHL035c (U11583)) appear 
to have the typical (MSD-NBD)^ organisation. YKR103w and YKR104w (Z28328 
and Z28329) appear anomalous as MSD-NBD-MSD and NBD only, respectively.
The two proteins of the ALDp subfamily ^-oxidise long chain fatty acids and are 
homologs of the components of the human peroxisome adrenoleukodystrophy factor. 
Co-immunoprecipitation demonstrates that these two half-transporters PXAl (or PAT2) 
and PXA2 (or PATl) form a heterodimer. PXA2 is a fairly stable protein but PXAl 
tends to degrade in the absence of PXA2. The complex has been hypothesised to form 
a peroxisomal fatty acyl-CoA transporter (Hettema et al., 1996; Shani et al,, 1996; 
Shani et al., 1995). The YEF3 and RLI subfamilies are the least characterised. These 
proteins have no TMs and their location within the cell remains unestablished. YEF3 
may act as an elongation factor and function at the ribosome and exhibits ribosome 
stimulated ATPase activity. GCN20 has been implicated in the regulation of amino acid 
utilisation interacting with a cascade that modulates elongating ribosomes. All other 
members of these families are appreciated only as ORFs and are of unknown function 
(Bauer, et a l, 1999).
1 , 2 .5  Fungal drug resistance and ABC multidrug transporters
With very few exceptions, antibiotics used in the treatment of fungal disease tend to 
target the wall of the fungal cell. Treatments gain specificity by directly or indirectly 
taigeting ergosterol, the bulk sterol in the plasma membrane. In mammalian cells it is 
cholesterol that fills this role. Ergosterol is critical for a number of membrane functions
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including fluidity, optimal cell division and the efficient activity of integral membrane 
proteins including chitin synthases. Antifungals act directly on fungal cells by 
interacting with ergosterol or by interrupting the ergosterol biosynthesis pathway and 
promoting defective membrane production and function (White et a i, 1998).
Only one therapeutic drug, 5-flucytosine, acts on targets that aie not associated with the 
cells wall. 5-FC is taken up by fungal cells by a cytosine permease and then 
deaminated to 5-fluorouracil by a fungal specific cytosine deaminase. The fluorouracil 
is then converted to 5-fluoro-dUMP, a thymidylate synthetase inhibitor, or 5-fluoro- 
UTP that is incorporated into mRNA and disrupts protein synthesis. Resistance to this 
drug is widespread and it is rarely administered as a sole therapy. This resistance arises 
from a defect in the cytosine deaminase synthesis (Vanden Bossche et al., 1997).
Direct targeting of the ergosterol is performed by polyenes, the most common of which 
is amphotericin B. These molecules are amphipathic allowing efficient ergosterol 
dependant intercalation with the membrane. The resultant porosity of the membrane 
results in the leakage of cellular components, especially potassium ions, and the 
breakdown of the proton gradient (Vanden Bossche et al., 1994). Polyenes are not 
known to be substrates for ABC transporters. Resistance is not a common occurrence. 
This may be due to the lower frequency of chnical use. Amphoterecin B cannot be 
administered orally and usually requires a program of injections making its widespread 
application logistically difficult. Instances where resistance has been noted tend to be in 
severely immuno-compromised patients such as cancer sufferers.
As the precise mechanism of action of polyenes is unknown the elucidation of the 
specific causes of resistance is not possible. It will probably involve some modification 
of the plasma membrane composition as has been noted in resistant strains of Candida 
spp. and Cryptococcus neoformans with a marked reduction in the ergosterol content 
(White, et a l, 1998). Unfortunately, the basis for this variation in biosynthesis is hard 
to pin down as mutations in biosynthetic enzymes are variable in each isolate examined. 
It is probable that the interaction of polyenes requires a defined sterol to phospholipid 
ratio (Broughton et al., 1991). Any mutation that alters this ratio will be beneficial so 
the range of mutations available is large.
More popular are the drugs involved in the interruption of ergosterol biosynthesis. 
Ergosterol is produced from squalene, a sterol precursor produced from acetate and 
acetyl co-enzyme A. The biosynthetic pathway involves the modification of squalene to 
lanosterol to ergosterol in a pathway involving 10 separate enzymes. Drugs which act 
on this biosynthetic pathway do so at several intermediate steps and are of four major
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groups; ally lamines, thiocarbamates, morpholines and azoles. The ally lamines and 
thiocarbamates act on the same target, the first enzyme in the pathway, squalene 
epoxidase. The napthalene group common to each drug seems to inhibit the action of 
this ergl gene product causing the intracellular accumulation of squalene (Favre & 
Ryder, 1996). Morpholines act on the erg24 and erg2 products, C-14 sterol reductase 
and C-8 sterol isomerase. The mode of interaction is not appreciated. To date no 
resistance mechanisms have been reported for these drugs. They are applied 
infrequently but if this situation changes then resistance mechanisms may develop.
For the moment the favoured antifungal therapy remains the azoles and it is with these 
drugs that we find the greatest and most problematic drug resistance. Azoles act on C- 
14 demethylase (lanosterol demethylase), a cytochrome P450 molecule. The active site 
of this enzyme lies within a pocket located above the prosthetic group. Azole binding to 
this site is irreversible, thus, blocking sterol modification. Azole resistance occurs by a 
range of mechanisms but the two main sources are drug efflux or modifications of the 
C-14 demethylase. ERG 11 mutations have been found in a number of clinical isolates 
of pathogenic fungi. These mutations tend to focus around the active site and would 
appear to block the access of the azole to the cavity. In many resistant strains, ERGl 1 
mutation is not observed. Instead, the upregulation of expression of certain ABC 
transporters results in expulsion of the azoles before an effective intracellular 
concentration is established (White, et al, 1998).
The process of ABC transporter mediated fungal azole resistance is best characterised in 
the PDR network of S.cerevisiae (Balzi and Goffeau, 1995). This system of ABC 
transporters and transcriptional regulators confers pleiotropic drug resistance, not only 
to a wide range of antifungals, but other drugs including anti-cancer agents. As well as 
a model for the MDR phenotype in mammalian cells the network provides a basis for 
the understanding of clinical drug resistance in pathogenic fungi. As will be discussed, 
the action of ABC transporters associated with this phenotype have been described in 
most major pathogenic fungi in both clinical and laboratory situations.
The first ABC drug transporter characterised in yeast was snq2. This 160kDa protein is 
located in the plasma membrane and confers resistance to the mutagen 4-nitroquinolone 
oxide and is implicated in cell cycle regulation. Deletion of this gene prolongs 
stationary phase and the biochemical preparation for the onset of exponential phase. 
(Decottignies et al., 1995). Contemporary to the initial isolation of snq2, a second gene 
encoding an ABC transporter was reported simultaneously by a number laboratories. 
This gene was named pdr5, (Balzi et al., 1994) stsl (Bissinger & Kuchler, 1994) and 
ydrl (Hirata et al., 1994) but the acceptedO nomenclature is now pdr5. This new
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transporter conveyed resistance to cyclohexamide, staurosporine, fluphenazine and 
sporedesmin when over-expressed. Both of these transporters are full sized proteins 
predicted to have 12 TMs and 2 NBDs. As drug transporters they are functional 
homologues of mammalian P-glycoprotein although they are not particulaiiy alike on 
the basis of sequence homology. Indeed the organisation of these proteins differs in 
that the MSDs follow the NBDs rather than the other way around. Degeneracy in key 
locations are also present. The highly conserved lysine residue of the P-loop, 
conserved in all MDR subfamily proteins, is replaced with a cysteine in the N-terminal 
NBD of PDR proteins. Similarly the conserved glutamic acid of the N-terminal Walker 
B is replaced with asparagine. The functional significance of these alterations is not 
known (Del Sorbo, et al., 1997).
These proteins are localised in the plasma membrane. They are relatively short lived 
with half-lives of 60-90 min prior to degradation. Degradation does not occur via the 
proteosome despite ubiquitination prior to internalisation (Egner & Kuchler, 1996). 
Instead the ubiquitin ligated protein is trafficked to the vacuole by endocytosis for 
digestion by vacuolar proteases. The dynamic control of the plasma membrane 
concentration of these two proteins may occur for a number of reasons. Firstly, the 
broad substrate competence of the transporters could mean that the constitutive presence 
at high concentration could be a result of the efflux of non-toxic or desirable 
compounds in the absence of toxins. Alternatively the efflux mechanism of PDR5 and 
SNQ2 may act at locations other than at the plasma membrane. The inward 
sequestration of substrate to either the exocytotic or endocytotic vesicle could expel or 
deliver these molecules to the vacuole respectively. In this case the turnover of the 
proteins through the vesicle transport system would be essential (Egner et al., 1995).
Cells that lack PDR5 and/or SNQ2 remain viable but exhibit hypersensitivity to a wide 
range of my cotoxins, including azoles. However, the interest in the ABC transporters 
of S.cerevisiae has tended not to focus on antifungals or azoles particularly, although 
the basic information about MICs and sensitivities of various strains has been 
established. The continued use of yeast as a malleable model of higher eukaiyotic 
function predominates. Despite the lack of sequence similarity and the inverted 
topology, PDR5 will transport substrates transported by P-glycoprotein. Rhodamine 
dye transport is often used as an assay to demonstrate functional homology between 
any given protein and Pgp. PDR5 is able to transport rhodamine 123 and rhodamine 
6G. This assay affords accurate measurements by fluorometric techniques and allowed 
the demonstration of competitive interactions on rhodamine binding by taxol, vincristine 
and vinblastine (anti-cancer drugs) as well as ionophoric peptides and steroids 
(Kolaczkowski etal., 1996). The proposed non-MDR role for P-glycoprotein, in lipid
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transport and membrane maintenance, appears to be true of PDR5 and SNQ2 which 
transport the steroid oestradiol in intact yeast cells (Mahe et a i, 1996). This re-enforces 
the opinion that drug transport is an unfortunate consequence of substrate tolerance by 
proteins intended for other physiological processes.
Transported substrates of PDR5 can be structurally unrelated with extensive 
investigations highlighting hundreds of compounds that are extruded by these proteins 
(Bauer, et a l, 1999). Attempts to define the structure or chemical basis for substrate 
recognition have not been totally conclusive. The PDR5 transported Tri-n-alkyltin 
chlorides are a range of amphipathic compounds composed of anions and hydrocarbon 
chains of varying lengths. These chemicals were systematically applied to PDR5 
transport assays, by gradually increasing the hydrophobic chain length or varying anion 
composition. While compounds with ethyl, propyl and butyl chains were transported 
efficiently, the processing of methyl and pentyl chains was poor. Also, the identity of 
the anion component had no bearing on the result. It was suggested that substrate 
competence in PDR5 is governed by molecular size and by the dissociation constant of 
the tri-n-alkytin anion. The three 2, 3 and 4 carbon chain length compounds had 
significantly higher values than the methyl or pentyl forms. Hydrophobicity did not 
appear to be a factor although only a limited number of compounds were tested (Golin, 
et a i, 2000).
A recent significant paper implicated TMIO in defining substrate specificity and 
inhibitor susceptibility (Egner et aL, 2000). Mutations introduced in TMIO affected the 
ability of PDR5 to efflux the azoles itraconazole and ketoconazole as well as rhodamine 
6G. Mutants S1360F and T1364F displayed a marked reduction in the transport of all 
these compounds. Only a slight reduction in ketoconazole transport was retained in the 
S I360A mutant while T 1364A remained greatly impaired in this respect. Itraconazole 
transport continued to be greatly reduced in both. Thus, TMIO contributes to the 
binding sites for these compounds and interactions at these binding sites are not 
identical. FK506, identified as a transport inhibitor of the Tapl/Tap2 complex 
(Heitman et al., 1993) also proved to be a PDR5 substrate. Mutant S I360A showed a 
very marked sensitivity to azoles through inhibition by this substrate. These data 
demonstrate that PDR5 drug export occurs through a common pathway involving 
TMIO although the precise nature of the interactions at this site varies with substrate. 
The impact of mutations on certain substrates is variable as is the affinity of interaction, 
shown by the high inhibition on azole transport by FK506.
PDR5 has two other homologues in yeast, PDR 10 and PDR 15, which have more than 
65% sequence identity with PDR5. These proteins are also drug transporters but are
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characterised to a far lesser degree. It would appear that these proteins are expressed in 
response to stress (Bauer, et a l, 1999). PDR 12 is a close homologue of SNQ2 (60% 
identity) but, in contrast to SNQ2, mediates the transport of weak organic acids rather 
than drugs. This protein was found to confer resistance to water soluble caiboxylate 
anions including sorbic acid, propionic acid and benzoic acid and has been implicated in 
the ability of yeasts to tolerate food preservatives and cause food spoilage (Piper et a l ,  
1998). Other PDR subfamily transporters have been identified, namely P d r ll ,  
YOROl 1 w and YNROTOw, but nothing is known beyond sequence information.
Pathogenic fungi also possess PDR subfamily genes. C.albicans has 10 PDR genes 
encoding ABC transporters although only 2 of these have been linked to a drug 
resistance phenotype. The most important of these is cdrl, the first to be identified. 
This gene was found by functional complementation study of a pdrSA S.cerevisiae 
strain. CDRl conveyed resistance to a wide range of antifungals including 
cyclohexamide, chloramphenicol and miconazole. The deduced amino acid sequence 
was consistent with PDR5 providing a full sized PDR type transporter (Prasad et a l ,
1995). Later studies showed that deletion of both cdrl alleles in C.albicans resulted in a 
strain that was highly susceptible not only to azoles but also to allylamines and 
morpholines (Sanglard et al., 1996). In addition to drug transport, CDRI also mediates 
the efflux of human steroid hormones including (3-oestradiol (Krishnamurthy et a l ,  
1998). This property could have implications for other fungal pathogens like 
P.brasiliensis as (3-oestradiol prohibits outgrowth of the organisms and development of 
infection. In this case the ability to efflux this hormone could eliminate the resistance to 
this organism in women (Aristizabal, et al, 1998).
A second gene, cdr2, was isolated using the same approach that uncovered CDRI. 
CDR2 has 84% identity to CDRI and will transport similar substrates including the 
azoles ketoconazole and itraconazole. The double deletion of cdr2 did not render 
C.albicans hypersensitive to drugs but the deletion when created in the cdrl A strain, 
increased the level of hypersensitivity (Sanglard, et al, 1997). This implies that CDR2 
is a secondary drug transporter that merely enhances the action of CDRI. Experimental 
drug resistance has shown that CDRI and CDR2 over-expression is frequent in strains 
developing a hyper-resistant phenotype on exposure to increased concentrations of 
fluconazole (as well as mutated ERG 11 and over-expression of the major-facilitator 
M DRl) (Cowen, et a l, 2000).
While the remaining 8 CDR transporters show sequence homology to these two 
proteins they do not carry functional homology with respect to drug transport. For 
instance CDR3 (56% identity to CDRI) fails to confer azole resistance and is found
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expressed only in WO-1 opaque phase cells suggesting a role in cell-cycle regulation 
(Balan et al., 1997).
Not surprisingly, similar transporters have been found in other Candida spp. The 
uptake of pH]fluconazole efflux in C.glabrata proved to be energy dependant with 
increased accumulation of drug on the interruption of respiratory function (Parkinson et 
al., 1995). One PDR subfamily gene has now been cloned from this organism, 
CgCDRl, that confers azole resistance to thepdrSA S.cerevisiae strain and proves to be 
directly responsible for azole resistance in clinical isolates (Sanglard et al., 1999). 
Similarly, Candida dubliniensis has CdCDRl that mediates fluconazole resistance in 
clinical isolates and the yet uncharacterised CdCDR2 (Moma et al., 1998).
Aspergillus nidulans has at least 3 ABC transporters. Two of these are full-size PDR 
class proteins designated AtrA and AtrB. AtrA is a constitutively expressed transporter 
that shows no affinity for any drugs tested while AtrB is upregulated in response the 
presence of drugs and is shown to confer resistance on over-expression in S.cerevisiae. 
However, the resistance was only 30% of that observed on over-expression of PDR5 
(Del Sorbo, et al., 1997). Deletion mutants of atrB are hypersensitive to all major 
classes of antifungals as well as some naturally occurring toxins such as camptothecin 
(Andrade et al., 2000). The third transporter is AtrC an MDR subfamily transporter. 
This has not been shown to be responsible for drug efflux but does exhibit a 10-fold 
increase on expression on the addition of cyclohexamide. The ABC transporters 
described for A.fumigatus and A.flavus all belong to the MDR subfamily. Each species 
has one full size transporter gene, afumdrl and aflmdrl respectively. On over­
expression AfuMDRl conferred resistance to the antifungal cilofungin, an echinocandin 
B analog. A.fumigatus has a second transporter gene, afumdr2, a half transporter with 
extensive similarity to m dll and mdl2 of S.cerevisae. No function has been ascribed 
and the intracellular localisation has not been investigated (Tobin, et a i, 1997). It is 
unknown if AfuMDR2 or AflMDRl will transport drugs as their competence to do so 
has not been addressed (Paul Skatrud, personal communication).
1 . 2 .6  The regulation of ABC transporter mediated fungal drug resistance
Many papers reporting the sequences of new fungal ABC drug transporters add 
supporting evidence not only of drug transport but also of upregulation of gene 
expression in response to drugs. This has often proved a good indicator of the 
transporters role in drug efflux. When both atrA and atrB of A. nidulans were
45
Chapter 1
examined, drug stimulated expression could only be detected for atrB. Only AtrB was 
able to transport drugs (Del Sorbo, et a l, 1997).
The trancriptional response to exposure to drugs is often a dynamic process co­
ordinated by specific transcription factors. The PDR network includes five such 
transcription factors; PD Rl, PDR3 PDR4 (Yapl), PDR7 and PDR9. The principal 
regulator is PD Rl, first noted in a multiple nuclear mutation study (Balzi et a l ,  1987; 
Meyers et a l ,  1992). Over 20 independent mutations in the pdrl locus have been 
associated with increases in drug susceptibility and are often coupled with effects in 
other areas of basic cytoplasmic and mitochondrial function. These include respiratory 
deficiencies and resilience to stresses such as temperature, pH and sub-optimal osmotic 
environments. Once cloned and sequenced, PDRl was recognised as a typical 
transcription factor containing a Zn^Q binuclear cluster (Balzi and Goffeau, 1995).
The first gene shown to be influenced by PDRl was pdr5 and this regulatory 
relationship was the focus of one of the initial reports recording the sequence of pdr5 
(Balzi, et a l, 1994). Gel mobility shifts, using the N-terminal region of PDRl in 
association with the promoter region of pdr5, demonstrated that a direction interaction 
occurred strengthening the postulate that PDRl was a pdr5 transcription factor. Further 
mapping of PDR 1 responsive genes has associated most of the major ABC transporters 
of yeast mentioned above including all of the PDR subfamily, ste6 of the MDR 
subfamily, transporters not of the ABC superfamily and an additional transcription 
factor locus pdr3.
PDR3 is a similar transcription factor to PDRl (36% identity with a highly conserved 
DNA binding domain) (Balzi and Goffeau, 1995). In a separate study this transcription 
factor was associated with the transcription of pdr5 explaining why a pdrl mutant 
results only in depressed transcription of pdrS and a mild hypersensitivity to 
cyclohexamide (Meyers, et a l, 1992). Not only PDR3 assists PDRl but also PDR4, 
PDR7 and PDR9. Only pdr3 appears to be regulated by PDRl as well as exhibiting a 
positive feedback by upregulating it’s own expression (Dexter et a l, 1994). In contrast 
to PDRl these genes appear to influence a limited range of promoters. PDR4, 7, & 9 
remain linked only with pdr5. PDR3 upregulates snq2 as a p drl A mutant shows a 
reduction of SNQ2 while in pdrlA!pdr3A the expression is abolished (Mahe et a l ,
1996). PDR3 and PDR I also contribute to the upregulation of yorl. Yorl has an 
overlapping yet distinct substrate range in comparison with PDR5 (Kolaczkowski et a l ,  
1998).
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The dissection of the pdr5 promoter established the identity of PDR Response Elements 
(PDREs). The three PDREs act as binding sites for PDRl and PDR3 and are of the 
general sequence “TTCCGCGGAA”. While only one of these PDREs is required for 
PDR3 dependant transcription (Katzmann et aL, 1994) all three are required for the 
correct regulation in the wild type strain involving both transcription factors. PDREs 
have been recognised on the promoters of other PDR transporters that are responsive to 
PDRl including yorl (Hallstrom & Moye-Rowley, 1998; Katzmann et aL, 1996).
A full understanding of the finer points of this regulatory network is not yet established. 
A number of other activating influences appear to play subtle roles and can be gene 
specific. For example, yorl possesses a PDRE but also an upstream activating 
sequence (UASyoRi) that positively influences expression. The influence of other 
transcription factors is also possible. The upregulation of expression of snq2 in 
response to 4-nitroquinoline oxide requires YRRl, another zinc finger containing 
transcription factor that binds to a non-PDRE regulatory element (Cui et aL, 1998). 
Functional analysis of the snq2 promoter denotes four positive sites for transcriptional 
activation. Both the YRR site and PDRE are in segment IV. The factors influencing 
transcription in the other three segments remain unknown (Cui et a l ,  1999). Also the 
regulation of PDRl itself appears to be an issue. As would be expected this 
transcription factor appears in response to stress but the signalling mechanism that 
stimulates PDRl production is not understood. The activity of PDRl is also regulated 
post-translationally by association with an Hsp70 called PDR13. The interaction of 
these two proteins further enhances the transcription of PDRl responsive genes 
(Hallstrom et a i,  1998).
Regulation of ABC transporter gene expression in pathogenic fungi is not well 
characterised. A transcription factor from C.albicans has been isolated by 
complementation of a pdrlAlpdrSA S.cerevisiae strain. This protein, FCRl is able to 
complement the mutations in this strain and provide fluconazole resistance in a PDR5 
dependant manner. Conversely, the double deletion mutant o ffc r l in C.albicans results 
in a hyper-resistant strain suggesting that while FCRl is a positive regulator of pdr5 it 
is a negative regulator of cdrl (Talibi & Raymond, 1999). It would seem that a direct 
transfer of information from S.cerevisiae to C.albicans might not be so straightforward 
in this case.
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1 .2 .7  Conclusions
ATP-binding cassette transporters represent an exciting and important group of proteins 
that have great scope for biomedical and biotechnological application. However, the 
prominence of these systems in undesirable clinical scenarios, such as cystic fibrosis 
and multidrug resistance of cancer and infectious diseases, requires expedient and 
effective intervention. Only on fully understanding the mechanisms and functions of 
these transporters can we hope to intervene with widespread success. While important 
advances, including the crystal structures of HisP and Ai'sA and the extensive 
biochemical characterisation of P-glycoprotein, moves us towards this goal the 
questions still outnumber the answers.
Influencing transporter function in the disease situation is possible. For example, the 
treatment of non-insulin dependent diabetes mellitus has long been achieved using 
sulphonylurea dmgs but the exact mode of action was not known. We now appreciate 
that the drug binds to an ABC protein to modulate insulin secretion (Aguilar-Bryan et 
al., 1995). We have already mentioned the therapeutic use of steroids like antiprogestin 
RU 486 to reduce the anti-cancer drug efflux of P-glycoprotein (Consiel, et a l, 1998). 
Perhaps the increase in the study of transporter modulators that are not actually 
transport substrates will lead to the discovery of compounds that can competitively 
inhibit the efflux of beneficial therapeutics.
Intervention may be more difficult in cases where it is a defective molecule rather than 
an undesirable efflux activity. Current treatments for cystic fibrosis sufferers only 
improve the quality of life by physically dispersing mucus. The difficulties in 
positively influencing the CFTR channel with drugs are immense at this stage. Most 
attention in emerging treatment of this disease goes to the technique of gene therapy. 
Gene therapists are trying to introduce the functional CFTR genes to tracheal epithelial 
cells in viral vectors.
The consequences of ABC mediated drug resistance in pathogenic fungi may turn out to 
be severe. Azole antifungals have long been used as the preferred and most effective 
therapeutic measure to mycoses. The multiple mechanisms of azole resistance 
developed by fungi now threatens this efficiency. At this stage resistance is not a 
problem of disastrous proportions. It is most frequently reported in situations of 
intensive therapy, such as in immuno-suppressed individuals (Sanglard et al., 1995). 
Mycoses that predominate in such individuals will be particularly amenable to the 
development and proliferation of these resistance mechanisms. Paracoccidiodiomycosis 
is one such disease. The added disadvantage in PCM is that there is no sequence
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information available for any components of the ERG pathway or for potential efflux 
ABC transporters. It is prudent that we should attempt to redress this problem with 
some urgency.
Chapter 2
Chapter 2
Materials and Methods
2 .1  Reagents and Materials
2 . 1 . 1  Origin of materials and reagents
General chemicals were acquired from Sigma (UK) Ltd unless otherwise stated. 
Microbial growth media was supplied by Oxoid or Difco. Enzymes used in molecular 
biology were supplied by Roche Molecular Diagnostics unless otherwise stated. 
Additional materials or reagents for specialised applications are noted in the relevant 
sections later in this chapter.
2 . 1 . 2  Preparation of chemical and media solutions
General chemicals were weighed on a Sartorius digital balance and dissolved in 
distilled water or milliQ distilled/deionized water where appropriate. Small amounts 
were weighed on a Mettler Toledo digital fine balance.
2 .1 .3  Sterilisation of reagents and materials
Media and reagents to be sterilised were either autoclaved or filter sterilised depending 
on their stability on heating. Heat stable materials were exposed to (12UC for 15 min 
at 4 atm of pressure). Heat labile liquid reagents were filter sterilised by syringe 
filtration through a 0.2p.m Gelman syringe filter. Non-autoclavable items (e.g. 
centrifuge containers) were sterilised by thorough washing in 100% ethanol followed 
by a drying period in a laminar flow cabinet.
2 .1 . 4  Centrifugation
Routine centrifugation of materials in microfuge tubes was performed in a Mistral 
Centaur benchtop microfuge. The centrifugation of microfuge tubes at lower 
temperatures and higher speeds was performed in a Sorval 1K15 benchtop
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refrigerated centrifuge. In order to centrifuge larger volumes, a refrigerated benchtop 
Sorval 4K15 centrifuge was employed, using either Sorval rotors 11150, 12172, or 
12256, depending on the type of tube and speed required.
2 .2  Microorganisms; growth and storage
A list of all bacterial and fungal strains used in this thesis is presented in table 2.1.
2 . 2 . 1  Growth of bacteria
Escherichia coli strains were propagated in or on Luria-Bertani (LB) broth or agar, 
supplemented with the appropriate additions or antibiotics where appropriate. Such 
broth was generally prepared from a pre-mixed broth base containing lOg NaCl, 5 g of 
yeast extract and lOg of bactotryptone for each litre of media to be produced. In order 
to prepare solid media, agar was added to 13.5% w/v prior to autoclaving.
Inoculation in liquid broth was achieved by transferring a single colony from a plate 
culture to an appropriate volume of medium. The culture was incubated, with shaking 
at 220rpm and 37°C, in a baffled Erlenmeyer flask or 25ml conical bottomed universal 
container.
Culture on solid media was achieved by spreading or streaking organisms onto the 
agar surface using a sterile spreader or microbiological loop. Plates were placed in a 
37^C incubator, in an inverted position, for 18h.
2 . 2 . 2  Growth of Saccharomyces cerevisiae
Saccharomyces cerevisiae strains that did not harbour a recombinant plasmid were 
propagated in YPD liquid medium or SC minimal medium, with shaking at 30^C, in a 
baffled Erlenmeyer flask. Culture on solid media was achieved on YPD or SC 
minimal agar (13.5% w/v) plates incubated at 30®C for 72hr. YPD medium was 
composed of 5g yeast extract and lOg bactopeptone dissolved in 750ml of distilled 
water and autoclaved. Prior to use, filter sterilised glucose was added to a final 
concentration of 2%. The volume was then made up to iL with sterile distilled water. 
Agar was added at 13% w/v for a solid medium.
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Microorganism Genotype Origin Application
Escherichia coli 
Novablue
endA l hsdR \7  (rKi2‘ 111^ 12'^ ) supE44 
thi -1 rec A" gyrA96 relA \ lac [F’ 
p ro h B  lac FZAM75 Tn70 (Tef)]
Calbiochem
Novabiochem
General cloning
Escherichia coli X Ll 
Blue
recAl endAl gyrA96 thi-1 h sd R ll 
supEAA relA l lac [F’ proAB lac F 
ZAM75 TniO (Tef)]
Stratagene General cloning
Escherichia coli XL 10 
Gold
Tet^A mcr A 183 A{mcrCB- 
hsdSMR-mrr) 173 endA l supEAA 
thi-l rec A l gyrA9(> rel A l lac Hte 
[F’ proA B lac VZA M lSTnlO  (Tef) 
Amy CamO
Stratagene General cloning
Escherichia coli 
Topi OF’
F’ { lac FTeF} mcr A  Aimrr-hsd 
RMS-fwcr BC) L80/<3cZ AM 15 
A/flcX74 deo R rec A l araD139 
A{ara - leu )l697 galU galK rpsL  
end A l nupG
Invitrogen pZERO™ cloning
Escherichia coli 
LE392
^wpE44 supF5S hsdR 514 galK2  
galT22 m etBl trpR55 lacY l
Laboratory
strain
collection
Lambda phage 
infection
Epicurian coli ® BL21 
-CodonPlus™ (DE3) 
-RIL
E.coli B F ompT had  S(rg'mg" 
)dcm^ T ef gal end A  Hte [argld ileY  
leuW  CamT
Stratagene pET21b mediated
recombinant
expression
Saccharomyces 
cerevisiae AD 1-8
M ata  p d r l-3 mq3 his7 ydrlA::hisG  
snq2A::hisG pdrSAv.hisG  
pdrlBAv.hisG pdrllA w h isG  
ycflAv.hisG  pdr3A::hisG  
pdrlSA'.'.hisG
Gifted by Prof 
A Goffeau
Heterologous
complemetation
Paracoccidiodes 
brasiliensis PBOl
Wild type; genome not yet defined Gifted by Prof
M .S.Soures
Felipe
Source of nucleic 
acids for PCR & 
RT-PCR
Table 2.1 Microorganisms and strains thereof, used in this study
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SC minimal medium was composed as follows;
0.67% of yeast nitrogen base without amino-acids, with ammonium sulphate
0.01% of adenine, argenine, cysteine, leucine, lysine, threonine, tryptophan,
uracil
0.005% of aspartic acid, histidine, isoleucine, methionine, pheylalanine, proline, 
serine, tyrosine, valine
The solution allowed to cool and filter sterilised glucose or raffinose was added to 
20% or 10% respectively. The volume was then made up to IL with sterile distilled 
water. Agar was added at 13% w/v for a solid medium.
Propagation of S.cerevisiae strains that possessed a recombinant plasmid containing 
the uraSA selectable marker gene was achieved in or on SC-U minimal media. This 
media is prepared in the same way as SC minimal media, but the uracil is omitted.
2 . 2 . 3  Long term storage of bacteria
Long term storage of important bacterial strains was achieved by the accumulation of 
frozen glycerol aliquots of the relevant strains. A 5ml overnight liquid culture of the 
microorganism, in a relevant medium, was propagated in a 25ml universal container. 
Replicate stocks were prepared by mixing 850pl of the mature culture with 150ql of 
sterile glycerol in a 1.5ml microfuge tube. The mixture was then placed at -70^C.
When it was necessary to retrieve the strain, a sterile microbiological loop was used to 
scrape a small amount of the frozen stock material from the surface of the aliquot that 
was then used to inoculate an agar plate. The glycerol stock was restored to -70°C 
before thawing could occur.
2 . 2 . 4  Antibiotics
Filter sterilised antibiotics were applied to the following final concentrations unless 
otherwise stated: ampicillin lOOmg/ml, carbenicillin lOOmg/ml, kanamycin 50 mg/ml. 
Chloramphenicol stocks were prepared at 34mg/ml, dissolved in 100% ethanol.
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2 . 2 . 5  Growth and preparation of E.coli LE392 for X phage 
infection
A LB agar plate was inoculated with E.coli LE392 cells from a glycerol stock. 
Following incubation, a single colony was used to inoculate 50ml LB broth 
supplemented with lOmM MgSO^ and 0.2% filter sterilised maltose. Growth was 
permitted for 6h at 37®C with shaking until the cells were in mid-log phase. The cells 
were harvested by centrifugation at 5000 rpm and 4°C for 10 minutes. Cells were re­
suspended in ice cold lOmM MgSO^ to a final O.D.ggo of 1.0. Cells were then ready 
for use in infection or could be stored at 4°C for up to 14 days.
2 . 2 . 6  Propagation of X phage on solid media
Plate lysates of individual X phage clones or X libraries were prepared on LB agar 
plates supplemented with lOmM MgSO^ and 0.2% filter sterilised maltose. To a 
1.5ml microfuge tube, 200fil of the previously prepared LE392 cells and lOOp.1 of an 
appropriate dilution of lambda phage (suspended in phage or SM buffer) were added 
and mixed. The mixture was incubated at 37°C in a waterbath for 20 min to allow 
phage adsorption to occur. The infection mixture was then added to 5ml of molten 
(55°C) Top LB agarose (LB+ 6% w/v agarose, lOmM MgSO^ and 0.2% filter 
sterilised maltose), which was then poured over the surface of the agar plates. The 
agarose was allowed to harden for 5 min at room temperature prior to inversion and 
overnight incubation at 37°C. Plaques were usually observed after 16h.
2 . 2 . 7  Propagation of X phage in liquid media
Liquid lysates of phage were also required. These were prepared from either a single 
phage plaque or from total phage libraries.
A single phage plaque and surrounding LE392 cells was picked using an aseptically 
cut-off 200p.l micro-pipette tip and ejected directly into 200ml of pre-warmed (37°C) 
LB broth (containing lOmM MgSO^). Overnight shaking at 280rpm and 37°C 
generally resulted in the lysis of a dense culture of LE392 cells. Lysis was assessed 
by the propensity of cellular debris in the culture media. In the event that lysis was 
not complete the culture could be rescued by adding another 200ml of pre-warmed LB 
broth with supplements and splitting between two 2L Erlenmeyer flasks. A further 3h
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of shaking would result in lysis. Once extensive lysis was observed, chloroform was 
added to 3% v/v and incubation continued for a further 15min to complete the 
process.
Liquid lysates from whole libraries were performed by infection and pre-adsorption as 
described in section 2.2.6, followed by inoculation of 200ml of LB (10% MgSO^) in 
a 2L Erlenmeyer flask. Incubation conditions were as described above for the 
amplification of single plaques.
Phage particles were isolated from bacterial debris by centrifugation of the lysed 
culture at 10,000rpm and 4°C for lOmin. Lysate was then stored at 4°C in the 
presence of 3% v/v chloroform.
2 .3  Analysis and Purification of Nucleic Acids
2 .3 .1  Agarose gel electrophoresis of DNA
For routine analysis of DNA, electrophoresis in horizontal agarose* gel slabs were 
used. Agarose was dissolved to an appropriate percentage (0.7 to 2%) in TAB buffer 
by boiling in a microwave (TAE buffer; 4.84g Tris base, 1.142ml glacial acetic acid, 
2ml 0.5M EDTA, made up to IL in distilled water). Once the agarose solution had 
cooled to around 65^C it was poured into a gel-tray. A comb was applied to the gel in 
order to create wells for sample loading and the gel was allowed to set for 30min at 
room temperature. Once the gel had solidified, it was overlaid with 10-20ml TAE 
buffer containing 10p,g per ml of ethidium bromide. The ethidium bromide was 
allowed to diffuse into the agarose gel for lOmins. The gel was then submerged in an 
electrophoresis chamber containing TAE buffer allowing for approximately 5mm 
depth over the gel.
The DNA sample for analysis was mixed with 6X DNA loading buffer (15% Ficoll 
[type 400], 0.25% bromophenol blue, 0.25% xylene cyanol). The sample was then 
applied to a well of the gel. To each gel would also be added 5pg of Ikb DNA ladder 
(Roche Molecular Diagnostics) for size reference. Applying lOOV of current to the 
chamber allowed the ionised DNA to migrate to the positive anode. Progression of 
the material through the gel could be monitored directly by visualisation of the xylene 
cyanol and bromophenol blue tracking dyes. Once the DNA had migrated a sufficient 
distance, it was visualised in the gel using an ultraviolet light transilluminator. When
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required the illuminated gel was photographed using a Polaioid MP 4^ instant camera 
system on Polaroid 667 film.
*On occasion when the purification of high molecular weight genomic DNA was 
required, LMP (Low Melting Point) agarose (1% in TAE) was used instead of 
standard agarose.
2 . 3 . 2  Small scale preparation of X DNA
Small scale preparation of DNA from X phage was achieved from either plate lysates 
or liquid lysates. Liquid lysates were prepared as previously described.
Plate lysates were prepared as previously described with a sufficient titre of phage so 
as to make the plaques confluent after 16h incubation. After this incubation the plates 
were overlaid with 5ml of phage buffer and the phage particles were allowed to 
diffuse into the buffer overnight at 4^ ’C with gentle shaking. The overlay buffer was 
then aseptically removed and centrifuged at 10,000 rpm for 10 min. The supernatant 
was removed stored with 3% chloroform or used immediatley.
For each small scale DNA preparation, 15ml of liquid lysate, or overlay buffer from 
plate lysates, was added to a 25ml polycarbonate centrifuge tube. Both DNase and 
RNase were added to a final concentration of Ijrg/ml and the lysate was incubated at 
3TC  for 20min. Following incubation the lysate was mixed with 6ml of ice cold 
phage precipitant (33% PEG 8000 / 3.3M NaCl) and incubated on ice for 2h. The 
precipitate was harvested by centrifugation at 12,000rpm for lOmins. The 
supernatant was discarded and the tubes allowed to dry for 40min at room 
temperature. The phage pellet was re-suspended in 500p,l of phage buffer and 
transferred to a 1.5ml microfuge tube. Excess PEG was removed by vortexing the 
phage suspension with 1ml of chloroform for 30s followed by 3min centrifugation at 
13,500rpm and 4^C. The upper aqueous layer was removed and processed by 
extraction with phenol (3 x 500|l i 1 treatments), phenol-chloroform-isoamyl alcohol 
(50:49:1) (IX  500|l i 1 treatment) and finally chloroform (2 X 5(X)p.l treatments). The 
DNA was then concentrated from the aqueous phase by ethanol precipitation.
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2 . 3 . 3  Alcohol precipitation of DNA
DNA was concentrated from aqueous solution by the addition of either 100% ethanol 
or isopropanol to induce DNA precipitation.
Ethanol precipitation was achieved by the addition of 2.5 volumes of ice cold 100% 
ethanol and 1/10 volume of 3M sodium acetate (pH4.5) followed by incubation at on 
ice (or at -20®C) for 20min to overnight. The precipitate was harvested by 
centrifugation at 15,300rpm for 35min at 4°C. The pellet was washed with an 
appropriate volume of ice cold 70% ethanol, re-centrifuged at 15,300rpm and 4‘^ C for 
5min, and allowed to dry at room temperature. The pellet was then dissolved in an 
appropriate volume of sterile distilled water, lOmM TrisHCl pH8.0 or TE depending 
on the intended downstream application.
Alternatively precipitation was performed using 0.7 volumes of room temperature 
isopropanol followed by immediate centrifugation at 15,300 rpm and 4°C for 35 
minutes. The precipitated DNA was then washed with 70% ethanol, re-centrifuged 
and re-suspended in water or buffer as above.
2 . 3 . 4  Small Scale preparation of plasmid DNA
Bacterial strains harbouring plasmid constructs were cultured in 5ml LB broth, 
containing appropriate selecting antibiotics, in a 25ml universal container. Cells were 
harvested from 3ml of the turbid culture by centrifugation at 12,000 rpm for 1 min. 
Plasmid DNA was then isolated using the QIAprep Spin Miniprep Kit (Qiagen) as per 
manufacturers instructions and as summarised below.
The cell pellet was re-suspended in 250p.l of buffer PI (proprietary composition, 
containing RNase at lOOjrg per ml). The cells were then lysed by a modified alkaline 
lysis procedure (Birnboim & Doly, 1979) upon the addition of 250p.l of solution P2 
(proprietary composition, containing NaOH and SDS). Precipitation of proteins, 
genomic DNA and other macromolecules was achieved by the addition of 270|xl of 
solution N3 (proprietary composition, containing high concentration of chaotropic 
salts). The precipitate was then separated by centrifugation at 14,000rpm for lOmin. 
The supernatant from the mixture was then decanted onto a mini-column housing 
membranes containing immobilised silica gel.
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The supernatant was drawn through the resin by centrifugation at 14,000rpm for 
Imin, the high salt concentration allowing the plasmid DNA to bind to the resin. The 
mini-column was then washed with TOOial of solution PE (proprietary composition, 
containing 80% ethanol). The wash buffer was drawn trough the mini-column by 
centrifugation for Imin at 14,000rpm. Residual wash buffer was further removed by 
a second additional centrifugation at 14,000rpm for Imin. The mini-column was then 
placed in a clean 1.5ml microfuge tube. To the column was added 50pl of hot (80*^0) 
IQmM TrisHCl pH8.0, directly onto the silica membranes, in order to elute the 
plasmid DNA under aqueous, low salt conditions. After standing for Imin, the eluate 
was collected by centrifugation at 14,000rpm for Imin. Plasmid DNA was then 
stored at -20°C until required.
2.3.5 Purification if P.brasiliensis DNA from Low Melting Point 
(LMP) agarose gels
The DNA of P.brasiliensis (PbOl) was prepared in Brazil and supplied as a solution at 
various levels of purity. Generally a large quantity of intact P.brasiliensis DNA was 
evident but a background of degraded DNA, RNA and other fungal materials were 
present, which was undesirable for highly sensitive applications, such as Universal 
GenomeWalker™ PCR (see section 2.5). In this case a further purification of DNA 
was performed by electrophoresis of the material through an LMP agarose gel 
(Flowgen). The high molecular weight band was excised from the LMP agarose gel 
and dissolved in an equal volume of TE buffer at 60*^ C. An equal volume of phenol, 
equilibrated with O.IM TrisHCl pH8.0, was mixed with the slice and the aqueous 
phase separated by centrifugation at 4000rpm for 3min. The aqueous phase was 
further extracted with an equal volume of phenol /chloroform/ isoamyl alcohol 
(25:24:1) and then chloroform alone. The DNA from this aqueous phase was then 
isolated by ethanol precipitation on ice for 20min. The DNA was re-suspended in an 
appropriate volume of lOmM TrisHCl (pH8.0) and the quality/quantity assessed by 
agarose gel electrophoresis.
2 . 3 . 6  Extraction of DNA from agarose gels
DNA was extracted from agarose gels for the purposes of cloning or probe synthesis. 
This was generally achieved using the QIAquick Gel Extraction Kit, as per 
manufacturers instructions and as summarised below.
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A volume (l-60pl) of the appropriate DNA solution was subjected to electrophoresis 
on an agai'ose gel containing ethidium bromide, as previously described. 
Visualisation of the resultant DNA band(s) by ultraviolet light allowed the excision of 
the required bands from the gel using a clean scalpel blade. The excised gel slice was 
then placed in a clean 1.5ml microfuge tube and the weight of the slice was then 
assessed. Up to 400mg of DNA/agarose was applied to each individual extraction 
procedure.
The gel slice was then mixed with a volume (30pl per lOmg of agarose) of solution 
QG (Gel solubilising buffer, proprietary composition). The agarose slice was 
allowed to dissolve in a 50°C water bath for lOmin with intermittent mixing. The 
solution containing the dissolved gel slice was then applied to a mini-column housing 
membranes impregnated with immobilised silica gel. Binding of DNA was achieved 
by drawing the solution through the mini-column by centrifugation at 14,000rpm for 
Imin. The column was washed with 500pl of solution QG to remove any traces of 
agarose (solution was applied to the column, allowed to stand at room temperature for 
5min and then drawn through by centrifugation at 14,000rpm for Imin). The mini­
column was then washed with 700^1 of solution PE (proprietary composition, 
containing 80% ethanol). The wash buffer was drawn through the mini-column by 
centrifugation for Imin at 14,000rpm. Residual wash buffer was further removed by 
a second additional centrifugation at 14,000rpm for 2min.
The mini-column was then placed in a clean 1.5ml microfuge tube. To the column 
was added 50ql of hot (80°C) lOmM TrisHCl (pH8.0), directly onto the membranes, 
in order to elute the DNA under aqueous, low salt conditions. After standing for 
Imin, the eluate was collected by centrifugation at 14,000rpm for Imin. Purified 
DNA was then stored at -20°C until required.
2 . 3 . 7  Purification of DNA from buffered solutions.
On some occasions, for example during sequential digestion of DNA using restriction 
enzymes with incompatible buffer systems, it was necessary to purify DNA from a 
buffered solution prior to performing the next application step. This was generally 
achieved using the Wizard™ DNA Clean-up System (Promega) as per the 
manufacturers instructions and as summarised below;
The DNA solution was made up to a volume of at least lOOpl using sterile TE buffer 
(pH8.5) in a clean 1.5ml microfuge tube. To the DNA solution was added 1ml of
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DNA clean up resin. This was then mixed by inversion of the tube 8 times. The 
mixture was then applied to a mini-column via a 3ml Luerlok™ syringe. In order to 
wash the resin, 2ml of 80% isopropanol was transferred through the column, again 
using the syringe. The column was dried of isopropanol by centrifugation, in a 1.5ml 
microfuge tube, for 2min at 14,000rpm. DNA was eluted by the application of 50pl 
of hot (80^C) sterile lOmM TrisHCl (pH8.0) to the column, standing for Imin, and 
harvesting the eluate by centrifugation at 14,000rpm for Imin.
2.3.8 Alternative Procedure for gel extraction/purification/ 
concentration and DNA
During the course of the research it was found that certain downstream applications 
performed better when DNA was extracted, purified or concentrated using the Qiaex 
11 resin (Qiagen). This improved performance was notable in DNA ligations 
involving sticky ends but not particularly in A-T ligations of PCR products..
DNA was extracted from an agarose gel slice in a 1.5ml microfuge tube. The gel slice 
was first solubilised in 3 volumes of buffer QX (gel solubilisation buffer, proprietary 
composition), at 50°C in a water bath, in the presence of 10-30pl of QIAEX II resin. 
The volume of resin was determined by the quantity of DNA applied. The resin was 
collected by centrifugation (all centrifugations in this procedure were at 13,000rpm for 
Imin) and the supernatant discarded. The pellet was re-suspended in SOOpl of buffer 
QX to remove any residual traces of agarose and collected by centrifugation. The 
wash supemate was discarded and the pellet was washed twice in 500pl of buffer PE 
(as above) and collected by centrifugation. The buffer PE was completely aspirated 
by pipette and the pellet was allowed to air dry for 10-30 min. The drying time was 
variable with the amount of resin used. The DNA was eluted by vortexing the resin in 
20pl of lOmM TrisHCl pH8.0 and incubation at 50®C for 10 min followed by 
centrifugation. The eluate was transferred to a clean microfuge tube and the 
centrifugation repeated. The supemate was transferred to a clean microfuge tube and 
stored at -20PC until required.
The procedure for concentrating DNA solutions or removing unwanted contaminants 
was identical to that of the gel extraction except the 10 min initial incubation time was 
performed at room temperature rather than 50^C and the wash with buffer QX was 
omitted.
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2 . 3 . 9  Purification of mRNA from total nucleic acid
RNA preparations from P.brasiliensis were partially prepared in Brazil and supplied 
as an ethanol submerged pellet of total nucleic acids. In order to purify high quality 
mRNAs from this pool it was necessary to eliminate genomic DNA and separate 
mRNA species from other RNAs.
The pellet was dried and re-suspended in 800pl of DEPC treated milHQ water. Once 
re-dissolved, 50U (50 p,l) of RNase-free RQl DNase (Promega) was added and the 
mixture incubated at 37®C for 30min. Inactivation of the RQl DNase was achieved 
by heating to IQPC for 10 min.
The separation of mRNA from total RNA was achieved using Streptavidin 
Magnesphere® Paramagnetic Particles (SA-PMPs) (Promega). These particles are 
composed of a magnetite core coated with streptavidin. The streptavidin binds to a 
biotinylated oligo (dT) probe which is used to specifically interact with the polyA tail 
peculiar to mRNAs. Magnetic separation of the streptavidin-Magnesphere®- 
biotinylated oligo (dT)-polyA mRNA complex allows isolation from total RNA.
To a 1.5ml microfuge tube was added total RNA at a concentration in excess of 
l.Omg in 500pl of nuclease free water. The tube was placed on heat block at 65®C for 
lOmin. Following this incubation, 3ml of oligo (dT) probe and 13ml of 20X SSC 
were added. The contents were mixed gently and allowed to cool to room temperature 
(lOmin cooling period).
Meanwhile, the SA-PMPs were prepared by re-suspending the particles in a 0.6ml 
tube as supplied. The re-suspended particles were captured at the side of the tube by 
exposure to a magnet housed in a magnetic stand (Promega). The supemate was 
removed and the particles washed three times in 300ql of 0.5X SSC, each time 
capturing the magnetic particles between washes. The washed particles were then re­
suspended in lOOpl of 0.5X SSC.
The entire contents of the oligo(dT) annealing reaction were added to the washed SA- 
PMPs and then incubated for lOmin at room temperature. The magnetic particles 
were re-captured and the supemate removed. The particles were washed four times in 
300pl of O.IX SSC. Care was taken to remove as much wash buffer as possible after 
the fourth wash without disturbing the particles.
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To elute, lOOpl of nuclease free water was added to the SA-PMPs and the particles 
were re-suspended. The particles were re-captured and the supemate transferred to a 
clean RNase free microfuge tube. The elution process was repeated with 150pl of 
nuclease free water. The mRNA was then ready for application in RT-PCR.
2 .4  Use of the Polymerase Chain Reaction (PCR)
2 . 4 . 1  Oligonucleotide primers for PCR
Oligonucleotide primers for PCR were synthesised by Life Technologies and supplied 
at a desalted purity on a 50nmol scale. Primers were re-suspended in a sufficient 
volume of lOmM TrisHCl pH8.0 to provide a stock concentration of 60pmol per 
microlitre.
Primer Application Sequence
MDRl Degenerate PCR (Chapter 3) G C (C T ) CTC G T (G C ) G G (G C ) CGC 
T C (G C ) GG
MDR2 Degenerate PCR (Chapter 3) GAT (A G )C G  (C T )T G  CTT (C T )T G  
(A G )C C  (A G )C C
PDRl Degenerate PCR (Chapter 4) G C (T C ) G G (T C ) AAG A C {T C )  
A C (T C ) CTC CTC
PDR2 Degenerate PCR (Chapter 4) (AG ) GC (C G )G A  GGG CTG GTG GAT 
(A G )G T
T7 General sequencing A T T  ATG CTG AGT GAT ATC CC
T3 General sequencing AAT TAA CCC TC A GTA AAG GG
SP6 General sequencing A T T  TAG CTG ACA CTA TAG
fXbafwdl p ftl  sequencing (Chapter 3) TCT AGA AGA GAT ACA TAG
fXbafwd2 p ftl  sequencing (Chapter 3) GGA TTG TGG GGG AAC GTA
fXbafwd3 p ftl  sequencing (Chapter 3) GAA CTG ATG  AAG GGC GTT
fXbafwd4 p ftl sequencing (Chapter 3) GTC AAT TCA TCA GTG ACT
fXbafwdS p ftl  sequencing (Chapter 3) GTG ATG CGG AGC CGG AGA
fXbarev2 p ftl  sequencing (Chapter 3) CAT A TT T C T  CCT TAG AAG
fXbarevS p ftl  sequencing (Chapter 3) GAT GAG GAT GTC TGG GTT
fXbarev4 p ftl sequencing (Chapter 3) CGT TGC TTC C T T  GCG GAA
fXbarev5 p ftl sequencing (Chapter 3) CTA T T A  TA T CGA TGG ACC
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P2SPANF1 pft2 cloning/sequencing GCG ACG AAG ACA ATT TCC
P2SPANR1 pft2 cloning/sequencing CTA TCC TCT CCC TTA ATC
SPANIFl pft2 cloning CAT GTT AAC TAT GTC TGC
SPANIF2 pft2 cloning AGG CTA ATT CCA AGA ACG
SPANIRl pft2 cloning ACC AGA AAC GTG GTC AAG
SPANIR2 pft2 cloning TCC CCA GTC AAG AAA ACG
P2F2 pft2 sequencing (Chapter 4) AAC GTG AAG GCA AAC GAT TG
P2F3 pft2 sequencing (Chapter 4) AAG CGG ATC TTG AAC AAC TT
P2F4 pft2 sequencing (Chapter 4) GCT TGG GCT CTC TGG CGC AC
P2F5 pft2 sequencing (Chapter 4) GCC GGC GCT GGG AGA ATT GC
P2R2 pft2 sequencing (Chapter 4) TGC AAG ATG AAA GAC CAG GT
P2R3 pft2 sequencing (Chapter 4) CCA ACG GGA TGT TCA TCC TC
P2R4 pfi2 sequencing (Chapter 4) GCA ATG CTG ACA CGT TTG CG
P2R5 pft2 sequencing (Chapter 4) TGT CTT CCG CCC AAC CCC AA
P2R6 pft2 sequencing (Chapter 4) AGA AGA ATC ACC ATT GTT TGA
Adaptor Tag GenomeW alker ' PCR 
(See appendix 2)
5 ' GTA ATA CGA CTC ACT ATA 
GGG CAC GCG TGG TCG ACG GCC 
CGG GCT GGT 3 '  3 '-H ^ N -C C  
c g a  c c a  5 '
Adaptl GenomeWalker^^* PCR GTA ATA CGA CTC ACT ATA GGG C
Adapt2 GenomeW alker * *^* PCR ACT ATA GGG CAC GCG TGG T
pftwalkl GenomeW alker * PCR GAC GCG CTC GCG CAA CGC ATT 
TCT TTC GGA GTT
pftwalk2 GenomeW alker * PCR GGT ACG CGA GGC ACT GCG CTT 
TTC AGC AAT GGC
SMART Oligo 5’ SMART RACE RT-PCR AAG CAG TGG TAA CAA CGC AGA 
GTA A(T3o)N„iN
(N =A ,G ,C  o r  T & N_i=A, G OR C)
U Pl 5’ SMART RACE RT-PCR CTA ATA CGA CTC ACT ATA GGG 
CAA GCA GTG GTA ACA ACG CAG 
AGT
UP2 5’ SMART RACE RT-PCR AAG CAG TGG TAA CAA CGC AGA 
GT
PT72 5’ SMART RACE RT-PCR 
and SSP-PCR
GCA AGC AGA GTA ACG CC
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PT7 5’ SMART RACE RT-PCR AGC CGA GCC TC T TCC CGC
PI Pro p ftl  RT-PCR CAC ACA TA T CGC GCT ATC
XS62 p ftl  RT-PCR TTC ACA T T T  GCT ATC CAT CT
XT72 p ftl  RT-PCR TAT TGT TGC CGC ACT AA
XT74 p ftl  RT-PCR GTT CGG CCT CAC ACT CCC CGT
Pl(g)RTfwd p ftl  RT-PCR / expression GCC ATG C TT GCC GCC TTC ACT  
CCA CGA
Pl(r)RTfwd p ftl  RT-PCR / expression GCC ATG GCG T T A  CTC TGC TTG
PlRTrev p ftl RT-PCR / expression T T T  TTC TTG GGA CGG CTG TTG
P2RTfwd p ftl  RT-PCR CCC GCG CTG CAG CTG CAA AG
P2RTrev p ftl  RT-PCR GGA AGT AGA TGA T T A  GGT TG
HSPfwd RT-PCR control GGT CTA GAA AGC TAC GCC TA
HSPrev RT-PCR control CCT CCT CGA CAG TAG GAC CG
PINBDF Heterologous expression CGG GAT CCG AGA A T T  TT T GAG 
CTG GAA AAG AGA GAG
PINBDR Heterologous expression GTG CTC GAG T T T  TTC TTG GGA 
CGG CTG TTG CTT
PINBDTF Heterologous expression CGG GAT CCG ACC AGA CCC GCA 
GTG ACT GTA TT T
PINBDTR Heterologous expression GTG CTC GAG CGT A TT GTT GCC 
GCG GAG TAA CGC
PINBDTWR Heterologous expression GTG CTC GAG AAC CAC CGA CTG 
CAC AGC CCC CCC
Table 2.2 Oligonucleotide primers used for PCR.
2 . 4 . 2 Routine PCR
PCR was routinely carried out using HotStarTaq™ thermostable DNA polymerase 
(Qiagen) and its associated buffers. A number of PCR reactions were performed 
which required special conditions (optimisation of reagent concentration or the use of 
Q-solution). Cycling parameters varied with each PCR and primer set but a general 
example of both cycling parameters and reaction mixture composition is presented. 
Particular PCR conditions for each reaction will be provided with the appropriate 
result in later chapters.
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Reaction Mixture Composition: ffinal amount!
Final volume lOO^ il
MgCl 1.5mM
dNTPs 200^iM
Primers 1.5pM (each)
lOX buffer IX
Polymerase 2.5 units
Template DNA Pg - Pg"^
Sterile milliQ water to lOOjil
* Template DNA concentration varied depending on the nature o f the template. Either pure DNA,
ligation reaction mixes, cDNA reverse strand synthesis reactions or untreated lambda phage were used
in reactions.
Cvcling parameters
1] 1 cycle 95^C 15min (Taq activation)
2] 35 cycles 94«C 30s
50-65°C 40s
72"C 30s-5min
3] 1 cycle 94®C 30s
50-65°C 40s
72®C lOmin
PCR was performed on either an Eppendorf Gradient Thermocycler or a Techne 
Cyclogene Thermocycler. Both of these thermocyclers possess heated lids. These 
lids were set to 105®C, removing the need for a mineral oil overlay in each reaction.
The use of HotStarTaq™ reduces the need for a hot-start protocol in PCR. However, 
reactions were set up on ice and transferred from ice to the thermocycler only when 
enzyme activation temperature (95®C) had been reached, to enhance specificity.
In order to reduce contamination, reaction reagents were combined using clean micro­
pipettes and DNase and RNase free barrier tips (10|il and lOOpl capacity; Promega).
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Autoclaved, thin-walled PCR reaction tubes (200|t1 or 500]al capacity; Starsted) were 
used for all reactions.
2 . 4 . 3  Single Specific Primer PCR (SSP-PCR)
SSP-PCR was used to isolated gene fragments from lambda clones that could easily 
be cloned and then sequenced. The entire genomic DNA of the recombinant phage 
clone was digested and the fragments ligated into the multiple cloning site (MCS) of a 
plasmid. A gene specific primer was coupled with a standard sequencing primer that 
annealed at the boundary of the vector MCS, Amplification then allowed the isolation 
of the DNA neighbouring the location of the gene specific primer.
Preparation of template for the reaction was achieved via the single digestion of 
pZERO^*  ^ (Invitrogen) vector DNA and lambda clone DNA with identical enzymes. 
The DNA from both digestions was then purified and a ligation of lambda DNA 
(750ng) to vector DNA (50ng) was allowed at 16°C for 4-16h in the presence of T4 
DNA ligase (section 2.6.5). After the ligation period the ligase was inactivated by 
heating at 65^C for 18min. The ligation reaction was diluted 1:10 with lOmM 
TrisHCl pH8.0 and applied as a template for PCR.
2 . 4 .4  PCR based DNA sequencing
DNA sequencing was carried out on DNA cloned into a commercial plasmid vector. 
Sequencing reactions were out-sourced and performed by BaseClear (Leiden, The 
Netherlands) on either ABI377 or LiCor automated sequencers. Purified DNA 
template (and primer if gene specific) were sent to the Company. Raw sequence data 
was supplied in the form of a trace and text file for manipulation and analysis as 
described below.
2 . 4 . 5  Reverse Trancriptase PCR (RT-PCR)
Standard RT-PCR was performed using the Access™ RT-PCR system (Promega). 
This kit makes use of an Avian Leukaemia Virus (ALV) reverse transcriptase and Tfl 
DNA polymerase. The use of Tfl polymerase allows high fidelity amplification 
afforded by the enzymes 3’-5’ exonuclease proof reading capacity.
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A one-tube format reaction was performed using the following reaction components 
and conditions.
To a 0.5ml thin-walled PCR, on ice tube was added;
Nuclease free water 
AMV/jy? 5X reaction buffer 
dNTP Mix (lOmM each)
Reverse Primer (60pmol per |il) 
Forward primer(60pmol per p.1)
25mM MgSO^
AMV reverse transcriptase (5U per pi) 
Tfl DNA polymerase (5U per pi) 
mRNA sample
30pl
lOpl
Ipl
Ipl
Ipl
2pl
Ipl
Ipl
3pl
The following cycling parameters were imposed;
1] 1 cycle 48”C 45min (RT Step)
2] 1 .cycle 94°C 2min
3] 40 cycles 94°C 30sec
60®C Imin
68°C 30sec-3min
4] 1 cycle 68®C 7min
The success of cDNA amplification was assessed by applying 5pi of the RT-PCR 
reaction to agarose gel electrophoresis.
2 . 4 . 6 Nested 5’ SMART^"" RACE RT-PCR
In order to assess the transcriptional start site of a gene, nested 5’ SMART™ RACE 
RT-PCR was performed. This procedure is facilitated by the annealing of a 5’ 
adaptor to the 3’ end of the first cDNA strand (SMART; Small Molecules Attaching to 
the 3’ end of RNA Trancripts). Reverse transcription for first strand cDNA synthesis
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was achieved using Superscript!!™ reverse transcriptase. This is an MMLV derived 
reverse transcriptase that exhibits the non-template directed addition of 3 to 5 cytosine 
nucleotides to the 3’ end of the completed first cDNA strand. This polyC motif 
allows the annealing of the 3’ GGGGG sequence of the SMART Ü™ oligo. Primers 
directed against the SMART !I™ oligo, coupled with the reverse gene specific oligo, 
allowed 5’RACE. A diagram of the procedure is presented in Appendix !.
The following components and reaction conditions were employed.
First strand svnthesis
To a 0.5ml thin-walled PCR tube, on ice, was added; 
mRNA sample 3pl
Reverse gene specific primer Ipl
SMART I!™ oligo Ipl
Oligo/Primer annealing was permitted at l( fC  for 2min.
Following primer annealing the following components were added to the reaction;
5X Reverse transcriptase buffer 2pl
D IT Ipl
dNTP Mix (lOmM of each) Ipl
Superscript II™ MMLV reverse transcriptase Ipl
This reaction was placed in a thermocycler block at 42°C and incubated for I.5h. To 
terminate the reaction the material was diluted in 250ml of Tricine-EDTA buffer and 
the block temperature was raised to 72°C for 7min.
Primary PCR
PCR was performed using the Advantage 2 PCR kit (Clontech). The following 
reagents and conditions were employed.
To a 0.5ml thin-walled PCR tube, on ice, was added;
5’ RACE ready cDNA 2.5pl
UPM* 5pl
Gene specific primer (60pmol per pi) Ipl
PCR grade water 34.5pl
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10 Advantage 2 PCR Buffer 5pl
dNTP mix (lOmM of each) Ipl
Advantage 2 Polymerase Mix Ipl
*UPM; Universal Primer directed against the SMART II™ oligo
The following cycling parameters were imposed;
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1] 5 cycles 94®C
72°C
5sec
3min
2] 5 cycles 94°C
70^ C
72°C
5 sec
lOsec
3min
3] 20 cycles
Secondary PCR
94°C
68“C
72®C
5 sec
lOsec
3min
A secondary PCR reaction was performed using a nested gene specific primer, a 
nested UPM and Ipl of a 1:50 dilution of the primary PCR as a template. The cycling 
parameters used in the primary reaction were repeated, except the 5 cycles of section 1 
were omitted.
The success of both primary and secondary PCRs was assessed by agarose gel 
electrophoresis.
2 .5 Universal GenomeWalker^^ SSP-PCR
Specialised SSP-PCR was performed using Universal GenomeWalker™ technology 
(Clontech.). A diagrammatic overview of the procedure can be found in Appendix II.
2 .5 .1 Preparation of DNA for library construction
High quality P.brasiliensis chromosomal DNA was subjected to five restriction 
digests with blunt cutting restriction enzymes (Dral, FcoRV, Pvnll, Stnl & Seal).
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The following were combined in a 1.5ml microfuge tube;
Genomic DNA (lOOng pi *) 25pi
lOX restriction enzyme buffer lOpl
Sterile deionised distilled water 57pl
Restriction enzyme (lOU pi'*) 8pl
The reactions were allowed to proceed for 2h at 37**C. Each reaction was then 
subjected to brief slow vortexing and restored to 37**C for a further 18h. Following 
incubation, the efficiency of each endonuclease was assessed by the application of 5pl 
of each reaction to agarose gel electrophoresis.
The remaining 95pi of DNA was purified and concentrated by ethanol precipitation. 
The resultant pellet was washed in 70% ethanol and allowed to air dry prior to 
dissolution in 20pl of lOmM TrisHCl pH8.0. The efficiency of ethanol precipitation 
was again assessed by agarose gel electrophoresis.
2 . 5 . 2  Ligation of GenomeWalker™ adapters to the blunt termini 
of restriction fragments
To a 0.5ml thin-walled PCR tube was added;
Restriction enzyme digested DNA 4pl
GenomeW alker adaptor 1.9pl
5X T4 ligase buffer 1. 6pl
T4 DNA ligase 0.5pl
In total, five ligation reactions were performed, one for each restriction digest. The 
tubes were incubated at 16**C in a thermocycler block for 16h. The ligation reactions 
were terminated by elevating the block temperature to 70**C for five minutes followed 
by the addition of 72pl of lOmM TrisHCl pH8.0. Prior to application in PCR, the 
contents of each tube were mixed thoroughly.
2 . 5 . 3  PCR genome walking using the GenomeWalker^*^ libraries
Genome walking was facilitated by SSP-PCR using the adapter ligated genomic 
libraries as template. In order to achieve high specificity a two-step nested PCR
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strategy was imposed. Sequentially, two pairs of primers were employed, each pair 
composed of an adapter directed primer and a gene specific primer. The gene specific 
primer and adapter directed primer in the primary reactions (GSPl and API 
respectively) were designed to allow the application of the second pair of primers 
(GSP2 and AP2) which would target a sequence internal to the primaiy PCR product. 
This allows increased specificity and the monitoring of the nested PCR performance 
by the visualisation of a decrease in the size of a secondary product in comparison to 
the primary.
As an additional measure to increase PCR specificity, a touchdown PCR protocol was 
performed. Essentially, this procedure imposes high stringency on the initial cycles 
of the PCR using high annealing temperatures that are gradually decreased. Once the 
target annealing temperature is reached it is held for the remaining cycles of the PCR.
Primary PCR
To a thin-walled 0.5ml PCR tube was added;
GenomeWalker™ library DNA Ipl
GSPl (lOOpM Hi ') lHl
API (IOhM) IM-1
lOX PCR reaction Buffer 5pi
Sterile distilled deionized water 40.5pi
dNTPs (lOmM each) Ipl
HotStarTaq™ polymerase 0.5pl
Five tubes were set up in total, one for each library.
The reactions were performed in an Eppendorf gradient thermocycler using the 
following cycling paiameters;
1] 1 cycle 95"C 15min
2] 10 cycles 94°C 30s
65“C (-0.5"C per cycle) 40s
72“C 4min
3] 25 cycles 94"C 30s
60"C 30s
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72**C 4min
4] 1 cycle 94°C 30s
60"C 30s
72**C lOmin
For each primary reaction, 5 pi of the product was analysed by agarose gel 
electrophoresis.
Secondary PCR
The primary PCR was diluted 1:50 in lOmM TrisHCl pH8.0 before serving as the 
template for the secondary reaction. PCR conditions were the same as those used in 
the primary PCR except primers GSPl and API were replaced by GSP2 and AP2 
respectively. Also, the number of cycles in stage 3 of the PCR was reduced from 25 
to 15. For each secondary reaction, 5pl of the product was analysed by agarose gel 
electrophoresis.
2 .6  Enzyme mediated manipulations of DNA
2 . 6 . 1  Restriction enzyme digestion
Digestion of DNA with restriction endonucleases was performed in 1.5ml microfuge 
tube at 37°C in a water bath. Reaction mixes contained the appropriate enzyme 
buffer, diluted to IX, 3-6 units of restriction endonuclease and an appropriate amount 
(50ng to 10|xg) of DNA. Sterile distilled water was added to a final volume of 20|ll1.
Digestion was allowed to proceed for 20m in^h  depending on template concentration 
and intended application of the DNA. Routinely, the preparation of plasmid DNA for 
sticky-end cloning was achieved in 20min, the digestion of plasmid DNA for analysis 
of cloning was performed in Ih while 4h was used for the digestion of larger 
concentrations of genomic DNA. Reactions were stopped at the endpoint either by 
immediate electrophoresis, by inactivation of the enzyme by heat (if the enzyme was 
heat labile) or by a previously described DNA purification technique.
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2 . 6 .2  Fluorescein labelling of probes for hybridisation
The production of DNA probes for hybridisation was achieved using the Amersham 
Gene Images™ kit. An appropriate amount of probe DNA (50-200ng), in a volume 
of 34|Lil was denatured by boiling for 5 minutes, followed immediately by incubation 
on ice.
To a 1.5ml microfuge tube, containing the DNA, was added;
Denatured DNA (50-200ng) 34pl
Flourescein labelled dNTPs lOjal
Random hexamer primers 5 pi
Klenow DNA polymerase (Amersham) 5U (Ipl)
The reaction was allowed to proceed at 37**C, in a waterbath, for Ihour. The reaction 
was stopped at the end point by the addition of EDTA to a final concentration of 
20mM.
Prior to using a probe for hybridisation, the success of the random prime labelling
reaction was assessed. To a strip of Hybond N+ (Amersham) nylon membrane was
placed 5pi of the probe labelling reaction and 5pi of fluorescent nucleotides at 
separated marked positions. The solutions were allowed to air dry for 60s and placed 
in a hybridisation tube containing 20ml of 2xSSC (20X SSC is 3M NaCl and 0.3M 
Na citrate pH7.0) at 60°C. The membrane was washed under these conditions, in a 
hybridisation oven that revolved the tube, for 15min. The success of probe labelling 
could be visualised immediately by placing the membrane, face down on a UV 
transilluminator. Typically all unincorporated nucleotides would be washed off and a 
fluorescent signal would remain, which arose from the fluorescein labelled dNTPs 
incorporated in the DNA probe.
2 . 6 . 3  A-tailing of proof read RT-PCR amplicons to allow A-T 
cloning
Following gel purification, an appropriate amount (c. 200ng) of a PCR amplicon, 
generated by a proof-reading polymerase was exposed to non-proof-reading Taq 
DNA polymerase in the presence of lOOpM dATP, 1.5mM MgCl^ and IX PCR 
reaction buffer. The mixture was incubated at 72**C for 15 minutes. The DNA was
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then re-purified by electrophoresis and gel extraction prior to inclusion in an A-T 
cloning reaction.
2 .6 .4  Dephosphorylation of vector ends
The sticky ends of single restriction enzyme digested plasmid DNA were 
dephosphorylated to reduce the frequency of self-self ligation during a cloning 
procedure. A 20pl single enzyme restriction digest of Ipg pZERO™ vector DNA was 
allowed to proceed for 15mins. To this reaction, 5 units of calf intestinal alkaline 
phosphatase (CIAP) was added and the reaction was further incubated for 5 min at 
37°C.
2 .6 . 5  Ligation of DNA to plasmid vectors
Vector systems used for cloning were linear, or made linear, to facilitate a T4 ligase or 
topoisomerase dependant insertion of the DNA of interest into the cloning site of the 
plasmid. Two types of system were used. For the cloning of PCR products (3’ 
adenylated), A-T cloning was used. For cloning of restriction fragments of DNA, 
sticky end ligations were performed by cutting the vector DNA to generate ends 
compatible with those of the DNA to be cloned.
A-T cloning
For general propagation and sequencing of PCR amplicons the pGEM-T Easy™ 
vector system was used (Promega). Reaction components were as follows;
To a 1.5ml microfuge tube was added;
pGEM-T Easy™ Vector DNA Iql (50ng)
2x Rapid ligation Buffer 5 p.1
Gel Purified PCR amplicon 3 p.1 (To give a 2:1 insert to vector ratio)
T4 DNA ligase 1 ql (5 Units)
Ligation was allowed to proceed for Ihr at room temperature or overnight at 4**C prior 
to transformation.
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For the construction of recombinant protein expression systems in Saccharomyces 
cerevisiae, the pYES2.1-V5-His Topo™ vector system (Invitrogen) was used.
Reaction components were as follows;
To a 1.5ml microfuge tube was added;
Topoisomerase activated pYES2.1 -V5-His Topo*  ^vector 1 |il
Gel purified PCR product 4|il
The ligation was allowed to proceed for 5min at room temperature. The ligation was 
stopped at the endpoint on addition of Ipl of stop buffer (proprietary composition).
The reaction was used to tranform S.cerevisiae.
Cohesive end cloning
For the cloning of DNA from restriction digests of recombinant lambda DNA, or the 
generation of template DNA for SSP-PCR, the pZERO™ vector system (Invitrogen) 
was used. Ligation was achieved using the Life Technologies T4 DNA ligase enzyme 
and buffer system.
Reaction components were as follows;
Digested pZERO™ vector DNA 5 Ong
Digested DNA to be cloned 200ng
5x Ligase Buffer 4pl
T4 DNA ligase Ipl (5 Units)
Sterile Distilled Water to 20 pi
Ligation was allowed to proceed for I-4hr at 16**C (in a PCR thermocycler) prior to 
transformation.
For cloning of DNA fragments for recombinant expression in E.coli strains, digested 
pET21b (Novagen) was used. Reaction components were as follows;
Digested pET21b DNA 50ng
Digested DNA to be cloned 30-200ng (to a 2:1 insert to vector ratio)
5x Ligase Buffer 4pl
T4 DNA ligase Ipl (5 Units)
Sterile Distilled Water to 20 pi
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Ligation was allowed to proceed for Ihr at room temperature prior to transformation.
2 .7  Transformation of E.coli and S.cerevisiae with plasmid
DNA
2. 7 . 1  Transformation of chemically competent E.coli
Chemically competent E.coli strains acquired from various commercial sources. 
Transformation protocols varied, as per manufacturer’s instructions. A typical 
protocol is described below;
To a 1.5ml microfuge tube on ice was added 50pl of thawed competent cells. The 
cells were then mixed with 1.7pl of lOOmM p-Mercaptoethanol and incubated on ice 
for lOmin. Following this 50ng-500ng of plasmid DNA or ligation reaction was 
added to the cells and gently mixed. This mixture was then incubated on ice for 
30mins. Heat shock was applied to the transformation by rapidly inserting the tube in 
a 42°C water bath for Imin. Tubes were rapidly restored to an ice bath for two 
minutes. To each tube, 450pl of SOC medium was added and the suspension was 
shaken at 220rpm and 37°C for 1 hour. Cells were then plated onto LB agar 
containing the appropriate antibiotic.
2 .7 . 2  Transformation of Bacteria by Electroporation
When a higher number of recombinants was required, electroporation of competent 
cells was used. To an ice-chilled 2mm electroporation cuvette (Equibio) was added 
50pl of electrocompetent cells and 50-500ng of DNA. The electroporation cuvette 
was inserted in a pre-chilled caniage into a BioRad Electroporator and exposed to 
200V/75mA of current. Cells were immediately re-suspended in 950pl of SOC media 
and shaken at 37**C for Ihr. Cells were then plated onto LB agar containing the 
appropriate antibiotic.
2 .7 .3  Transformation of S.cerevisiae with plasmid DNA
A single colony of the S.cerevisiae strain was used to inoculate 10ml of YPD in a 
50ml Erlenmeyer flask. The culture was shaken at 200rpm and 30**C overnight. The
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following morning the culture O.D.ggQ was assessed and a dilution was made so as to 
bring the to 0.4 in 50ml of YPD. Outgrowth was permitted at 30**C and
200rpm for 3h. Cells were pelleted at 2,500rpm and 4®C for lOmin. The pellet was 
re-suspended in 40ml of TE buffer and the centrifugation repeated. The pellet was re­
suspended in 2ml of Yeast Transformation Buffer (IX  Lithium Acetate/ 40% PEG- 
3350/ IX TE) and incubated at room temperature for 30min.
For each transformation the following components were mixed in a 1.5ml microfuge 
tube;
Plasmid DNA Ipg
Denatured Salmon Sperm DNA lOOgg
Yeast Suspension lOOp.1
Y east Transformation Buffer 700pl
This mixture was incubated at 30®C for 30min. On the addition of 88|il of DMSG 
(dimethylsulphoxide) the cells were heat shocked at 42**C for 7 min. The cells were 
harvested at 8000rpm for Imin, re-suspended in 1ml of TE buffer and 50-100fxl were 
spread on a SC-U selective plate. Plates were incubated at 30**C in an inverted 
position for 72h to allow transformant colonies to grow.
2 . 7 . 4  Selective screening of recombinant bacterial clones
Blue/White screening of recombinant pGEM-T Easv™ clones
Differentiation between successful and unsuccessful insert cloning in pGEM-T 
Easy™ was allowed by the insertional inactivation of the p-Galactosidase gene and 
resultant perturbation of hydrolysis of X-gal (5-bromo-4-chloro-3-indolyl- p -D- 
galactoside), a non lactose substrate analogue. Expression from the P-Galactosidase 
gene is under the control of the lac promoter and as such successful transcription 
requires the presence of the non-utilisable lactose analogue IPTG (isopropyl-p-D- 
thiogalactopyranoside). To each plate of LB agar (lOOpg per ml ampicillin) was 
spread lOOpl of sterile lOOmM IPTG (Melford laboratories). The p-galactosidase 
activity was detected by the inclusion of X-gal on the plates. Prior to inoculation 
lOOp.1 of 2%w/v X-gal, in dimethyl formamide, was spread onto the agar surface. 
The surface moisture arising from IPTG and X-gal application was allowed to dry on 
placing the plates at 37**C for a minimum of 30min prior to use.
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Plates were incubated, in an inverted position, at 37**C for 16-18h, and white colonies 
picked and propagated for further analysis.
Analvsis of recombinant pZERQ™ constructs by insertional inactivation of the ccd B 
gene.
Discrimination between recombinant and self-ligated plasmid constructs in the 
pZERO™ vector was also achieved by insertional activation of a plasmid borne gene. 
In this case however the re-ligation of linearised plasmid to the original form (i.e. 
without insert) reconstituted the ccdB gene. This gene, which was also under the 
control of the lac promoter, is lethal to cells that express the encoded protein. The 
protein acts on the bacterial DNA gyrase and its presence results in perturbation of 
ATP-dependant negative supercoiling. As such, all clones that do not possess a 
plasmid containing recombinant insert are rendered inviable. In order to activate the 
expression of the ccd gene, IPTG was added to the molten LB agar (with 50jag per ml 
kanamycin to a final concentration of ImM. Following inoculation, the plates were 
incubated for 16-18hr at 37°C, and evident colonies were picked and propagated for 
further analysis.
2 .8  Southern transfer and hybridisation of DNA
2 . 8 . 1  Southern transfer of DNA from agarose gels
DNA samples for Southern blotting were run on an agarose gel as described above 
(section 2.3.1). To assist in analysis two lanes of molecular weight markers were 
run, flanking the samples on both sides and scale was applied to the gel photograph 
by placing fluorescent rulers either side of the gel during photography.
The gel was then transferred to denaturing solution (1.5M NaCl/0.5M NaOH) on a 
shaking platform for 45 minutes. The gel was then washed in dH^O and neutralised 
by incubation in neutralising buffer (1.5M NaCl/0.5M TrisHCl pH8.0) for 30 min. 
This neutralising buffer was discarded and the gel was placed in fresh buffer for a 
further 15min.
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The transfer of DNA to the Hybond N+ membrane was achieved by the method of 
Southern (Southern E.M., 1970). Essentially, a platform was made in a reservoir of 
20x SSC (as in section 2.6.2). A wick made from Whatman 3M filter paper covered 
the platform and was draped from the platform into the SSC. Onto the platform was 
placed the treated agarose gel in an inverted position (well face down). A section of 
Hybond N+, cut 1mm smaller than the gel at each edge, was placed on to of the gel 
avoiding the trapping of air. The nylon membrane was overlaid with 2 sheets of 
Whatman 3M paper that had been soaked in 2X SSC for lOmin. Approximately 
10cm of absorbent paper towels were placed on top of the assembly to accumulate the 
transferred SSC. A 500g weight was applied to the top of the stack of towels. 
Transfer was allowed overnight.
The efficiency of transfer was assessed by re-staining the gel in 40mls of TAB buffer 
containing ethidium bromide (0.2|xg per ml).
2 . 8 . 2  Transfer of DNA to nitro cellulose membranes from X 
plaque lawns
The transfer of lambda plaque DNA to nitro-cellulose was performed after the method
of Sambrook, Fritsch & Maniatis (1989). Plaque lawns of recombinant X phage were
grown overnight on 10 cm x 10cm square petri dishes. The plates were placed at 4**C 
for 2h to allow hardening. DNA transfer was achieved by placing a section of 
Hybond N+ nitro-cellulose membrane onto the agar surface for 2min to allow phage 
particles to adsorb. The membranes were cut at several places to provide orientation 
marks. These were noted on the plate to aid later analysis. The membranes were then 
treated for 5min in dénaturant (1.5M NaCl/0.5M NaOH), followed by 4 min in 
neutralising solution (1.5M NaCl/0.5M TrisHCl pH8.0). Following a brief wash in 
2xSSC the membranes were wrapped in saran wrap. The membranes were then 
exposed to 12,000 j per cm^ of ultraviolet light in a cross-linker to secure the DNA to 
the membrane. Membranes were used directly for hybridisation or stored at 4**C until 
required.
2 . 8 . 3  DNA:DNA hybridisation
The hybridisation procedure was performed in a Techne hybridisation oven. 
Generally, the protocols for the hybridisation of membranes derived from Southern
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blots or plaque lifts were identical. The membranes were pre-hybridised for 2h at 58- 
65°C in pre-hybridisation buffer (5xSSC/l%SDS/5% dextran sulphate/1:10 dilution 
of blocking reagent (Amersham)). Tubes were rotated at c.80rpm to allow mixing. 
After this period, denatured probe (5-40ng per ml of hybridisation fluid) was added to 
the tube. Hybridisation was allowed to proceed for 12-16hrs at 55-68**C.
2 ,8 .4  Washing and detection of bound probe
Unbound probe was removed from the membrane by sequential washings at 60°C in 
decreasing concentrations of SSC in the presence of SDS. Three 10 min washes were 
imposed; 2xSSC/0.1%SDS, lxSSC/0.1%SDS, and finally 0.5xSSC/0.1xSDS. The 
membrane was then blocked for Ih at room temperature using a 1:10 dilution of liquid 
block in buffer A (lOOmM TrisHCl, 300mM NaCl pH9,5).
The membrane was washed briefly in buffer A and probe detection commenced. In 
order to detect bound probe the membrane was exposed to mouse anti-flourescien 
HRP conjugate. The antibody was applied to the membrane at a 1:5000 dilution in 
20ml of bufferA plus 0.5% w/v bovine serum albumin (fraction V), per hybridisation 
tube. This was incubated at 25°C for 1.5h. Unbound antibody was removed by 
3x10min washes in buffer A with 0.3% v/v Tween 20.
To induce signal from the antibody, 2pl of CDP-Star detection reagent (proprietary 
composition) was applied per cm^ of membrane (generally 200pl was used). The blot 
was soaked in the detection reagent for 2min and excess reagent was removed. The 
blots were then transferred to a plastic envelope within an autoradiography cassette. 
A sheet of Hyperfilm™ MP (Amersham) was placed into the cassette under safelight 
illumination so as to be exposed to the signal generating face of the membrane. 
Exposure was allowed for 15min - 4h before developing the film in an automatic 
developer.
2 . 8 . 5  Analysis of results derived from agarose gels
The image observed on the blot was marked to allow the distance of positive signals 
to be measured from the originating wells. The relevant DNA on the original gel was
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then identified by reference to the scale on the original photograph, as shown by the 
fluorescent rulers.
2 . 8 . 6  Analysis of results derived from X plaque lifts
The orientation marks on the blot images were marked. These images were then 
aligned with the markings on the original phage plates, on a white light box to identify 
positive plaques. Plaques giving a positive signal were marked, on the underside of 
the plate, for further investigation.
2 .9  Heterologous expression of recombinant proteins
2 . 9 . 1  Expression of recombinant proteins from pET21b in 
Epicurian coli ® BL21 CODON PLUS™ (DE3)-RIL
The heterologous production of recombinant proteins derived from P.brasiliensis was 
achieved in Epicurian coli ® BL21 CODON PLUS™ (DE3)-RTL cells. Bacterial 
strains harbouring expression constructs were streaked onto a LB agar (lOOpg per ml 
carbenicillin, 34 |ig per ml chloramphenicol) plate to allow the isolation of a single 
colony. Following overnight incubation and growth, a single colony was used to 
inoculate a starter culture. The starter culture was grown in a volume of media 1/10 of 
that used in the final expression culture. Outgrowth was allowed at 37**C with 
shaking (200rpm) until the O.Dgoo reached 0.5. The starter culture was then added as 
a 1/10 volume to the media intended for expression (LB plus l(X)|xg per ml 
carbenicillin/1 OOpg per ml chloramphenicol) and growth continued under similar 
incubation conditions until an approximate O D^Q^of 0.6. was reached.
At this point expression was induced by the addition of IPTG to a final concentration 
of ImM. In order to induce expression, the de-repression of two promoters is 
achieved by the inactivation of the lac repressor {lad). This is an allosteric effect 
occurring upon interaction of this protein regulator with IPTG. The de-repression of 
the chromosomal lacUV 5 promoter permits the production of T7 RNA polymerase 
that instigates transcription from the Tllac promoter, allowing transcription of
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recombinant mRNA. The Tllac promoter is also under the control of the lac 
repressor, allowing a further level of control of repression prior to induction.
For time-course experiments samples were aseptically removed at Ih intervals to 
allow monitoring of protein production by SDS-PAGE.
2 . 9 . 2  Preparation of Total Cell Protein (TCP) samples for analysis 
of recombinant expression
In order to assess the extent of heterologous protein expression, a culture of the 
recombinant strain was grown in the appropriate medium and induced as described 
above. Prior to induction and at Ih intervals thereafter a 1ml aliquot was removed 
from the expression culture. The cells were harvested by centrifugation at 13,000rpm 
for 1 minute. The cell pellet was prepared for analysis by SDS-PAGE as described in 
section 2.9.6.
2 . 9 . 3  Expression of recombinant proteins from pYES2 in 
Saccharomyces cerevisiae
The heterologous production of recombinant proteins of P.brasiliensis origin in 
S.cerevisiae was achieved in the following manner. Yeast strains harbouring 
expression constructs were streaked onto ScU' Minimal agar (2% glucose) plates to 
allow the isolation of a single colony. Following 72h incubation and growth a single 
colony was used to inoculate a starter culture. The media for this starter culture was a 
volume of ScU’Minimal broth (2% glucose), 10% of that of the final intended volume 
for expression. Outgrowth was allowed at 30**C with shaking (200rpm) until 
overnight. The OD^qq of the overnight culture was assessed and an appropriate 
volume of the starter culture was designated for the inoculation of the induction 
medium; 100ml ScU Minimal broth (2% galactose/l%Raffinose). This volume of 
starter culture was calculated as the amount of cells that were required to bring the 
GDgoo of the expression culture to 0.5. The required volume of the starter culture was 
pelleted at 3000rpm for 5min and washed once in the galactose/raffinose induction 
medium. The re-suspended pellet was transferred to the pre-warmed induction 
medium and incubated at 30°C for 24h.
In order to assess protein production over time, samples were taken at 4h intervals 
during the course of expression.
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2 . 9 . 4  Electrophoresis of protein under denaturing conditions
by SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Composition and preparation of gels
Analysis of protein derived from recombinant systems was achieved by separation of 
those proteins by electrophoresis. Electrophoresis was carried out on vertical 
polyacrylamide gel slabs according to the procedure first described by Laemmli 
(Laemmli, 1970). Each gel system consisted of a separating gel and a stacking gel.
For separating gels the percentage acrylamide ranged from 10% to 12 % depending on 
the resolution required at certain molecular weights. Typically a 12% gel was used 
and was composed and polymerised as follows:
1] The following reagents were mixed in a 10ml beaker;
Distilled water 3.5ml
1.5M TrisHCl pH8.8 5.22ml
10% SDS lOOpl
30% w/v acrylamide/bis solution (Biorad) 4.0ml
2] This solution was then degassed for 15 min in a vacuum chamber.
3] To initiate polymerisation, the following were added and gently mixed;
TEMED* 5)Ltl
10% APS*^___________________________ 50|iil t0.5mM final concentration)
Final volume 10ml
The gel mix was carefully loaded into a BIO-RAD mini-gel apparatus and overlaid 
with water saturated butanol. Polymerisation was allowed to proceed for 45min at 
room temperature.
For stacking gels the percentage acrylamide was 7%. This gel was composed and 
polymerised as follows:
1] The following reagents were mixed in a 10ml beaker;
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Distilled water 6ml
0.5M TrisHCl pH6.8 2.5ml
10% SDS lOOpl
30% w/v aciylamide/bis solution 1.3 ml
2] This solution was then degassed for 15 min in a vacuum chamber.
3] To initiate polymerisation, the following were added and gently mixed;
TEMED* 10|il
10% APS*^ 50pl r0.5mM final concentration^
Final volume 10ml
(*TEMED; N,N,N’N ’-tetramethylethylenediamine (CgH^gN^ ). *^APS; Ammonium 
Persulphate (NH^S^Og), prepared fresh daily.)
Following removal of the overlaying butanol the stacking gel was carefully applied on 
top of the separating gel. A gel comb (10 or 16 wells) was inserted into the stacking 
gel and polymerisation was allowed to proceed for 45min at room temperature. When 
polymerisation was complete, the comb was removed and the wells were gently 
flushed with running buffer (see section 2.9.8).
2 .9 .5  Assembly of electrophoresis apparatus
The gels were inserted and clamped into a central manifold and placed inside an 
electrophoresis tank. The central chamber was then filled with IX SDS-PAGE 
running buffer (per litre; 3g of Tris base, 14.4g of glycine, Ig of SDS, often made as 
a 5X stock) until a depth of approximately 7mm was present above the height of the 
gel. The outer chamber was also filled with running buffer at a sufficient level to 
allow the electrode to be completely submerged.
2 . 9 . 6  Preparation of samples for SDS-PAGE
Samples for SDS-PAGE were prepared in various ways depending on the origin of 
the material. Bacterial pellets to be analysed directly were re-suspended in an 
appropriate volume lOX SDS-PAGE loading buffer (per 8ml; 4ml of distilled water,
83
Chapter 2
1ml of 0.5M TrisHCl, pH8.6, 0.8ml of glycerol, 1.6ml of 10% SDS, 0.4ml of 2 (3- 
mercaptoethanol and 0.05% w/v bromophenol blue). The samples were then boiled 
for 5 min and placed on ice until required.
Protein preparation from yeast cells was achieved using osmotic lysis coupled by 
mechanical shearing. To a yeast cell pellet was added a volume of PBS (usually 
lOOpl per 1ml of original culture). An equal volume of lOX loading buffer was added 
and the sample was vortexed for 30s. The sample was then placed in boiling water 
for 5 min prior to application on a gel.
Samples not derived directly from microorgansism followed a similar pattern except 
that no vortexing was necessary. An appropriate volume of sample for analysis was 
mixed with an equal volume of lOX loading buffer and boiled for 5min.
2 . 9 . 7  Electrophoresis protocol
To the each sample well of the gel was added 5-20pl of protein sample using a lOOpl 
capacity Hamilton syringe. Each gel included a lane of LMW molecular weight 
calibration markers (Pharmacia biotech). Current was applied at 200V and the 
electrophoresis was allowed to run until the required separation was considered to be 
achieved (usually 40-50min).
2 . 9 . 8  Analysis of SDS-PAGE gels
Analysis of polyacrylamide gels was achieved using Gelcode® Blue Protein Stain 
(Pierce). Initially the gel was removed from the glass plates and placed into a 10cm x 
10cm square petri dish filled with distilled water. The gel was washed in the water 
for 15min with gentle agitation to remove SDS (because SDS inhibits the staining 
procedure). The water was discarded and the 15min wash repeated. The water was 
again discarded and 20ml of Gelcode® Blue Protein Stain was applied. The staining 
was allowed to proceed for Ihr and then the stain was removed and replaced with 
water to allow destaining. Following destaining protein bands could be visualised 
with clarity.
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2 .1 0  Analysis of recombinant expression by western 
blotting
Western immuno-blotting was used to confirm the presence of a His^ tag on 
recombinant proteins, or simply to demonstrate the presence and identity of those 
proteins.
2 . 10 .1  Western transfer of proteins onto nitro cellulose membrane
Electrophoresis of gels intended for western transfer was achieved as previously 
described for SDS-PAGE gel electrophoresis. Gels were run in duplicate, one for 
transfer and one for direct analysis by staining. The transfer gel was removed 
following electrophoresis and immersed in transfer buffer (per litre; 3.03g of Tris 
base, 14.5g of glycine and 200ml of 100% methanol, made up to IL with distilled 
water) for 40min prior to assembly of the transfer apparatus. For each gel, a section 
of Hybond C (Amersham) nitro-cellulose membrane was cut to the exact size of the 
separating gel. Two pieces of Whatman 3M filter paper were also cut to this size. 
Both the membrane and the filter papers were soaked in the transfer buffer for 20min 
prior to the assembly of the transfer apparatus.
The gel transfer cassette was assembled as follows. Firstly an abrasive nylon fibre 
pad, soaked in transfer buffer was placed on the cathodic face of the cassette. Onto 
this pad was placed one of the soaked 3M filter papers. The stacking gel was trimmed 
from the separating gel and a comer of the separating gel was trimmed removed to 
allow orientation. The separating gel was then placed on top of the filter paper. A 
replicate comer of the Hybond C paper was cut and the paper was laid over the gel, 
avoiding any trapping of air. Finally, the other 3M filter paper was applied and a 
second abrasive soaked nylon pad. The cassette was then closed and placed in an 
electrophoresis tank. The cassette was inserted so that the protein samples could 
migrate from the gel onto the nylon membrane, in the direction of the anode. An ice 
block was placed in the tank and the chamber was filled with 4°C transfer buffer . A 
magnetic stirrer was also added to provided circulation and cooling of buffer during 
the procedure.
A current of lOOV was applied for Ih to allow transfer. Following disassembly of the 
cassette, the membrane was reversibly stained in 20ml of 0.1% w/v Ponceau S in
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0.5% v/v acetic acid until the transferred proteins could be visualised. The membrane 
was then destained by 2 x lOmin washes with 40ml PBS.
2 .1 0 . 2  Processing of the western blot
The membrane was removed, placed in a 10 x 10cm dish and blocked for Ihr with 
50ml 3% w/v skimmed milk in wash buffer (1.21 g of Tris base, 8.7g of NaCl and 
800pl of concentrated HCl made up to IL [pH7.4]). Following blocking the 
membrane was transferred to a heat sealed bag containing 30mls of 3% skimmed milk 
and a 1:300 dilution of mouse anti-HiSg monoclonal antibody (Pharmacia). The 
antibody was allowed to bind on incubation at 37®C for 3 hours with agitation. The 
blot was then washed 4 x 5min with 40ml of wash buffer and gentle agitation. 
Secondary antibody binding was performed in 30ml of 3% w/v skimmed milk in 
wash buffer containing a 1:1000 dilution of rabbit anti-mouse HRP conjugated 
antibody. Again incubation was for Ih at 37®C with gentle agitation. Prior to 
detection the blot was washed 4 times with wash buffer as described above. Proteins 
with bound antibody were detected by immersing the gel in a developing solution 
(30mg of 4-chloro-1 -napthol dissolved in lOmls methanol was added to 50mls 
TrisNaCl followed by 30pl of 30% w/v hydrogen peroxide). The colour signal was 
allowed to develop in the dark and the reaction halted by washing in distilled water 
once the desired intensity was reached. The blot was then air dried and stored in the 
dar k between sheets of Whatman 3M filter paper to discourage fading.
2.11  Purification of Hisg-tagged proteins
2. 11 .1  Small scale purification of His^-tagged proteins under
denaturing conditions
Purification of high concentrations of protein derived from inclusion bodies was 
performed under denaturing conditions. On a small scale this was done using the Ni- 
NTA Spin kit (Qiagen).
The spin columns were equilibrated by the application of 600pl of equilibration buffer 
(8M urea / O.lMNaH^PO^/ O.OIM TrisHCL pH8.0). The buffer was passed through 
the column by centrifugation at 2000rpm for 2min. The column was then loaded with 
600|il of protein solution re-solubilised in the equilibration buffer. This was passed 
through the column by centrifugation at 2,000rpm for 2min.
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Unbound proteins were washed from the column by 3 applications of 600pl wash 
buffer (as equilibration buffer but pH6.3) and eluted by two applications of 200pl of 
elution buffer (as equilibration buffer but pH4.5). Again centrifugation at 2,000rpm 
for two minutes was used to pass buffers through the column. The success of 
purification steps was analysed by SDS-PAGE.
2 .1 1 . 2  Larger scale purification of His^-tagged proteins under 
denaturing conditions
Larger preparations of inclusion body derived proteins were performed using Ni-NTA 
agarose (Qiagen). The principles used were the same as those imposed on the Ni- 
NTA spin columns.
Preparation of the insoluble protein fraction
Following the required period of induction the cultures were removed from the 
incubator and placed on ice for 5min. The cells were then harvested by centrifugation 
at SOOOrpm for lOmin at 4"C. The supernate was discarded and the pellets placed on 
ice. The cells were re-suspended in an appropriate volume of re-suspension buffer 
(50mM NaPi, 300mM NaCl, pH8.0) to allow for a 1:200 concentration factor in 
reference to the original culture volume. The cell suspension was then treated with 
lysozyme (Img ml"‘ final concentration) and DNAse (Spg ml ' final concentration) and 
incubated on ice for Ih.
The cells were then disrupted using a OneShot™ Cell disrupter (Constant Systems 
Ltd). Cells were forced, under high pressure, through a small aperture in the base of 
a cell disrupter cup. This treatment is efficient at breaking cells. A volume of 5ml 
could be processed at any one time. The disrupted material was recovered from the 
cell disrupter cup and the insoluble protein and/or cell debris was harvested by 
centrifugation at 10,000xg for 30min. The pellet was re-suspended in 30ml of PBS 
containing 0.1% triton X I00 and re-centrifuged. This latter procedure served to 
remove any miscellaneous cell debris from the inclusion body material.
Nickel affinity chromatography
The insoluble pellet was re-suspended in 20ml of Denaturing Re-suspension Buffer 
(8M Urea, O.IM NaH2PO^, O.OIM TrisHCl pH8.0) by shaking overnight at room
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temperature. To 10ml of this solubilised pellet was added 2ml of 50% Ni-NTA 
agarose (Qiagen). This mixture was loaded directly onto a glass chromatography 
column (Biorad Econocolumn). The column was allowed to drain at a rate of 1ml per 
minute. The column was washed 4 times in 8ml of Denaturing Wash Buffer (8M 
Urea, O.IM NaHjPO^, O.OIM TrisHCl pH6.3) and eluted 4 times in 0.5ml 
Denaturing Elution Buffer (8m Urea, O.IM NaH^PO^, O.OIM TrisHCl pH4.5).
The success of each step of purification was assessed by SDS-PAGE.
2 . 11 .3  Purification of His^-tagged proteins under native conditions
Native folded soluble recombinant protein was purified from E.coli cultures using the 
NTA Ni-agarose.
Preparation of soluble protein
The preparation of the soluble fraction was as described for the preparation of the 
insoluble fraction. However after centrifugation at 10,000 x g for 30min, the 
supernate was retained for purification rather then the insoluble pellet. It should also 
be noted that the composition of the re-suspension buffer was 50mM NaPi*, 300mM 
NaCl, 15% glycerol, 15mM imidazole, pH8.0, containing EDTA free protease 
inhibitors (Complete™ EDTA free protease inhibitor tablets (Roche Molecular 
Diagnostics). Care was taken to perform all re-suspension and disruption steps on ice 
as much as possible. The supernate from the 10,000 x g spin was decanted into clean 
9ml ultracentrifuge tubes (Sorvall) and exposed to ultracentrifugation (Sorvall OTD 
combi ultracentrifuge) at 43,000rpm for 1.5h to remove the cell membranes. The 
supernate from this spin was applied to native purification.
* NaPi is Sodium Phosphate buffer, made by combining volumes from 0.5M  NagHPO., and 0.5M  
NaH^PO^ stocks. To make IL o f 50mM NaPi, 93.2m ls of 0.5M  NagHPO,, and 6.8ml o f 0.5M  
NaHzPO^ were added to 900ml of distilled water.
Nickel affinitv chromatography
To the isolated soluble fraction was added a volume of 50% Ni-NTA agarose (1ml of 
Ni-NTA agarose was applied per 8mg of anticipated recombinant protein as this was 
the advised optimal binding capacity of the nickel resin). The mixture was then 
incubated, with gentle shaking (90rpm), at 4°C for Ih.
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To a glass chromatography column was added the soluble fraction/Ni-agarose 
preparation. The column was allowed to drain at a rate of 1ml per min until only the 
agarose was retained. The column was washed with an appropriate column of wash 
buffer (50mM NaPi, 300mM NaCl, 15% glycerol, 40mM imidazole, pH8.0, 
containing EDTA free protease inhibitors). Generally 5 washing steps were applied, 
using 4ml of wash buffer per ml of 50% resin at each stage. Elution of bound protein 
was achieved using high concentrations of imidazole in elution buffer (50mM NaPi, 
300mM NaCl, 15% glycerol, 300mM imidazole, pH8.0, containing EDTA free 
protease inhibitors). A total of 6 elution steps were applied each imposing 500pl of 
elution buffer. The success of each step of purification was assessed by SDS-PAGE
2 . 11 . 4  Dialysis of purified protein
Purified protein was dialysed prior to downstream procedures generating fluorescence 
data. This allowed the removal of intrinsically fluorescent imidazole prior to these 
experiments. Dialysis tubing (12-14kDa pore size) was cut into 8cm sections and 
boiled for 10 min in 2% w/v NaHCO/lm M  EDTA. The tubing was washed 
extensively in distilled water and boiled for a second time in ImM EDTA. The 
extensive water washing was repeated and the tubing was submerged in ImM EDTA 
and stored at 4 '^C until required
The purified protein solution was transferred pre-prepared dialysis tubing (12-14 kDa 
pore size) and secured using dialysis clips. Dialysis of the protein was performed in 
dialysis buffer (50mM NaPi, 300mM NaCl, 15% glycerol, pH8.0, containing EDTA 
free protease inhibitors). A ratio of 1:1000 was imposed on the dialysate to dialysis 
buffer and the dialysis system was incubated with gentle stirring at 4®C for 48h. The 
protein was then recovered from the dialysis tubing, aliquoted into 1.5ml microfuge 
tubes and snap frozen in a dry ice/ethanol bath.
2 .1 2  Ligand binding analysis
2 . 12 .1  Stopped-flow analysis of nucleotide/protein interactions
The transient process of nucleotide interactions with a protein nucleotide-binding 
domain was measured in a stopped flow device (Applied Photophysics). This
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apparatus allows the measurement of transient changes in the fluorescence output 
following the rapid mixing of protein and ligand solutions. By plotting values derived 
from alterations in this emission over a selected time-base, a graphical representation 
of progressive increases or decreases in fluorescence can be obtained. Depending on 
the filter used on the output light, the fluorescence of either tryptophan (protein) or 
ligand can be analysed and conformational changes demonstrated. An increase in the 
fluorescence of a given tryptophan relates to a conformational change that results in 
the internalisation of the residue to an environment shielded from quenching water 
molecules. A decrease in fluorescence signal relates to an externalisation and an 
increased exposure to the quenching phenomenon.
Interactions between protein and ligand occured in a mixing chamber, equilibrated to 
20''C. Delivery of both protein and ligand solutions to this chamber was achieved by 
pushing equal volumes of each solution (approx. lOOpl) from external reservoirs using 
nitrogen-driven hydraulic plungers. Tryptophan excitation light, at a wavelength of 
280nm, was constantly applied to the mixing chamber. This light originates from an 
argon lamp and the wavelength is selected on passage through two monochromators.
Output or emission light was filtered to select for the appropriate wavelength and 
collected in a photomultiplier tube (PMT). Alterations in the level of fluorescence 
resulted in a proportional alteration in the voltage output of the PM tube. It was these 
PM volts that were plotted to relate the fluorescence behavior of the contents of the 
mixing chamber.
In our experiments we examined the interactions of a protein nucleotide-binding 
domain with the fluorescent nucleotide analogue MANT-ATP (2’-(or 3’)-0-(N- 
methylanthraniloyl) adenosine 5’ triphosphate) (Molecular Probes Inc.). The changes 
in tryptophan fluorescence were measured on a 50millisecond logarithmic time base 
collecting emission light at 320nm. Changes in the fluorescence of the MANT-ATP 
ligand were measured in the same way using a 420nm filter. The data was processed 
on an Acorn II microcomputer using Applied Photophysics software.
For each experiment, solutions of both protein and MANT-ATP were prepared using 
the buffer used for the dialysis of the test protein (50mM NaHgPO^, 300mM NaCl, 
15% glycerol).
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2 . 12 . 2  Steady-state analysis of protein/drug interactions
The analysis of interactions between a protein nucleotide-binding domain and the 
azole drug ketoconazole was measured, on the basis of fluorescence, in a Jascow 
Series II fluorimeter. Excitation light was applied at a wavelength of 285nm via a 
series of chromating mirrors. This input light serves to excite fluorophores in a quartz 
cuvette and the fluorescent emission is measured at right angles to the input light.
For the purposes of our experiments a total volume of 200pl was used in a Hellma 
suprasil quartz cuvette. This volume contained a constant concentration of protein and 
variable concentrations of ligand. Again, the buffer system used was the same as that 
used for protein dialysis (section 2.11.4). Ligands applied were ketoconazole (made 
as a stock solution of lOmg ml ' in DMSO), and ATP (at a stock concentration of 
lOOmM). For the study of azole binding, the drug was applied at concentrations of 
zero to lOOpM. The effect of ATP on this system was examined using a constant 
concentration of lOmM ATP. All observations were made at 20"C.
Measurements were made by exciting the system at 285nm and scanning output from 
290nm to 500nm, allowing for fluorescence peaks derived from both protein and 
ketoconazole to be measured. Inner filter effects imposed by ATP or ketoconazole 
were quantified by positioning a 2ml Hellma suprasil quartz cuvette in front of the test 
cuvette containing protein or protein + ligand. This 2ml cuvette was filled with buffer 
containing lOmM ATP or an appropriate test concentration of the azole drug. The 
resultant decrease in the fluorescence output from the test cuvette was recorded and 
experimental observations were corrected accordingly. AH experimental observations 
were made with the 2ml cuvette placed in front of the test cuvette to eliminate 
variations in the transmission of excitation light.
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Chapter 3
Isolation and sequencing of p f t l .  an MDR-like ABC half 
transporter from Paracoccidiodes brasiliensis
The objective of the experiments reported in this chapter was to screen the genome of 
P.brasiliensis for genes encoding ABC transporters belonging to the MDR subfamily. 
This was to be achieved by the application of degenerate PCR primers, a technique 
which had proved useful for isolating fragments of such genes by other investigators 
(Bozdech et al., 1996; Tobin et al., 1997). The full length genes corresponding to any 
relevant generated fragments would be isolated, cloned and sequenced.
The primers used (denoted as MDRl and MDR2 in table 2.2) had previously allowed 
the isolation of gene fragments from Aspergillus fumigatus and Aspergillus flavus that 
appeared to encode a segment of nucleotide-binding domains of MDR-like proteins. 
The corresponding full length genes, afumdrl, afumdrl and aflmdrl were then cloned 
and completely sequenced (Tobin, et ai, 1997).
This chapter reports that a single gene fragment was obtained from P.brasiliensis DNA, 
using this degenerate PCR. This gene fragment appealed to correspond to a segment of 
an MDR-like gene. This amplicon was used to screen a X gene library. A single phage 
clone was isolated which contained the major part of an open reading frame. The 
complete sequence was attained using SSP-PCR techniques (Venkatakrishna & Ames, 
1989) on P.brasiliensis genomic DNA. The complete gene sequence revealed a 2627bp 
open-reading frame, including two putative introns and encoding for an 827 amino acid 
half-transpoiter molecule with extensive homology with afumdr2.
2 .
3 .1  PCR amplification of an MDR-like gene fragment using degenerate 
PCR
In an attempt to identify MDR-like ABC transporter genes in P.brasiliensis the primers 
successfully used in the cases of A.fumigatus and A.flavus (Tobin, et a l, 1997) were 
adapted. The codon usage in the degeneracies was altered based on the codon usage of 
Neurospora crassa and Aspergillus nidulans (Gurr et a l, 1987). These oligonucleotides 
were designed to tai'get the motifs ALVGPSG (MDRl forward primer) and
92
Chapter 3
GGQKQRIA (MDR2 reverse primer). Both of these motifs are conserved in the 
nucleotide binding domains of proteins that share sequence homology with human P- 
glycoprotein (Gottesman & Pastan, 1993).
Primers MDRl and MDR2 were applied in PCR, over a range of annealing 
temperatures, as seen in Fig 3.1a. A single band was consistently observed. The 
amplicon from the reaction performed at 56°C was extracted from the agarose gel and 
ligated into pGEM-T Easy™. The ligation reaction was transformed into competent 
XL 1-Blue E.co/i cells. Recombinant plasmids were selected on the basis of blue/white 
screening, with 47 of 68 colonies displaying the required white phenotype. The 
plasmids harboured by five white clones were prepared by mini-prep and analysed for 
insert by EcoRl restriction digestion. Four were found to contain DNA of the 
appropriate size (Fig 3.1b). The recombinant inserts of pM D R l.l, pMDRl.2 and 
pMDRl.3 were analysed by automated sequencing using vector directed standard 
primers (M l3 forward and M l3 reverse). All three clones possessed an identical 413bp 
sequence of P.bmsilensis DNA that showed considerable homology with a number of 
ABC transporter genes including afumdr2, m dll and mdl2 (Fig 3.2). This sequence 
was projected to belong to a putative open reading frame that we termed p ftl (pftl; 
Paracoccidiodes fungicide transporter).
3 .2  Screening of lambda libraries for the p f tl  gene
In order to isolate the complete p ftl  gene, X phage gene libraries would be screened. 
Three libraries were in our possession (gifts from Prof. Maria Sueli Soures Felipe, 
Departmento de Biologia Celuiar, IB, Universidade de Brasilia, Brasilia, Brazil); a 
IDASHII genomic DNA libraiy and two ÀZAP cDNA libraries. The cDNA libraries 
were constructed using the mRNA of either the yeast form or the mycelial form of the 
organism (all X library technologies had been constructed using kits from Stratagene). 
Prior to the execution of the screening procedure the libraries were titred to assess the 
viable phage population. Serial dilutions of phage stocks (1x10"' to 1x10^) were 
performed and pfu assessed on the lowest dilution that could be accurately counted. The 
XDASHn genomic library displayed the highest viable phage count with the stock 
library calculated to be at 4.5x10^ pfu per ml. The yeast cDNA and mycelial cDNA 
libraries titred at 3.2x10^ and 2.6x10^ pfu per ml respectively.
In order to establish the feasibility of screening the lambda phage libraries for the 
complete p ftl gene, the total DNA of each of the libraries was examined by PCR.
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Fig3.1a. Degenerate PCR screening of P,brasiliensis DNA for MDR- 
like ABC transporter gene fragments
1] 55°C annealing temperature
2] 57°C annealing temperature
3] 59°C annealing temperature
4] 61°C annealing temperature
5] 63°C annealing temperature
6 ] 65°C annealing temperature
PCR conditions; lOOpl reaction volume with 1.5mM MgClj. Activation at 95''C for 
15min / dénaturation at 94°C for 30s / annealing at various temperatures for 40s / 
extension at 72°C for Imin. A total of 25 cycles concluded with a lOmin 72°C 
extension.
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94
Fig3.1b p-GEM-T Easy '^  ^ clones containing the MDR1/MDR2 
fragment
DNA (500ng) from each of 5 plasmid preparations (pM DRl.l - pMDRl.5) was 
digested with 5 Units of EcoRI at 37°C for Ih. The digested DNA was examined on a 
0.9% agarose gel. The correct clones were confirmed on observation of the c.400bp 
MDR1/MDR2 fragment.
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Accession Number Protein ; Source Author
1] gi|2673955 (U62935)
2] emb|CAB42370.1
3] gb|AAB52482.1|
4] gi|4204793
5] emb|CAA94202.1|
6] emb|CAB04797|
7] emb|CAA94219.21
8] emb|CAA94220.2|
9] p|Q00449|MDR4
10] gbjAAF23176.1|AF216497
11] gb|AAF17668.1|AC009398
12] gi|l 166606
13] pir||A42150
14] pir||S21957
15] emb|CAA94203.1|
16] gb|AAD28285.1 |AF136523
17] reflNP_003733.1||
18] reflNP_015053.1|MDL2|
19] gi|311095 (L16959)
20] gb|AAD22645.11AC007138
AfuMDR2; Aspergillus fumigatus 
Putative permease; Schizosaccharomyces pombe 
Putative ABC transporter; C.elegans 
P-glycoprotein PMDRl; Solanum tuberosum 
P-glycoprotein homologue; C.elegans 
YgaD; Bacillus subtilis 
P-glycoprotein homologue; C.elegans 
P-glycoprotein homologue; C.elegans 
Mdr4; Drosophila melonogaster 
P-glycoprotein homologue; Gossypium hirsutum 
P-glycoprotein homologue; Arabidopsis thaliana 
P-glycoprotein homologue; C.elegans 
P-glycoprotein Atpgpl; Arabidopsis thaliana 
P-glycoprotein pgpl - Arabidopsis thaliana 
P-glycoprotein homologue; C.elegans 
Bile salt export pump BSEP; Homo sapiens 
Bile salt export pump BSEP; Homo sapiens 
MDL2; Saccharomyces cerevisiae 
MDL2; Saccharomyces cerevisiae 
Putative P-glycoprotein; Arabidopsis thaliana
(Tobin etal. ,  1997)
(See note 1 )
(See note 2)
(Wang et al.., 1996) 
(See note 2)
(Cummings e ta l ,  1997) 
(See note 2)
(See note 2)
(Wu et at.., 1991) 
(Cui,X., Unpub.) 
(EckerJ.,Unpub.) 
(Wilson, 1994)
(Dudler & Hertig, 1992) 
(Dudler,R., Unpub.) 
(See note 2)
(Mol, O., Unpub.) 
(Stautnieks et al. 1998) 
(Goffeau etal.,  1996) 
(Dean et al., 1994) 
(Huang et al.. Unpub.)
Fig 3.2
This figure is adapted from a BLAST output generated on searching the NCBI database 
(http://www.ncbi.nlm.nih.gov/BLAST/) using the MDR1/MDR2 fragment sequence. 
The 20 genes with highest homology scores are presented, as generated using the 
BLASTx algorithm. BLASTx analysis allows similarity searching to be performed on 
the basis of deduced amino acid sequences acquired by translation in all three reading 
frames, in forward and reverse directions. The description of identity for each hit has 
been altered from the original output to ease reader identification.
Note 1; Identified by the European S.pombe genome sequencing project, Sanger centre.
Note 2; Identified by the C.elegans genome sequencing consortium, Sanger centre.
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The library DNA was prepared by infecting aliquots of E.coli LE392 cells with lOpl of 
stock phage, as described in section 2.2.7, and the libraries were amplified in liquid 
media. Following this high multiplicity infection, the DNA was prepared and dissolved 
to an approximate concentration of 150ng per pi for each library (data not shown). The 
MDRl and MDR2 primers were applied in PCR to examine each of the three libraries 
for the presence of the p ftl  gene fragment. For each test PCR reaction, 300ng of total 
library DNA was used. As can be seen in Fig 3.3, the required fragment could only be 
observed in the X DASHII genomic library. Despite repeating the procedure, evidence 
of the gene was not observed in the X ZAP cDNA libraries constructed using the cDNA 
of either the yeast form or mycelial form of the organism. It was concluded that the p ftl 
gene was absent in the cDNA libraries and the complete sequence would be pursued by 
screening the genomic library only.
The X DASHII library was plated to allow well separated plaques. The library stock 
was diluted by a factor of 10'  ^ and lOOpl of this dilution was used for infection. This 
allowed approximately 450 plaques to be screened per 10 x 10 cm plate. Assuming an 
average insert size of 20kb, each plate would present 9Mb of P.brasiliensis DNA. The 
typical size of the haploid P.brasiliensis genome is now known to be 31.3Mb (Montoya 
et al., 1999) indicating that this genome will be present on a minimum of 4 plates of this 
titre, assuming that no identical clones appear.
The plaque material from each plate was transferred to nitro-cellulose membranes prior 
to hybridisation. At least two replicate membranes were prepared for each plate so as to 
allow the assessment of reproducibility of putative positive signals.
To isolate the required recombinant phage clone, the p ftl gene fragment, derived from 
the MDR1/MDR2 PCR, was labelled using fluorescein tagged nucleotides. Successful 
fluorescein labelling was confirmed by visualisation of bound Klenow polymerase 
amplicons on nitro-cellulose by UV transillumination. This labelled DNA was applied 
as a probe in a plaque hybridisation procedure.
After extensive screening a single plaque, Xpftl, was found to give a positive signal on 
two replicate membranes (Fig 3.4a). The plaque was found to be well isolated on the 
corresponding plate, was picked and a 10 '^  dilution of the harvested phage re-cultivated. 
A secondary hybridisation on these lawns of Xpftl demonstrated that the initial signal 
was genuine (Fig3.4b). All signals observed on this image corresponded to plaques on 
the cultured plate of the isolated phage clone.
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Fig3.3 MDR1/MDR2 PCR screening of phage library DNAs
1] P.brasiliensis genomic DNA (positive control)
2] ÀDASHII genomic library DNA
3] A.ZAP cDNA library (yeast form)
4] ÀZAP cDNA library (mycelial form)
5] No DNA (negative control)
PCR conditions were as stated in Fig3.1a. The annealing temperature 
was 56''C.
Chapter 3
a.
Fig.3.3
98
Fig3.4a Primary hybridisation screen of IDASHII genomic library
The left-hand image represents the signal obtained from the initial lift 
of plaque material from a phage library culture plate. The right-hand 
image is the signal obtained from a second plaque lift from the same 
plate. Thus replicate membranes were available to confirm the position 
of positive signals.
Hybridisation conditions; 140ng of labelled probe (at 7ng per ml of 
hybridisation buffer) was applied to replicate filters. The membranes 
were incubated in the presence of probe for 18h at A series of 3
stringency w ashes w ere applied  using 2xSSC /0.1% SD S, 
lxSSC/0.1%SDS and 0.5xSSC/0.1%SDS in succession. Again the 
solutions were at 58°C. The membrane was blocked for Ih at room 
temperature. Following this, anti-fluorescien antibody was applied at 
1:2000 dilution of stock as supplied. Unbound antibody was washed 
off, detection reagent applied and exposure to X-ray film was allowed 
for 2h.
Fig3.4b Replicate filters of secondary screen on the Tpft 1 clone
H ybridisation conditions; As described for F ig3.4a, except 
hybridisation temperature and stringency washes were performed at 
63"C.
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3 .3  Subcloning P.brasiliensis DNA from Xpftl
In order to obtain fragments of the p ft l  gene from the lambda clone, a series of 
subcloning experiments was performed. Initially, a high multiplicity liquid culture of 
Xpftl was prepared and the phage DNA isolated by standard methods to provide 50pg of 
Xpftl DNA. The DNA was then digested, using restriction enzymes that would allow 
cloning into the multiple cloning site of the pZERO™ vector. Each restriction enzyme 
was used individually to provide 10 separate reactions, each containing 500ng of phage 
DNA. The digested DNA was electrophoresed on a 0.9% agarose gel (Fig3.5a). The 
DNA on this gel was then transferred to a nitro-cellulose membrane and exposed to 
Southern hybridisation, again using the fluorescein labelled MDR1/MDR2 fragment as a 
probe. The resultant Southern blot is presented in Fig3.5b. While a signal is present in 
all lanes, it can be observed that the X b a f  EcoYH and Pstl digests gave positive signals 
from bands of approximately 2.5, 3.9 and 4.8kb respectively. It was decided that these 
bands were the most suitable for subcloning.
Initially, 12 individual 30pl Xbal digests were performed and electrophoresed. From aU 
digests, the appropriate 2 .5kb fragment was gel extracted and the product isopropanol 
precipitated to concentrate. Of this DNA, 200ng was added to a ligation mix with 50ng 
of Xbal digested pZERO™ and the fragment was consequently cloned (Fig 3.6). 
Sequencing of this construct is discussed in more detail in section 3.5. The X bal 
fragment did contain a substantial portion of the p ftl  gene, including a well-defined stop 
codon representing the 3’ terminus of the gene.
The 5’ section of the gene was not included in the Xbal fragment DNA so the EcoRI and 
eventually the Pstl gene fragments were targeted for further investigation. In order to 
circumvent the requirement for the laborious accumulation of digested fragment for 
cloning, the portions of each fragment predicted to contain the required 5 ’ sequence 
were generated using SSP-PCR. EcoRI and Pstl restriction digests were performed 
using 2|Lig of Xpftl DNA per reaction. Following 4h incubation at 37®C, the reactions 
were placed at 60®C for 20min to inactivate the restriction endonucleases. Examination 
of an aliquot of each digest demonstrated satisfactory digestion. A volume of 7 pi 
(700ng) of digested DNA was applied to a ligation with 50ng of appropriately cut 
pZERO™. The total digested fragments of the lambda clone were allowed to ligate at 
I6°C for 18h. This ligation mix was diluted 1:10, in lOmM TrisHCl pH8.0, and used 
as a template for PCR. Using the p ft l  specific primer PT72 and either the vector 
directed
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Fig3.5a Restriction digests of Ip/tl  DNA
Digests were performed using 500ng of DNA per digest in a volume 
of 20pl. DNA was incubated at 37®C for 4h in the presence of 5 units 
of the appropriate restriction endonuclease.
Lane 1] Xbal
Lane 2] Hindlll
Lane 3] EcoRl
Lane 4] BatnUl
Lane 5] Notl
Lane 6 ] Pstl
Lane 7] Xhol
Lane 8] S a d
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Fig3.5b Southern Blot of gel in Fig3.5a
Lanes are as Fig 3.5a
The blot was hybridised at 65°C for 40h with 500ng of the p ft l  gene fragment as a 
probe (25ng per ml of hybridisation buffer). The blot was washed for 13min with 
each of 2X SSC/0.1% SDS, IX SSC/0.1% SDS and 0.5X SSC/0.1% SDS at 60"C. 
Anti-fluorescein was allowed to bind and the blot was exposed to X-ray film for 
40min following the addition of detection reagent.
NB: This figure represents the blot on Xpftl DNA. The image was rendered using 
Adobe Photoshop™ 3.0.5. The original image generated on X-ray film could not be 
digitally scanned with clarity.
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Fig3.6 Cloning of the 'kpftl derived Xbal fragment in pZERO™
The 2.5kb Xbal fragment was cloned to the Xbal site of pZERO™. The ligation was 
performed using 50ng of linearised vector DNA and 250ng of the purified insert 
DNA. The ligation was incubated at 16°C in a thermocycler for 4h prior to 
transformation into TOPlOF’ E.coli cells.
The insert was found to be cloned in 3 of the 6 putative clones examined. The 
construct pPlXbaS was selected for automated sequencing.
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T7 or SP6  primers the 5’ region of p ftl possessed by each fragment was amplified (Fig 
3.7a/b). These amplicons were cloned into pGEM-T Easy™ and the relevant region of 
each insert sequenced (see section 3.5).
It was discovered that the EcoRI fragment provided further sequence data for the 5 ’ end 
of p ftl  but again the complete ORF was not present. The larger Pstl fragment also 
contained additional information but revealed that the p ftl  gene sequence was truncated 
during libraiy construction. Based upon a comparative alignment with the deduced 
amino-acid sequence of AfuMDR2, the phage clone Xpftl contained the bulk of the open 
reading frame but the gene appeared to have been severed during the partial Sau3A 
digest used to generate inserts for the librai-y.
3 .4  Genome walking to complete the p f t l  gene sequence.
Further screening of the library, using the 350bp sequence at the established 5’ region to 
generate a probe, resulted in the re-isolation of the same Xpftl phage clone. The lambda 
genomic library had undergone several rounds of amplification prior to acquisition, 
which might result in individual clones being present in multiple numbers. This notion 
is supported by the high number of plates that had to be screened to find the initial p ftl  
phage clone. Previous amplification would have selected for phage that replicated 
fastest, containing smaller inserts and would thus bias the representation of such clones 
in the library. In order to generate the region of the p ftl  gene that contained the ATG 
start codon, two PGR based techniques were employed. 5’RACE RT-PCR was 
attempted on P.brasiliensis mRNA. An amplicon pertaining to p ftl  was generated but 
did not provide a conventional position for the translational start of the gene. This 
result, and its potential significance, is discussed in more detail in Chapter 5. Also 
GenomeWalker™ SSP-PCR was performed using adapter-tag ligated, digested genomic 
DNA as a template. This would allow genome walking to amplify the sequence 
upstream of that that already obtained.
A series of 5 individual restriction digests, containing 2pg of P.brasiliensis genomic 
DNA, were perfoimed using the blunt cutting enzymes Pvull, E'coRV, Oral, Stul and 
Seal. The digested DNA was precipitated and re-suspended to allow ligation of adapter 
tags to the blunt termini of each fragment. PCR was then performed on a 1:10 dilution 
of each ligation mix using the p ftl specific primer and an adapter tag specific primer. A 
nested PCR approach was employed using primers pftwalkl and Adapt 1 for the primary 
PCR and primers pftwalk2 and Adapt2 for the secondary PCR (see Appendix II).
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Fig3.7 SSP-PCR reactions allowing the isolation of the pftl  
sequence contained within the genome of ^ ftl.
a) SSP-PCR on ligated Xpftl EcoRI digested DNA.
Lanel] Gene specific primer SSPl/ Vector specific primer T7.
Lane2] As lane 1 but with no template (negative control).
Lane3] Gene specific primer SSPIA^ector specific primer SP6 .
Lane4] As lane 3 but with no template (negative control).
PCR conditions: lOOpl reaction volume with 1.5mM MgCl2. Activation at 95°C for 
15min / dénaturation at 94*^ C for 30s / annealing at 55°C for 40s/ extension at 72®C for 
2min. A total of 35 cycles concluded with a lOmin extension at 72®C.
b) SSP-PCR on ligated Xpftl Pstl digested DNA.
Lanel] Gene specific primer SSPl/ Vector specific primer T7.
Lane2] Gene specific primer SSP 1/Vector specific primer SP6 .
PCR conditions: lOOpl reaction volume with 1.5mM MgClg. Activation at 95°C for 
15min / dénaturation at 94‘^ C for 30s /  annealing at 55°C for 40s/ extension at 72®C for 
3.5min. A total of 35 cycles concluded with a lOmin extension at 72®C.
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The results of both primai y and secondary PCRs can be observed in Fig3.8a & Fig3.8b 
respectively.
A number of amplicons can be observed, of various sizes in the primary PCR. The 
secondary PCR indicated the prominence of 2 small products in the EcoRV  and Pvull 
lanes that displayed a suitable shift in molecular weight to have been generated from a 
tme secondary PCR. Both the EcoRV fragment (511 bp) and the Pvull fragment 
(312bp) were cloned into pGEM-T Easy™ and sequenced. Both proved to be from p ftl  
and provided information regarding the position of an ATG start codon. Both 
amplicons were of the same sequence in the region around the ATG start codon and the 
5’end of the gene. The larger EcoRN fragment contained an additional 199bp that gave 
information about the sequence of the proposed immediate promoter.
3 .5  The sequence of p f t l
AH sequence data received were analysed using the Autoassembler™ (Perkin Elmer) 
sequence analysis software. This allowed the assembly of the complete contiguous 
DNA sequence as provided from the data gathered from the Xbal, EcoRV  and Pstl 
fragment clones and the GenomeWalker™ products. A diagrammatical representation is 
presented in Fig 3.9. Note that each section of the gene is sequenced at least in duplicate 
ensuring that sequencing is performed in opposing directions. The nomenclature for 
each sequence is based on its origin. Sequences named “fX&a...” are derived from the 
2.5kb cloned Xbal fragment DNA. The “EVGW” and “PIGW” are from the EcoRV 
and the P v m II  genome walker products respectively. Sequences maiked as “EcoRISSP” 
and “P^flSSP” are from the EcoRI and Pstl SSP-PCR products of Fig3.7. The 
inclusion of sequences generated by 5’RACE will be discussed in Chapter 5.
The complete nucleotide sequence, including the deduced amino acid sequence, can be 
observed in Fig3.10 while the comparative alignment of amino acids with the closest 
matching homologue AfuMDR2 is presented in F ig 3 .ll. The comparative alignment 
was perfoiTned using the Genejockeyll sequence analysis software (Copyright; 
P.L.Taylor, Biosoft).
In FigS.lO, please note the inclusion of 2 putative introns at nucleotide positions 1248- 
1317 and 1953-2031 (denoted in blue). These sections were proposed to be introns on
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Fig3.8a Primary GenomeWalker™ PCR
PCR was performed using the following cycling parameters;
1 cycle] 94°C 15:00
35 cycles] 94°C 0:30
63°C 0:40
72°C 3:00
1 cycle] 94°C 0:30
63°C 0:40
12°C 10:00
Lane 1 ] Pvull library
Lane 2] Oral library
Lane 3] EcoRV  library
Lane 4] Stul library
Lane 5] Seal library
Fig3.8b Secondary GenomeWalker™ PCR
PCR was perfoimed using the following cycling parameters;
1 cycle] 94°C 15:00
25 cycles] 94°C 0:30
63°C 0:40
72°C 3:00
1 cycle] 94°C 0:30
63°C 0.40
72°C 3:00 (Lane order as in Fig3.8a.)
Ikb
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Fig 3.10 The nucleotide sequence and deduced amino acid sequence 
of p f t l
- 2 7 6  a t c g c c t a t a g c t c t c g a g a t c c t c c t a g a a t c c t c  -2 4 1
-2 4 0  a a g a t c c t c t a g a t a t a t a t t g t c t a t c c g a t c t c t t a g c t c t t a t a a g c t t c g g c g c c g  -1 8 1
-1 8 0  c a a t a a t c q c t a t a a a c a c t c c t c a q a t a t a t a c a c a c a t a t c a c a c t a t c t t c a c t a t c  -1 2 1
-1 2 0  q a a a t a t c t c t t c q a t t c t c c Q a t t c t t a t a t a c c a c t a a a t c c a a c t a a a t c a a a t a t a  -6 1
-6 0  a g c t c t t a g c c c g a t c a a t a c t c c t g a t a t c c t a t t a t t c t a a t c t c c t t g t t c c t t a a t  -1
1 ATGGCACTTGCCGCCTTCACTCCACGAGCATCTTCACGTCGCATTGCTCAGTTTGGATCG 60
(1) M A L A A F T P R A S S R R I A Q F G S  (20)
61 CGATCGCTTCCCTTATTTAACTATACCTCCTTCCATGCCCAGAGACCATCGCTTGATGCT 120
(2 1 ) R S L P L F N Y T S F H A Q R P S L D A  (40)
121 AGCGGTGGCTTAAGACGTCACCAGTCGAACGCCCCCATCGTAACCCAACGACCAGACATC 180
(41)  S G G L R R H Q S N A P I V T Q R P D I  (60)
181 CTACGGCAGCCAGACATCCGAAAGTCATCTGCAACAAATATACATGTCACTATTTCATCT 240
(61)  L R Q P D I R K S S A T N I H V T I S S  (80)
241 ATCGTGGGACCTGGTTGTCTTCAGCAGGTCCGATTCCTCTCCTCTACGACAGCACGGCGA 300
( 81)  I V G P G C L Q Q V R F L S S T T A R R  ( 100)
301 AAAGAAGCCAAACCGGAGCCCGCGAAAAAGCTGCGGAAGCCGCAGAAGCCGCAGACAGAG 360
(101)  K E A K P E P A K K L R K P Q K P Q T E  ( 120)
361 CTAGAAAAGAAACAAGAAACCGCTCTAGAAGAGATACATAGAGGATTTGAGCGTACGGAG 420
(121)  L E K K Q E T A L E E I H R G F E R T E  ( 140)
421 AAGGCATCACAAGCAGCGAAATTAAACCTTAGCGCAAGATTATCAAAGGATGCGGGCGGG 480
(141)  K A S Q A A K L N L S A R L S K D A G G  ( 160)
481 AAGAGGCTCGGCTTTCGCGAGATATGGCGGTTATTGAAAATTGCCCGTCCAGAGGCCAAA 540
( 161 )  K R L G F R E I W R L L K I A R P E A K  (180)
541 ATCCTGTCCATGGCGTTACTCTGCTTGCTCATCTCGTCATCTATCACCATGTCGATTCCG 600
( 181 )  I L S M A L L C L L I S S S I T M S I P  (200)
601 TTTTCCATCGGCAAGATTCTCGATATCGCAACGCATAGCAGCCCTGAAGGTGGCAATGAA 660
(201)  F S I G K I L D I A T H S S P E G G N E  ( 220)
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661 TTGTTCGGCCTCACACTCCCCGTCTTCTACAGTGTCCTGGGCGGTGTTCTTTTGTTGGGT 720
( 221 )  L F G L T L P V F Y S V L G G V L L L G  (240)
721 GCTGCTGCAAACTGTGGTCGTATTATAATTCTACGGATTGTGGGGGAACGTATTGTTGCG 780
( 241)  A A A N C G R I  I I L R I V G E R I V A  (260)
781 CGACTAAGATCTAAGCTCTTCAGACGTACTTTTATGCAGGATGCGGAGTTTTTCGATGCC 840
( 261)  R L R S K L F R R T F M Q D A E F F D A  (280)
841 AACAGAGTCGGTGACTTGATTTCCCGGCTAAGCTCGGATACGATAATCGTCGGCAAAAGT 900
( 2 81)  N R V G D L I S R L S S D T I I V G K S  ( 300)
901 ATCACGCAGAATCTTTCAGATGGACTTAGGGCTGCTG'TrAGTGGCGTTGCTGGGTTTGGT 960
( 3 01)  I T Q N L S D G L R A A V S G V A G F G  ( 320)
961 CTGATGGCCTTTGTCAGTCTTAAGCTGTCAAGCATTCTCCTTTTGCTGATACCCCCAGTG 1020
( 321)  L M A F V S L K L S S I L L L L I P P V  ( 340)
1021 TCCCTTGGAGCGTTCTTATACGGCAGATCAATCAGAAATATTAGTCGCAAGATTCAGAAG 1080
( 341)  S L G A F L Y G R S I R N I S R K I Q K  ( 360)
1081 AACCTGGGTAGCCTGACCAAAATCGCGGAGGAGCGTCTGGGAAATGTGAAGACAAGTCAG 1140
( 361 )  N L G S L T K I A E E R L G N V K T S Q  (380)
1141 TCTTTTGCAGGAGAGATTTTGGAGGTCCATCGATATAATAGGCAAACCAGGAGAATTTTT 1200
( 3 8 1 )  S F A G E I L E V H R Y N R Q T R R I F  (400)
1201 GAGCTGGGAAAGAGAGAGTCTCTCGTTAGCGCAGCGTTCTTTAGCACCgtgagtacttC 1259
( 4 01)  E L G K R E S L V S A A F F S T  (416)
1260 t a a t c a c t a a t t t t c a t c a a a t c t g g t a t a t g c t g a c a g c t a t t t g t a t c t t t g c a g A C C  1319
( 4 1 7 )  T (417)
1320 GGTTTGATGGGAAATATGACGATTTTGAGTTTACTCTATGTTGGTGGTGGAATGGTCCAG 1379
( 4 1 8 )  G L M G N M T I L S L L Y V G G G M V Q  (437)
1380  TCCGGGGCCATTTCCATTGGAGACTTGACTTCATTCCTCATGTATGCAGCATACGCTGGA 1439
( 4 38)  S G A I S I G D L T S F L M Y A A Y A G  (457)
1440  TCAAGCATGTrTGGCTTGTCCAGCTTCTATTCAGAACTGATGAAGGGCGTTGGTGCTGCC 1599
( 458)  S S M F G L S S F Y S E L M K G V G A A  ( 477)
1500 AGTCGACTATTCGAGCTCCAAGACCGCCATCCCACTATTCCCCTTACTGTAGGAGATAAA 1559
( 478)  S R L F E L Q D R H P T I  P L T V G D K  (497)
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1560  GTGGTTTCGGCAAGGGGAGCGATCCGGTTCAAGAATTTGGATTTCAGTTATCCCACCAGA 1618
( 498)  V V S A R G A I R F K N L D F S Y P T R  (517)
1620 CCCGCAGTGACTGTATTTAAAGACCTCGACTTTGAGATTCCGCAAGGAAGCAACGTTGCA 1679
(518)  P A V T V F K D L D F E I  P Q G S N V A  ( 537)
1680 ATCGTCGGCCCCTCGGGGGGCGGTAAATCCACGATTGCCTCCTTGTTACTGCGCTTCTAC 1739
( 538)  I V G P S G G G K S T I A S L L L R F Y  (557)
1740 AAACATACCAGAGGCCAGATCCTGATAGATGGGAAGGAC ATCTCCTC AATGAATGCAAAG 1799
(558)  K H T R G Q I L I D G K D I S S M N A K  ( 577)
1800 TCTCTACGAAGGAAAATCGGCGTCGTCGCGCAGGAGCCCGTACTCTTCTCTGGAACTATC 1859
(578)  S L R R K I G V V A Q E P V L F S G T I  ( 597)
1860  GCTGAGAACATATCCTACGGCAAGCCCCATGCGACAAGGACGGAAATTATCGCAGCGGCG 1919
(598)  A E N I S Y G K P H A T R T E I I A A A  (617)
1920 CGCAAGGCCAACTGTCAA'irCATCAGTGACTTCgtaagtgacatctaccttcctctcca 1978
(618)  R K A N C Q F I S D F  (628)
1979  a g c a t tc c c a c c t a c c c g g t t t a c t a a t a c a a g a c tc g t t t c t c g a t t c a g C C C G A T G G C  2038
( 6 29)  P D G  (631)
2 03 9  CTCGACACACACGTAGGCGCCCGCGGCGCTCAACTCTCCGGCGGCCAAAAGC AGCGAATC 2098
( 632)  L D T H V G A R G A Q L S G G Q K Q R I  ( 651)
209 9 GCCATCGCCCGTGCCCTGATTAAAAACCCAGACATCCTCATCCTCGACGAAGCCACGTCC 2158
( 6 5 2 )  A I A R A L I K N P D I L I L D E A T S  ( 671 )
2 15 9  GCCCTCGATGCCGAATCCGAGACGCTGGTCAACAGCGCTCTTGCCGCGTTACTCCGCGGC 221 8
( 672 )  A L D A E S E T L V N S A L A A L L R G  (691)
2 21 9  AACAATACGACAATCAGCATCGCCCACCGTCTCTCCACCATCAAGCGCTCCGACACCATC 2278
( 692)  N N T T I S I A H R L S T I K R S D T I  ( 711 )
2 27 9  ATCGTACTCAGCGGTGACGGCCACGTTGCGGAGCAAGGTTCGTATCAGGAACTGAGCGCG 2338
( 712 )  I V L S G D G H V A E Q G S Y Q E L S A  (731)
2 33 9  CGACCGGACGGCGCGTTTACGAAGCTTATGGAGTGGCAGATGAGCTCTGAAGGGGGGGCT 2398
( 732 )  R P D G A F T K L M E W Q M S S E G G A  (751)
2 39 9  GTGCAGTCGGTGGTTAGGGGACCGCCGTCTGAGAAGGAGGAGTTGCAGCAGATGCTGCAG 2458
( 752)  V Q S V V R G P P S E K E E L Q Q M L Q  (771)
245 9 GAAGGGGAGGAAGATTATGGGGAGTATGATGATGATAGTGATGCGGAGCCGGAGAAGCTT 2518
( 772)  E G E E D Y G E Y D D D S D A E P E K L  (791)
I I I
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2 51 9  GTTGAGAGGGACGGCGTTGCTGAGGGAGCTTCTAAGGAGAAATATGCTGTGGCTGCTGGG 25 78
( 7 9 2 )  V E R D G V A E G A S K E K Y A V A A G  (811)
257 9  ATAGAGGCCAGTATTGCTACTTCTAAGCAACAGCCGTCCCAAG/\-'-‘^ AAT>vGatggatagc 263 8
(8 12)  l E A S I A T S K Q Q P S Q E K *  ( 827)
2 63 9  a a a t g t g a a t a c t c t t t g c t t g c t g t g t c a c t t c c c t c c t c t t t g t t c c c c a g c t c c t a t  2698
2 69 9  c a t c c c a g t c c c a a a g g t c a c g a t c c t g t g g t c t c g t c c t t c a a g g c c t g a a g a c c a t a g  2758
275 9 a t t c g t t t c t c c t t t a t c c t c t g c c c a t c t t a c c c c g t c c t c c a t c g c a t a g g a c t t t g c  281 8
2 81 9  t a a a c c a t a c c c t t g a a c t t t c t c t t t t t t c t t t c c c t c c a t c a t c t a t g g a t g c a t g a t  287 8
2 87 9  a t t t g g t a t t t t a c c g t g c t t c c t c a t g c a t t t a t a t a t t a t a t c t a g a t g c a t g c t c g a  293 8
2 93 9  g c g g c c g c c a g t g t g a t g g a t a t c t g c a g a a t t t c c a g c a c a c t g g c g g c c g g t a c t a g t  2998
2 99 9  g g a  3001
Nomenclature; Nucleotide positions are recorded in black numerals, amino acids in bracketed blue.
Nucleotide data; Coding nucleotides are denoted by uppercase letter. Non-coding bases are denoted 
by lowercase letters. Putative introns are presented in blue. Potential promoter features (CAAT and 
TATA elements) are underlined. A putative poly-adenylation signal is present in green.
Amino acid data; The Walker A box is denoted in green. The Walker B box and centre region is
denoted in red. The transcriptional stop site is marked as *.
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Fig 3.11 Comparative alignment of the deduced amino acid sequences 
of afuM D R l  (top) and p f t l  (bottom)
10 20  30 40 50 60 70
I  I  I  I  I  I  I
M -R G IR SL PC W A P G L ST K R IP PR E L FA D L F PN A C V ISA R H SA R N G L IR Q F SG C SG SISN SC N P R P Y R SA IT SL L SA N
I I  I  I I  I  "  I -  •  - I  I I  I I  - M M
M A LA A FTPR A SSR R IA Q FG SR SL PL FN Y T SFH A Q R PSL D A SG G L R R H Q SN A PIV T Q R PD IL R Q PD IR K SSA T N IH V T
I  I  I  I  I  I  I
10 20  30 40 50 60 70
80 90 1 0 0  1 1 0  1 2 0  1 3 0  1 4 0  150
I  I  I  I  I  I  I I
V C SK G V SAVQPRFLSTVRLFSTSQRSLEPK SNVKSTG GQ W RPELH QDQEH EDIEKG FELSERAAQ AAQVNLSAKLA
I  "  I I  I  I I I  I I  I  I I I  I  '  '  I
ISSIVG PG CLQ Q VRFLSSTTARRK EAK PEPAK K LRK PQ K PQ TELEK KQ ETALEEIH RG FERTEKASQ AAKLNLSARL
I  I  I  I  I  I  I  I
80 90 1 0 0  1 1 0  12 0  1 3 0  1 4 0  1 5 0
1 6 0  17 0  18 0  19 0  2 0 0  2 1 0  2 2 0  2 3 0
I  I  I  I  I  I  I  I
K DG AAG K KAGFK EIW RLLLIARPEAKK LALAFLFLLVSSG ITM SIPFSIGK IM DTSTK ATTEG GNELFG LSLPM FYG
I - I - - I  " I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I l - I -  " l " l . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I -  I -  I I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . I " l " l
SK D A G G K R L G FR E IW R L L K IA R P E A K IL SM A L L C L L ISSSIT M SIPF SIG K IL D IA T H SSP E G G N E L FG L T L P V F Y S
I  I  I  I  I  I  I  I
1 6 0  1 7 0  1 8 0  1 9 0  2 0 0  2 1 0  2 2 0  2 3 0
2 4 0  2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  30 0
I  I  I  I  I  I  I
A L A G IL T L G A A A N Y G R IIIL R IV G E R IV A R L R SK L F R Q T F V Q D A E F F D A N R V G D L ISR L SSD T IIV G K SIT Q N L SD G
• I  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I -  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
V L G G V L L L G A A A N C G R IIIL R IV G E R IV A R L R SK L FR R T FM Q D A E FFD A N R V G D L ISR L SSD T IIV G K SIT Q N L SD G
I  I  I  I  I  I  I
2 4 0  2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  30 0
3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0  3 7 0  38 0
I  I  I  I  I  I  I  I
L R A A V SG A AG FG LM AYV SLK LSSILAL LLPPIG LG AFFY G R AIR NLSR Q IQ R NLG TLTK IAEER LG N VK TSQ SFAG E
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
L R A A V SG V A G FG L M A FV SL K L SSIL L L L IPPV SL G A FL Y G R SIR N ISR K IQ K N L G SL T K IA E E R L G N V K T SQ SFA G E
I  I  I I  I  I  I  I
3 1 0  3 2 0  3 3 0  3 4 0  35 0  3 6 0  3 7 0  3 8 0
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3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  4 4 0  4 5 0  4 6 0
I I  I  I  I  I  I  I
VLEVRRYNNQ VRKIFELG K KESLISATFFSSTG FAG NM TILALLYVG GG M VQ SG AITIG ELTSFLM YTAYAGSSM FG
I - - - I  I   I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I - I  I . . . . . . . . . . . . . . . . . . . . . . . . . .
ILEVHRYNRQTRRIFELG K RESLVSAAFFSTGL-M GNM TILSLLYVG GG M VQ SG AISIG DLTSFLM YAAYAGSSM FG
I I I  I  I I  I  I
3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  4 4 0  4 5 0  4 6 0
4 7 0  4 8 0  4 9 0  5 0 0  5 1 0  5 2 0  530
I  I  I  I  I  I  I
L SSFY SE L M K G V G A A SR L FE L Q D R Q PT ISPT K G E K V A SA R G PIR FE N V T FSY PT R PA V PIFR D L N FE IPQ G T N V A IV
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I - - - I  •  - I  I - -  - I  . . . . . . . . . . . . . . . . . . . . . . . . . .  I ' l - I  I . . . . . . . . . . . .
L SSFY SE L M K G V G A A SR L FE L Q D R H PT IPL T V G D K W SA R G A IR FK N L D FSY PT R PA V T V FK D L D FE IPQ G SN V A IV
I  I  I  I  I  I  I
4 7 0  4 8 0  4 9 0  50 0  51 0  5 2 0  530
5 4 0  5 5 0  5 6 0  57 0  5 8 0  59 0  6 0 0  6 1 0
I I  I I  I  I  I  I
G PSG G G K ST IA SIL L R FY SPT E G R V L IG G K D IT H M N A K SL R R K IG IV SQ E PV L FSG T IA E N IA Y G K PQ A K R SE IV A A
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . I I - I - - I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I - I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I - - - - I -  - I - - I - -
G P SG G G K ST IA SL L L R F Y K H T R G Q IL ID G K D ISSM N A K SL R R K IG W A Q E P V L F SG T IA E N ISY G K PH A T R T E IIA A
I  I  I  I  I  I  I  I
5 4 0  5 5 0  5 6 0  57 0  5 8 0  59 0  6 0 0  6 1 0
6 2 0  6 3 0  6 4 0  6 5 0  66 0  6 7 0  68 0  690
I  I  I  I  I  I  I  I
ARK ANCQ FISD FPDG LDTQ VG PRG AQ LSG G Q K Q RIA IAR ALIK DPDILILDE ATSA LDAESETLVN SALTA LLRG NN
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I -  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . .
AR K A NCQ FISD FPDG LDTH VG AR G A Q LSG G Q K Q R IAIARA LIK NPDILILDEA TSALD AESETLVNSALAA LLRG NN
I  I  I  I  I  I  I  I
6 2 0  6 3 0  6 4 0  65 0  660  6 7 0  6 8 0  690
7 0 0  7 1 0  7 2 0  7 3 0  7 4 0  7 5 0  7 6 0
I  I I  I  I  I  I
TTISIAHRLSTIKRSDTIIVLGPDGRVAEQGSYEELSARPDGAFTKLM EW QM SGGEVM DQLANTPANPVAQETSW DL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I -  •  I  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I  -  I I I  -
T TISIAH RLSTIK RSDTIIVLSG DG H VAEQ G SYQ ELSARPDG AFTK LM EW Q M SSEG G AVQ SW RG PPSEK EELQ Q M L
I  I  I  I  I  I  I
7 0 0  7 1 0  7 2 0  7 3 0  7 4 0  7 5 0  7 6 0
7 7 0  7 8 0  7 9 0
I  I  I
Q S D D G T E IS E D T N IP S E P R K ID
-  I  I  -  I  I  -  -  -  I
QEGEEDYGEYDDDSDAEPEKLVERDGVAEGASKEKYAVAAGIEASIATSKQQPSQEK
I  I  I  I  I  I
7 7 0  7 8 0  7 9 0  8 0 0  8 1 0  8 2 0
114
Chapter 3
the basis of disruption of the expected open reading frame (in comparison with the 
sequence of homologues), frameshift in the ORF and the presence of semi-conserved 
splice sites in the sequence which were consistent with those observed in other genes 
s&qu&nced from P.brasiliensis (Da Silva et al., 1997; McEwan et al., 1996; Nino-Vega 
et al., 1998).
3 .6  D iscussion
Paracoccidiodes brasiliensis possesses an open reading frame which would appear to 
encode for an MDR-like ABC half-transporter. A gene, p ft l ,  has been sequenced, 
consisting of 2627 base pairs, interrupted by two putative introns at positions 1248- 
1317 and 1953-2301. The deduced amino-acid sequence indicates that the gene encodes 
a 827 residue protein with a predicted molecular weight of 89.5kDa and isoelectric point 
of 9.95. The p ftl  gene represents the first ABC transporter, indeed the first transporter 
protein of any kind, to be reported for P.brasiliensis.
The application of the MDRl and MDR2 degenerate primers allowed the amplification of 
only one gene fragment. The gradient imposed in reaction annealing temperature was 
imposed in an attempt to amplify fragments from genes with a partial identity to the 
degenerate primers. Even at relatively low annealing temperatures only a single product 
is observed. Indeed later sequencing revealed that this product was derived from a 
partial primer mismatch. The ALVGPSG motif used to design the MDRl forward 
primer is degenerated to AIVGPSG in Pftl. This is in keeping with the same 
observation in afumdrl. However in the A.fumigatus amplification the additional 
amplicon revealing afumdrl was also generated. The results of the PCR on 
P.brasiliensis genomic DNA suggests that an afumdrl homologue is absent in this 
organism.
The unfortunate truncation of open reading frames during partial digestion is a common 
shortcoming of this method of library construction. The use of adapter tag SSP-PCR to 
generate new flanking sequence directly from genomic DNA appears to be an effective 
and powerful tool for overcoming such problems. The PCR reactions required a degree 
of optimisation before satisfactory results were observed. Continued optimisation, 
specifically for each mini-library may have allowed the acquisition of a larger amplicon 
from libraries that, under our conditions, did not yield a product. It could be considered 
that successful application of this technology supersedes the need for hybridisation 
based librai-y screening. It is possible to isolate entire open reading frames using only 
SSP-PCR. The effort involved in lambda library screening was perhaps
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disproportionate in the case of the p ftl investigation, the situation being exacerbated by 
the fact that the gifted library had undergone an undefined number of rounds of 
amplification prior to acquisition. An unamplified libraiy where selective outgrowth had 
not occurred would have reduced the probability of repetitive isolation of the same clone 
as experienced in this investigation.
The gene appears to encode a protein exhibiting a number of features recognised as 
being typical of ABC transporters. Pftl is composed of two domains, namely a 
membrane spanning domain at the N-terminus and a typical P-glycoprotein-like 
nucleotide-binding domain at the C-terminus. A Kyte-Doolittle plot, indicating 
hydropathy, was performed by Tobin for AfuMDR2 and was inteipreted as proving the 
membrane spanning domain to have at least four hydrophobic, potentially membrane 
spanning segments. The same plot, on P ftl, was virtually identical, which is 
unsurprising considering the degree of amino-acid conservation (data not shown). The 
plots are not definitive however, and the absence of circular dichroism data at this point 
prohibits any conclusive enumeration of a-helices that may span the membrane. The 
implications of the number of spanning helices, and indeed the fact that the gene is a 
half-transporter molecule, will be further discussed, in the context of other data, in 
Chapter 8 . Despite a widely acknowledged lack of conservation between membrane 
spanning domains of different ABC transporters (Higgins, 1992) the sequence 
homology with the other fungal half transporters of this type remains high in the MSD, 
although is less than observed for the C-terminal nucleotide binding domain. This high 
degree of identity would imply a selective pressure for conservation implicating the 
association of these genes with an advantageous function.
Featured within the amino acid sequence of the nucleotide binding domain are motifs 
that are recognised as being diagnostic of ABC transporters, namely the Walker A 
(AIVGPSG) and B (DEATSALD) motifs and the signature region in the nucleotide 
binding domain. While the Walker A and B sites of many typical fungal ABC 
transporters, such as AtrA (Del Sorbo et a i, 1997), PDR5 (Baizi et al., 1994; Bissinger 
& Kuchler, 1994) and CDRl (Prasad et al., 1995) are heavily degenerated, those 
possessed by p ftl  are less so. These particular sequences display far more similarity to 
mammalian proteins than such fungal drug transporters. Indeed, the structural topology 
of Pftl is more closely related to mammalian molecules as the MSD precedes the NBD. 
In the aforementioned fungal transporters it is the hydrophilic domain that pre-empts the 
hydrophobic.
A considerable interest has recently emerged regarding appropriate model systems for 
studying homologues of P-glycoprotein. It has been proposed that similar molecules
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could be used to generate useful data that would relate directly to anti-cancer drug 
resistance. Indeed the use of LtnrA of Lactococcus lactis to confer an MDR-like 
phenotype on a mammalian cell line demonstrates the efficiency of ABC half 
transporters from lower organisms in this endeavour (Van Veen et al., 1998). The 
similarity of Pftl to P-glycoprotein, paiticularly in the NBD, could add additional 
importance for the investigation of this protein in such a context.
The short 5’ sequence flanking the proposed ATG start codon exhibits a number of 
possible promoter elements. In particular there are a number of sequences that may 
pertain to “CAAT” or ‘TATA” boxes. It is especially difficult to ascribe any definitive 
importance to any individual element observed in the promoters of such fungal genes. It 
is typically observed that the organism degenerates motifs involved in regulation with 
respect to both sequence and position. Without extensive further investigation, 
involving nucleotide protection assays and/or reporter fusion assays on selected 
promoter mutants, at this time it is impossible to make any significant analysis of the 
particulars of the transcriptional initiation of p ftl .  However, at this stage it was 
considered interesting that the p ftl  gene was not observed in either of the cDNA lambda 
libraries on PCR analysis. Initial explanations could include a technical failure to clone 
the required cDNA during library construction, the fact that p ftl  is not an expressed 
reading frame in P.brasiliensis, or that induction of p ftl  expression is tightly regulated 
and that expression was absent under the conditions used to generate cDNA for each 
library. Clarification of this issue was considered very important and is dealt with in 
Chapter 5.
Pftl represents a fourth member of a small but growing subfamily of fungal ABC 
transporters. AfuMDR2, the two half transporters of S.cerevisiae (MDLl and MDL2) 
(Dean, et al., 1994), and now Pftl suggest that an important role exists for these 
proteins. Until the closing stages of the writing of this thesis no function had been 
assigned to any of these proteins. Very recently. Young et al. (2000) demonstrated that 
MDLl and MDL2 can be found on the S.cerevisiae mitochondrial membrane. MDLl, 
but not MDL2, is responsible for the transport of oligopeptides that are products of the 
action of the m-AAA protease. The sequence similarity between Pftl and MDLl could 
suggest a similar role for this transporter. However the sequence of Pftl is more akin to 
that of MDL2 which does not act as an oligopeptide transporter. Later in this thesis we 
demonstrate an alternative substrate affinity for Pftl that suggests a possible 
involvement in other processes.
The afumdr2 gene of A.fumigatus remains uninvestigated and can provide no further 
infomiation on any potential function of these genes. Further investigation should be
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performed. It is possible that these molecules will possess affinity for, and even be 
involved in the transport of oligopeptides. The extensive sequence homology with Pgp 
may result in an affinity for hydrophobic substrates that may include drugs, pheromones 
or lipids. The striking similarity at the amino-acid sequence level with the larger, full 
sized, countei-parts supports this notion.
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Chapter 4
Identification and sequencing of pft2.  a full-sized PDR-like ABC 
transporter ^ene from Paracoccidiodes brasiliensis
While p ftl  represents the first ABC transporter described for P.brasiliensis it is not 
especially homologous to the majority of transporters known to be involved in fungal 
drug resistance. Pftl is a member of the MDR subclass of ABC transporters. While 
the MDR-like AfuMDRl has been shown to transport antifungals (Tobin, et al. 1997), 
pleiotropic drug resistance in fungi is best characterised in the PDR subclass of 
proteins that includes PDR5 (Balzi, et al. 1994). These transporters, exhibiting an 
(NBD-MSD)2 topology, are heavily degenerated with respect to the conserved motifs 
of P-glycoprotein-like molecules although conservation between members of the 
subclass can be considerable (Bauer, et al. 1999). These transporters are of 
significant importance. The PDR-like CDRl from C.albicans has been shown to be 
involved in clinical azole resistance (Sanglard, et al. 2001).
Following the successful application of degenerate primers in PCR and the 
identification of p ftl it was decided to develop a second set of primers specifically 
targeting PDR-subclass genes. This could screen the P.brasiliensis genome for the 
presence of genes encoding these transporters. On considering the existence of 30 
ABC transporters in the genome of S.cerevisiae (Goffeau, et al. 1996) it is almost 
certain that p ft l  would not represent the comprehensive inventory of P.brasiliensis 
ABC transporters.
This chapter reports the successful application of the degenerate primers PDRl and 
PDR2 in amplifying a fragment of a second gene encoding a PDR-like ABC 
transporter in P.brasiliensis. This amplicon was used to screen a lambda genomic 
library allowing the isolation of a single phage clone. Subcloning of fragments 
derived from the DNA of this clone allowed a partial sequence to be compiled. The 
DNA sequenced to this point spans 3792bp and a sequence of 1053 amino acids can 
be deduced from this data. The partial sequence is thought to belong to an open 
reading frame encoding an ABC transporter belonging to the PDR subfamily.
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4.1 Multiple alignments and the design of degenerate oligonucleotides
Following the success of the MDR subclass oligonucleotides in the identification of 
p ftl  a similar approach was adopted to identify other transporters. In this approach a 
multiple alignment of notable proteins of the PDR-subfamily was performed. Amino 
acid sequences of the C-terminal nucleotide-binding domains of the selected proteins 
were eventually targeted for primer identification. The results of the multiple 
alignment, highlighting the motifs selected for primer design, can be seen in Fig4.1. 
Also illustrated are the nucleotide sequences with degeneracies used as deduced from 
the sequences of the targeted amino acid motifs. Again the allocation of degeneracies 
was based on the codon usage of N. crassa and A.nidulans (Gurr, et a i, 1997).
The multiple alignment identified a number of potential targets for primer design. 
The two targets chosen, AGKTTLL and TIHQPSA, allowed for a minimal amount of 
degeneracy based on codon usage and represented two regions that were totally 
conserved in all of the proteins of this class. This is in contrast to the M DRl primer 
used for p ftl, where a single amino acid could have been, and was, degenerated from 
L to I.
4.2 PCR amplification of a PDR-like gene fragment using degenerate PCR
Primers PDRl and PDR2 were used in a PCR reaction with P.brasiliensis genomic 
DNA as the template. The results of the PCR can be observed in Fig4.2. A band of 
c.500bp was observed (the expected size was 495bp, assuming no introns were 
present) and also a smaller band of c.280bp. Despite the use of a range of annealing 
temperatures, only these bands were observed. The performance of PCRs over a 
range in temperatures was variable but higher annealing temperatures favoured 
consistent high levels of amplification. Both amplicons from the 62°C reaction were 
cloned into pGEM-T Easy™ and sequenced using T7 and SP6 sequencing primers. 
Three individual clones were analysed for each fragment in order to ascertain whether 
multiple amplicons of similar size were present.
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F ig4 .2  PDR1/PDR2 degenerate PCR analysis of P.brasiliensis 
genomic DNA
Lanes 1 to 12 are PCR reactions with annealing temperatures increasing in l^C 
increments (54^C to 66®C). Lane 13 is a template free negative control performed with 
the annealing step at 60®C.
PCR conditions; lOOpl reaction volume containing L5mM MgCl. Activation at 95®C 
for 15min. Dénaturation at 94°C for 30s / annealing at various temperatures for 40s / 
extension at 72°C,A total of 30 cycles concluded with a final lOmin extension at 72°C.
Chapter 4
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Fig 4.2
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The sequence of the smaller product showed no obvious reading frame and no 
homology with any known sequence when analysed on BLAST at either the 
nucleotide or amino acid level. The primers were not incorporated into the amplicon 
in frame. This product was not considered to represent an ABC transporter gene and 
was not investigated any further.
The replicate sequence results for the clones containing the larger c.500bp fragment 
showed that all clones contained identical 492bp DNA. When analysed by BLAST 
the DNA showed considerable homology to other PDR-subclass ABC transporters. 
The first 20 hits on the BLASTx algorithm are displayed in Fig4.3. Highest 
homology is observed with AtrA of Aspergillus nidulans but considerable identity and 
similarity is evident for transporters involved in clinical and experimental drug 
resistance including PDR5 and CDRl. The sequence was predicted to belong to a 
putative open reading frame that we termed pft2.
4.3 Screening of lambda libraries for the pft2 gene
The PCR using PDRl and PDR2 was repeated using total library DNAs. Again the 
ÀDASHH genomic DNA library (constructed using a partial SauSA digest of 
P.brasiliensis genomic DNA) and the two ÀZAP cDNA libraries (constructed using 
total cDNA from either the yeast form or the mycelial form of the organism) were 
considered. As in the case of p ftl, the gene fragment could only be detected by PCR 
in the IDASHII genomic library and was absent in both cDNA libraries (data not 
shown).
It was decided to pursue the pft2 gene in the ^DASHII library only. The library was 
diluted by a factor of 10  ^and lOOpl of this dilution was used to infect LE392 E.coli 
cells. This allowed for 450 plaques per 10cm x 10cm plate (see section 3.2).
Hybridisation on membranes derived from 1 plaque lifts was performed. Following 
detection, a predominant hybridisation signal was observed in an identical position on 
two replicate filters as shown in Fig4.4a. Specific hybridisation conditions are as 
noted in the figure legend. Secondary screening of this lambda isolate also proved
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Accession Num ber Protein : Source Author
1] gi|7493926| AtrA; Aspergillus nidulans (Del Sorbo, et al. 1997)
2] gi[ 11686501 Bfrl ; Schizzosaccharomyces pombe (Nagao, et al. 1995)
3] gi|13446213| Brefeldin A transporter; Schizzosaccharomyces pombe (See note 1 )
4] gi|3420017| Cgrl ; Candida glabrata (Miyazaki, H. Unpub. data)
5] gi|3288709| Pmrl ; Pénicillium digitatum (Nakaune, et al. 1998)
6] gi|5327107| MgAtr2; Mycosphaerella graminicola (Zwiers, 2000)
7] gi|6175524| CgCDRl; Candida glabrata (Sanglard, eta l. 1999)
8] gi|1321667| Ydrl; Saccharomyces cerevisae (Hirata, et al. 1994)
9] gi|6324727| Pdr5; Saccharomyces cerevisae (Goffeau, eta l. 1996)
10] gi[7160817| AtrE; Aspergillus nidulans (Andrade, A. Unpub. Data)
11] gi|913016| Snq2 homologue; Schizzosaccharomyces pombe (Miyazaki, et a/. 1998)
12] gi|7493952| ABCl ; Pyricularia grisea (Urban, et al. 1999)
13] gi|6320614| Pdrl5; Saccharomyces cerevisae (Goffeau, et al. 1996)
14] gi| 122489211 ABC transporter; Rhizoctonia solani (Young Jin, L. Unpub. Data)
15] gi|6324904| PdrlO; Saccharomyces cerevisae (Goffeau, et al. 1996)
16] gi|8101775| BcatrO; Botryotinia fuckeliana (Del Sorbo, G. Unpub data)
17] gi|5921714| Cdr4; Candida albicans (Franz, et al. 1998)
18] gi| 122489231 ABC transporter; Alternaria alternata (Young Jin, L. Unpub. Data)
19] gi|5921713| Cdr3; Candida albican (Balan, et al. 1997)
20] gi|2492604| Cdr2; Candida albicans (Sanglard, eta l. 1997)
Fig 4.3
This figure is adapted from a BLAST output generated when searching the NCBI 
database (http//www.ncbi.nlm.nih.gov/BLAST/) using the 492bp PDR1/PDR2 
amplicon sequence. The 20 genes with highest homology scores are presented as 
generated using the BLASTx algorithm. The description of identity for each hit has 
been altered from the original output to ease reader identification.
Note 1; Identified by the European S.pombe genome sequencing project, Sanger 
centre.
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Fig4.4a Primary hybridisation screen of i^DASH genomic library
The left-hand image represents the signal obtained from the initial lift of 
plaque material from a phage library culture plate. The right-hand image 
is the signal obtained from a second plaque lift from the same plate. 
Thus replicate membranes were available to confirm the position of 
positive signals.
Hybridisation conditions; 140ng of labelled probe (at 7ng per ml of 
hybridisation buffer) was applied to replicate filters. The membranes 
were incubated in the presence of probe for 18h at 62°C. A series of 3 
stringency washes were applied using 2xSSC/0.1%SDS, 
lxSSC/0.1%SDS and 0.5xSSC/0.1%SDS in succession. Again the 
solutions were at 62°C. The membrane was blocked for Ih at room 
temperature. Following this, anti-fluorescien antibody was applied at 
1:2000 dilution of stock as supplied. Unbound antibody was washed 
off, detection reagent applied and exposure to X-ray film was allowed 
for 20min.
F ig4.4b  Replicate filters of secondary screen on the 2,pft2 clone
Hybridisation conditions; As described for Fig4.4a, except hybridisation 
temperature and stringency washes were performed at 65°C.
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positive as shown by the strong hybridisation signals observed on replicate 
membranes prepared from plaque lawns of this clone. The results are shown in 
Fig4.4b. Again, specific hybridisation conditions are noted in the legend.
4.4 Subcloning P.brasiliensis DNA from
In order to obtain fragments of the p ft2  gene from the lambda clone for further 
sequence analysis a series of subcloning experiments were performed. Following a 
high multiplicity liquid culture infection of LE392 with Xpjt2, the DNA from the 
phage was prepared as previously described. To ten individual restriction enzyme 
digests was added 500ng of phage DNA. Each restriction digest was performed using 
a different restriction enzyme, chosen on the basis on their suitability for cloning into 
the MCS of pZERO™. The restriction digests were electrophoresed on a 0.9% 
agarose gel (Fig4.5a). The DNA was then transferred to nitro-cellulose membrane 
and exposed to Southern hybridisation using the PDR1/PDR2 fragment as a probe. 
Labelling of the probe with fluorescein was assessed on UV illumination and 140ng 
of labelled probe was applied to the hybridisation (at 7ng per ml of hybridisation 
solution). The resultant Southern blot is presented in Fig4.5b.
The Southern blot revealed fragments of various sizes that could have been accessible 
to cloning. (Two bands exist on the H indlll and Xbal lanes as these sites are internal 
to the sequence of the PDR1/PDR2 fragment probe.) Initially, it was decided to use 
the c7.8kb Æ'coRI fragment as a principal target for cloning. Following isolation by 
gel extraction, this fragment could be digested further by Hindlll, providing smaller 
DNAs with incompatible cohesive ends, allowing more efficient cloning.
H indlll digestion of the c.7.8kb EcoKl fragment resulted in the generation of two 
separate EcoRH H indlll fragments (2.2kb/4.2kb) from the ends of the original 
fragment and a central 1.4kb Hindlll fragment (data not shown). This digestion was 
cleaned and used in a ligation with EcoRllHindUl digested pZERO™ DNA. Of the 
two potential clones (2.2kb insert and 4.6kb insert) only the 2.2kb could be identified 
among the recombinants, in plasmids pEH4, pEH5 andpEH6 (Fig4.6). This insert of
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Fig4.5a Restriction digests of Xpft2 DNA
Digests were performed using 500ng of DNA per digest in a total 
volume of 20pl. DNA was incubated at 37®C for 4h in the presence of 
5 Units of the appropriate restriction endonuclease.
Lane 1] Hindlll
Lane 2] Kpnl
Lane 3] Sad
Lane 4] BamHl
Lane 5] Ecom
Lane 6] Pstl
Lane 7] EcoRY
Lane 8] Notl
Lane 9] Xbal
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Fig4.5b  Southern Blot of gel in Fig4.5a
Lanes are as Fig 4.5a
The blot was hybridised at 65°C for 40h with 500ng of the pft2 gene fragment as a 
probe (25ng per ml of hybridisation buffer). The blot was washed for 13min with each 
of 2X SSC/0.1% SDS, IX SSC/0.1% SDS and 0.5X SSC/0.1% SDS at 60^C. Anti- 
fluorescein was allowed to bind and the blot was exposed to X-ray film for lOmin 
following the addition of detection reagent.
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pEH6 was then sequenced using T7 and SP6 primers followed by gene specific 
primers in a walking strategy.
The intervening 1.4kb between the 3’ terminus of the pEH6 insert and the original 
PDR1/PDR2 fragment was amplified by PCR (using a proof-reading polymerase) 
circumventing the need to accumulate this insert from the lambda DNA. Two 
opposing primers (SPANRl and SPANFl) were designed to anneal to sequences from 
the pft2 fragment and the pEH6 insert respectively. These primers were applied to the 
phage clone DNA and the product of the PCR is also illustrated in Fig4.6 on cloning 
into pGEM-T Easy™. As can be observed, the expected product of c l.6kb  was 
cloned. Once cloned the DNA of pSPAN5 was sequenced.
It was evident that the DNA sequence obtained at this point contained the immediate 
promoter and the translational start codon for pft2. The 3’ sequence remained to be 
sequenced. This would be present in the 4.2kb EcdRHHindlll fragment that failed to 
clone in the initial experiment. Despite repeated attempts this larger fragment would 
not clone to pZERO™ in the presence of the smaller 2.2kb DNA also generated in the 
restriction digest of the XDNA. In attempts to subclone this 4.4kb fragment, extensive 
digestion of large amounts of the Xpft 2 DNA was performed initially with EccRI and 
the //m d lll. A total of 20 restriction digests were performed using EcoRl, Each 
restriction digest received 5pg of Xpft2 DNA. The volume was made to a total of 20pl 
and the reactions incubated for 3h at 37°C. All digests were electrophoresed on a 
0.9% gel and the 7.8kb EcoRl fragments was purified in 6 Qiaex II gel extraction 
procedures. The 20pl eluates from the gel extractions were applied to six Hindlll 
restriction enzyme digests and the products were again electrophoresed on a 0.9% gel. 
The 4.4kb EcoRUHinéHl fragments were gel extracted allowing the accumulation of 
250ng of the fragment in a volume of 40jal. Ligation reactions were attempted on a 
number of occasions using a wide range of ligation conditions and vectoninsert ratios. 
Positive control reactions were performed simultaneously with each test ligation and 
all were transformed into Novablue competent cells. Despite the consistent good 
performance of the control reactions in these experiments, no clone containing the 
required EcoRUHinàHl fragment could be identified.
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F ig4 .6  Restriction enzyme digestion of plasmids containing the 
2.2kb E c o R H H in d lll  fragment and the SP A N R l/SP A N F l 
PCR amplicon
Lanes 1 to 6 are Hindlll digests of potential pZERO™ clones containing 
ih t EcoRVHindlll fragment. These were denoted "pEH". Only clones 
pEH3, pEH5 and pEH6 contained the required insert.
Lanes 7 to 11 are EcoRI digests of potential pGEM-T Easy™' clones 
containing the SPANFl/SPANRl amplicon. This was successfully 
cloned in pSPAN4 and pSPAN5.
Lane 1] pEHl
Lane 2] pEH2
Lane 3] pEH3
Lane 4] pEH4
Lane 5] pEH5
Lane 6] pEH6
Lane 7] pSPANl
Lane 8] pSPAN2
Lane 9] pSPAN4
Lane 10] pSPAN5
Lane 11] pSPAN6
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The failure to clone this remaining pft2 fragment could have occurred for a number of 
technical reasons. While 4.4kb is a larger fragment, the successful cloning of DNA of 
this size is commonplace. However, it does require a large concentration of insert in 
order to drive the ligation to a satisfactory result. The extensive repurification of 
fragments following sequential digests meant that a very high concentration of insert 
could not be obtained easily. The laborious gel extraction and digestion procedure 
may also have damaged the termini of the insert DNA making it unreceptive to sticky 
end cloning. However, it should be noted that the vector DNA was prepared 
simultaneously and identically to the insert DNA and continued to perform well in 
control reactions. An alternative explanation is that pZERO™ containing the insert 
was deleterious to the host strain on transformation and the outgrowth of 
transformants was inhibited. The application of ligation reactions to SSP-PCR should 
have demonstrated successful ligation independently of transformation result. All 
attempts at SSP-PCR on these ligations were unproductive. The recalcitrance of this 
final fragment of DNA to both PCR and cloning remains unexplained. Attempts to 
complete the sequence of this gene are ongoing.
4.5 The sequence of pft2
All sequences were compiled using Auto As sembler™. The diagrammatical 
representation of the contig is presented in Fig4.7. It should be noted that any area of 
the DNA has been sequenced at least in duplicate, and in opposing directions. 
Sequences derived from pEH6 run between "sp6" and "T7". The two aforementioned 
sequences were gathered on sequencing pEH6 from the SP6 and T7 sites flanking the 
MCS. The application of gene specific primers are denoted as "FI" - "F5" and "Rl" - 
"R5", "F" for the forward direction and "R" for the reverse. The sequences derived 
from the internal pft2  PCR include "Span" in the annotation. Primers applied to 
internal sequences of this amplicon are also marked as "IF" or "IR" depending on the
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orientation. The sequences of the original PDR1/PDR2 fragment are denoted with 
"fPDR".
The nucleotide sequence and deduced amino acid sequence of the partial pfi2 contig 
are presented in Fig4.8. Additional annotations are as described in the legend. Fig4.9 
displays the alignment of the partial Pft2 amino acid sequence with that of AtrA.
4.6 Discussion
Following the successful application of degenerate primers in the amplification of the 
p ftl gene fragment it was decided to extend this approach to identify other genes for 
ABC transporters. Multiple alignments of amino acid sequences of proteins that 
belong to the PDR-subfamily of ABC transporters allowed the identification of two 
totally conserved motifs in the C-terminal nucleotide-binding domain. The design of 
degenerate primers for PCR allowed the isolation of a 492bp fragment with extensive 
similarity to a number of notable transporters, including PDR5 (Balzi, et a l  1994), 
demonstrating the PDR-subfamily in P.brasiliensis. A number of clones containing 
the initial c.500bp amplicon were sequenced and all proved to have an identical insert 
suggesting that the PCR amplified from only one coding sequence. This sequence 
was proposed to belong to a larger open reading frame that we termed pft2.
A  single lambda phage clone was isolated from a IDASHII P.brasiliensis genomic 
DNA library. Subcloning and sequencing of a 2.2kb fragment from this clone 
revealed a partial sequence of an ABC transporter including a well defined 
translational start codon and 397bp of the immediate promoter with a number of 
putative “CAAT” and “TATA” elements. This 2.2kb fragment did not contain the 
sequence of the hybridisation probe (the PDR1/PDR2 amplicon). The intervening 
sequence between these two regions was amplified by a proof-reading polymerase 
and cloned and sequenced.
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Fig4.8 The partial nucleotide sequence and deduced amino acid sequence
of pft2
- 3 9 7  g a a t t c g g a t c c g g c g a c g g a g g c g g g t c c t t g g g t  - 3 6 1
- 3 6 0  t c t a g c t g a c a a t c g t g a a a c c a g c t g c c c t c a a c a c c c a t c c c c a t t c a t t c a a t t g g c  - 3 0 1
- 3  00  a g g a c c a g a t t c g c c t t g c t c a a a c c c a g a g t t c c a g g c t g g a a a a c t g c c c a a t c t c t g  - 2 4 1
- 2 4  0 t a a t a a t c c c c a a g a g a g c a c c t t g g a a c a c a t t t t c c c c g g g g c a a t t t a t a c t c c a g t  - 1 8 1
- 1 8 0  a g t g g g c a a a t a a c a c c a c a t c t c t t t c g t c t c a c a g t t c c a g g c t g t a a t t c t a g t t t a  - 1 2 1
- 1 2 0  t t g a a c t a c c t c g t t c t t t t t c t t a t a t a c a t a t a t a t a t a t g t a t a t a t a t a t a t c t q t  - 6 1
- 6 0  a t a a t t g c t t t t t g a a t c c t t a c a a g g c t g t g c c c g a t a t c a a a c t c t c t c c a a g a a c a a  - 1
1 ATGGCGGGCGATTCGCCGCAATCTTCATTTCACGAAGATCCAGAATACCTTCCGAACGTG 6 0
(1 )  M A G D S P Q S S F H E D P E Y L P N V  ( 2 0 )
61  AAGGCAAACGATTGCAATGACGATGAAGATGAATCAAACAATGGTGATTCTTCTTCTAAC 12 0
( 2 1 )  K A N D C N D D E D E S N N G D S S S N  ( 4 0 )
1 2 1  GAGGATACCAGGTTTAATCTCATTCGAACATTAACCAGAGACCGAAATACAGAGCTCTCG 1 8 0
( 4 1 )  E D T R F N L I R T L T R D R N T E L S  ( 6 0 )
1 8 1  AGAATAGCCTCCGTCTTCTCCCATGCCGACGAGCATTCCACTGCTACTGACTCCCTAGCA 24  0
( 6 1 )  R I A S V F S H A D E H S T A T D S L A  ( 8 0 )
2 4 1  CGGATAGATACCCTTGCTGGCCTCCAACTCGGAGATGCCGTGCTGAACCCATCCAGCCCG 3 00
( 8 1 )  R I D T L A G L Q L G D A V L N P S S P  ( 1 0 0 )
3 0 1  CAGTTCGACTTTTACAAATGGGCCCGCATGCTTATGAAGCTGATGGAGGAGGATGGGCTC 3 60
( 1 0 1 )  Q F D F Y K W A R M L M K L M E E D G L  ( 1 2 0 )
3 6 1  AAGAGACGACGGACCGGCATCACCTTCAGGAACCTGAGTGTCTACGGTTCCGGGCCCGCG 42 0
( 1 2 1 )  K R R R T G I T F R N L S V Y G S G P A  ( 1 4 0 )
4 2 1  CTGCAGCTGCAAAGCACCGTCTCCACACCGATCATGGCACTCTTCCGGTTCCAAGAGACG 4 8 0
( 1 4 1 )  L Q L Q S T V S T P I M A L F R F Q E T  ( 1 6 0 )
4 8 1  TTTGGGGTTGGGCGGAAGACACGCAAGCGGATCTTGAACAACTTCAATGGAGCGTTGAGG 54 0
( 1 6 1 )  F G V G R K T R K R I L N N F N G A L R  ( 1 8 0 )
5 4 1  GAGGGGGAGATGCTTGTCGTGCTGGGGAGGCCCGGGAGTGGATGCAGCACCTTTCTCAAG 6 0 0
( 1 8 1 )  E G E M L V V L G R P G S G C S T F L K  ( 2 0 0 )
6 0 1  ACCATATGTGGAGAAACACATGGGCTTGAGCTGGGCAAGGAGGCCTCGGTTCAATACAAC 6 6 0
( 2 0 1 )  T I C G E T H G L E L G K E A S V Q Y N  ( 2 2 0 )
6 6 1  GGTATTCCCCAGACAACGTTCAAGAAGGAATTTCGCGGCGAAGCTGTGTACAGTGCGGAG 7 2 0
( 2 2 1 )  G I  P Q T T F K K E F R G E A V Y S A E  ( 2 4 0 )
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7 2 1  GATGAGAAACATTTCCCCCATCTTACAGTTGGACAGACGTTGGAGTTTGCTGCTGCTTGT 
( 2 4 1 )  D E K H F P H L T V G Q T L E F A A A C  
7 8 1  CGGACTCCTTCTGCAAGAGTGATGGGCATGGAGAGGAAGGAGTTCTCTCACCATATTGCA 
( 2 6 1 )  R T P S A R V M G M E R K E F S H H I A  
8 4 1  AGGGTGGTCATGGCCATTTTCGGCTTAAGCCATACCGTCAACGCCAAAGTTGGTGATGAC 
( 2 8 1 )  R V V M A I F G L S H T V N A K V G D D  
9 0 1  TACGTCCGAGGCGTCAGTGGCGGCGAACGCAAACGTGTCAGCATTGCGGAGCTTGGGCTC 
( 3 0 1 )  Y V R G V S G G E R K R V S I A E L G L  
9 6 1  TCTGGCGCACCGGTAGTCTGCTGGGACAATTCAACCAGGGGGCTTGACTCAGCTACAGCT 
( 3 2 1 )  S G A P V V C W D N S T R G L D S A T A  
1 0 2 1  CTTGAGTTTACCAAGGCGCTGCGAATCGCCTCTGATGTCATGGGAGCTACACAGGCCGTT 
( 3 4 1 )  L E F T K A L R I A S D V M G A T Q A V  
1 0 8 1  GCCATCTACCAGGCCAGCCAGGCAATCTACGACTTGTTTGACAAAGCTGTTGTTCTCTAC 
( 3 6 1 )  A I Y Q A S Q A I Y D L F D K A V V L Y  
1 1 4 1  GAAGGGCGCCAGATCTACTACGGTCCCGCTAACTCAGCCAAGAAGTATTTCGAAGACATG 
( 3 8 1 )  E G R Q I Y Y G P A N S A K K Y F E D M
12 01 GGCTGGTATTGCCCGCCCCGCCAGACAAATGGCGATTTCCTCACCTCTATCACCAACCCG 
( 4 0 1 )  G W Y C P P R Q T N G D F L T S  I T N P
12 61 ATGGAGCGGAGAGTCAGGGACGGGTTTGAATCCAAAGTTCCCCGAACCGCCCATGAGTTT 
( 4 2 1 )  M E R R V R D G F E S K V P R T A H E F
1 3 2 1  GAGACGTATTGGCGCAACTCGCAGCAATTCAAGGACATGCAGGCTGAAATTGAGCAGTGC 
( 4 4 1 )  E T Y W R N S Q Q F K D M Q A E I E Q C
1 3 8 1  GAGGATGAACATCCCGTTGGCGGGCCGGCGCTGGGAGAATTGCGCGAGGCCCACAACCAG 
( 4 6 1 )  E D E H P V G G P A L G E L R E A H N Q
1 4 4 1  GCGCAGGCAAAGCACGTTCGCCCGAAATCACCGTATACCATAACCATACTTATGCAGGTG 
( 4 8 1 )  A Q A K H V R P K S P Y T I T I L M Q V
1 5 0 1  AAGCTGTGTACTACCCGTGCCTACCAGCGCCTGTGGAATGATAAAGCATCGACGATTTCC 
( 5 0 1 )  K L C T T R A Y Q R L W N D K A S T I  S
1 5 6 1  AGGGTGATGGCGCAACTGATCATGTCTTTGATTATCGGCTCGCTCTACTTTAACACGCCA 
( 5 2 1 )  R V M A Q L I M S L I  I G S L Y F N T P
1 6 2 1  CAAGTTACCAGCAGTTTTTTCTCGAAGGGTTCGGTTTTGTTCTTTGCTATTCTGCTCAAT 
( 5 4 1 )  Q V T S S F F S K G S V L F F A I L L N
1 6 8 1  G C A T T G C T T T C T A T T T C T G A A A T T A A T A C G ta a g ttta c ttcg ctg ctcca a ta a a a ta a  
( 5 6 1 )  A L L S I S E I N T
1 7 4 1  a t a a a a t a a a a t a a a a a a a a a a a a a a a a a a a a a a a a a a g t g a t g g t t a c t g a c a g a a t c t
7 8 0
( 2 6 0 )
8 4 0
( 2 8 0 )
9 0 0
( 3 0 0 )
9 6 0
( 3 2 0 )
1020
( 3 4 0 )
1 0 8 0
( 3 6 0 )
1 1 4 0
( 3 8 0 )
1200
( 4 0 0 )
1 2 6 0
( 4 2 0 )
1 3 2 0
( 4 4 0 )
1 3 8 0
( 4 6 0 )
1 4 4 0
( 4 8 0 )
1 5 0 0
( 5 0 0 )
1 5 6 0
( 5 2 0 )
1 6 2 0
( 5 4 0 )
1 6 8 0
( 5 6 0 )
1 7 4 0
( 5 7 0 )
1 8 0 0
135
Chapter 4
1 8 0 1  t t a t a g g c t t t g t a a g g t c t t t c c c a a c c t g g t c t t t c a t c t t g c a g t c a c t a a c a t a a c 1 8 6 0
1 8 6 1  aaagacTCCCAACGCCCTATCGTCTCCAAACACGTATCATACGCCTTATACTATTCCTGC 
(5 7 1 )  S Q R P I V S K H V S Y A L Y Y S C
1 9 2 1  GTCGAAGCTTTTGCAGGGATCGTTTCCGATATTCCCATAAAGTTGATAACTAGCACTGTC 
(5 8 9 )  V E A F A G I V S D I P I K L I T S T V  
1 9 8 1  TTCAACCTAATCATCTACTTCCTCGGAGACTTGCGACGGCAGGCGGATCATTTCTTCATT 
(6 0 9 )  F N L I I Y F L G D L R R Q A D H F F I  
2 0 4 1  TTCTTCCTTTTCACTTTCATCACCATGTTAACTATGTCTGCAATATTCCGGACGCTTGCC 
(6 2 9 )  F F L F T F I T M L T M S A I F R T L A  
2 1 0 1  GCTGCGACGAAGACAATTTCCCAGGCTCCCGCATTCGCGGGAGTCATGGTTTTGGCTATT 
(6 4 9 )  A A T K T I  S Q A P A F A G V M V L A I
2 1 6 1  GTCATATATACGGGTTTCACAATTCAGCGGTCATATATG t  a a g  t g  t  c t c t c c g c t t a a t g
(6 6 9 )  V I Y T G F T I Q R S Y M
2 2 2 1  g t t c t g g t a t c t t g c t c g t t t t c t t g a c t g g g g a t g t t a t g c t a a a a t c c c c t g t g a c a g
1 9 2 0
( 5 8 8 )
1 9 8 0
( 6 0 8 )
2 0 4 0
( 6 2 8 )
2100
( 6 4 8 )
2 1 6 0
( 6 6 8 )
2220
( 6 8 1 )
2 2 8 0
2 2 8 1  GCGCCCATGGATGAATGGATAAGCTGGATTAATCCTGTGGCATATGCATTCGAAGCTATC 
( 6 8 2 )  A P M D E W I S W I N P V A Y A F E A I  
2 3 4 1  CTGGTAAACGAAGTACATAACCAACGCTACGCATGTGCACTGATTGTCCCGCCATATGGA 
( 7 0 2 )  L V N E V H N Q R Y A C A L I V P P Y G  
2 4 0 1  GAAGGAATGAACTTCCAGTGTCCAATTGCCGGGGCGGTGCCCGGCGAGAGATCGGTGTCC 
( 7 2 2 )  E G M N F Q C P I A G A V P G E R S V S  
2 4 6 1  GGCGATGCTTGGGTAGAATCGCAATATGGCTACAAGTACTCCCATATCTGGCGGAATCTC 
( 7 4 1 )  G D A W V E S Q Y G Y K Y S H I W R N L  
2 52 1  GGCTTCATCTTCGCATTCCAGGTCTTTTTCTACGTGGTGTATCTTACTGCGACGCAGCTG 
( 7 8 2 )  G F I F A F Q V F F Y V V Y L T A T Q L  
2 5 8 1  AACACTGCCTCAGCCTCGACCGCAGAATTTCTTGTTTTCCGCCGCGGTAATGTTCCGATA 
( 7 8 2 )  N T A S A S T A E F L V F R R G N V P I  
2 6 4 1  TATATGCTGAAACAAGACGATGAAGAGAATGGCAAAGCAGCTCCTCCTGCTGCTGCTGCT 
( 8 0 2 )  Y M L K Q D D E E N G K A A P P A A A A  
2 7 0 1  GCTGCTGCTGCTGCTGCAGCTGCTGAGGCTAATTCCAAGAACGAAGAAGATAAAACCAAC 
( 8 2 2 )  A A A A A A A A E A N S K N E E D K T N  
27  61 GTCCTTCCCCCTCAGACTGACGTTTTCACATGGAGGAATGTAACTTATGACATCACGATT 
( 8 4 2 )  V L P P Q T D V F T W R N V T Y D I T I
2 3 4 0
( 7 0 1 )
2 4 0 0
( 7 2 1 )
2 4 6 0
( 7 4 1 )
2 5 2 0
( 7 6 1 )
2 5 8 0
( 7 8 1 )
2 6 4 0
( 8 0 1 )
2 7 0 0
( 8 2 1 )
2 7 6 0
( 8 4 1 )
2 8 2 0
( 8 6 1 )
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2 8 2 1  AAGGGAGAGGATAGAAGGATCCTTGACCACGTTTCTGGTTGGGTTCGACCCGGTACACTT 
( 8 6 2 )  K G E D R R I L D H V S G W V R P G T L
2 8 8 1  ACGGCACTGATGGGCGTCTCTGGAGCCGGCAAAACTACCCTGCTCGACGCGCTCGCGCAA 
( 8 8 2 )  T A L M G V S G A G K T T L L D A L A Q
2 9 4 1  CGCATTTCTTTCGGAGTTATCACGGGGGATATGTTTGTCAATGGAAAGCCCCTTGACCTA
( 9 0 2 )  R I S F G V I T G D M F V N G K P L D L
3 0 0 1  TCCTTCCAGCGCAAAACTGGCTACTGTCAACAGCAAGATCTACATCTCGAGACAAGCACG 
( 9 2 2 )  S F Q R K T G Y C Q Q Q D L H L E T S T
3 06 1  GTACGCGAGGCACTGCGCTTTTCAGCAATGTTAAGACAGCCAAAGAGCGTTTCCAAGCAG 
( 9 4 2 )  V R E A L R F S A M L R Q P K S V S K Q
3 1 2 1  GAAAAATACGAGTTTGTTGAAGACGTGATTAAGATGTTGAACATGGAGGATTTTGCGGAA 
( 9 6 2 )  E K Y E F V E D V I K M L N M E D F A E
3 1 8 1  GCGGTTGTTGGTAACCCTGGTGAAGGACTCAATGTTGAGCAGCGGAAACTTCTCACCATC 
( 9 8 2 )  A V V G N P G E G L N V E Q R K L L T I
3 2 4 1  GGGGTTGAACTGGCTGCAAAACCGCAACTACTGCTCTTCCTTGACGAACCAACTTCCGGC 
( 1 0 0 2 )  G V E L A A K P Q L L L F L D E P T S G
33 01 CTTGACTCACAAAGTGCATGGGCGATTGTTACTTTTCTCCGGAAGCTTGCTGGCCATGGT
( 1 0 2 2 )  L D S Q S A W A I V T F L R K L A G H G
33 61 CAAGCTGTGCTCTCCACCATCCACCAGCCCTCCGCA
( 1 0 4 2 )  Q A V L S T I H Q P S A
2 8 8 0
( 8 8 1 )
2 9 4 0
( 9 0 1 )
3 0 0 0
( 9 2 1 )
3 0 6 0
( 9 4 1 )
3 1 2 0
( 9 6 1 )
3 1 8 0
( 9 8 1 )
3 2 4 0
( 1 0 0 1 )
3 3 0 0
( 1 0 2 1 )
3 3 6 0
( 1 0 4 1 )
3 3 9 5
( 1 0 5 3 )
N o m e n c la tu r e ;  N u c leo tid e  p o s itio n s  are  re co rd e d  in b lack  n u m era ls , am in o  ac id s  in b ra c k e te d  b lue.
N u c le o t id e  d a ta ;  C o d in g  n u c le o tid e s  a re  d e n o te d  by u p p e rc a se  le tte r. N o n -c o d in g  b a se s  a re  d e n o te d  
by lo w e rca se  le tte rs . P u ta tiv e  in tro n s  a re  p re se n te d  in b lu e . P o te n tia l p ro m o te r  fe a tu re s  (C A A T  and  
T A T A  e le m en ts )  a re  u n d e rlin ed
A m in o  a c id  d a t a ;  P u ta tiv e  W a lk e r  A  b o x e s  a re  d e n o te d  in  g re en . T h e  W a lk e r  B b o x e s  an d  c e n tre  
re g io n s  are  d e n o te d  in red .
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Fig4.9 Comparative alignments of AtrA (top) and the partial deduced amino 
acid sequence of Pft2 (bottom)
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I  I  I  I  I  I  I
KAQCRPGSAAVPSHDNPPNDDLEDATLDPNSASFSLEKW LRAAVSDASQQGLSTPSGGIPLQKSDRP
• I  I I  I I  I I I  I  I  I I  * 1 1  I  I I I  I I
HADEHSTATDSLARIDTLAGLQLGDAVLNPSSPQFDFYKWARMLMKLMEEDGLKRRRTGITFRNLSV
I  I  I  I  I  I  I
70  80 90 10 0  1 1 0  12 0  1 3 0
12 0  13 0  140  1 5 0  16 0  17 0  180
I  I  I  I  I  I  I
RAQTAALQLQPTVGSVLTAPLRSRVCCDTGEYEPRRILHGFDGVMKTGELLLVLGRPGTGCSTFLKA
I  I  I  • •  I  I  I  •  I  •  I  I  •  I  • • •  I  •  I  *  I I  •  •  I  •  I  I  I
YGSGPALQEQSTVSTPIM ALFRFQETFGVGRKTRKRILNNFNGALREGEM LW LGRPGSGCSTFLKT
I  I  I  I  I  I  I
140  15 0  1 60  17 0  18 0  1 9 0  20 0
19 0  2 0 0  2 10  22 0  2 3 0  24 0
I  I  I  I  I  I
VCGETNGLHIDADSVLHYNGVSQQRMMKEFKGEWYNQEVDKHFPHLTVRQTLEFGAAARTPAHRFQ
I  • • • •  I  • •  I  I  I  I  I  I  I  • • •  I  I  •  • • • ! • •  •  •  I  •  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . I  •
ICGETHGLELGKEASVQYNGIPQTTFKKEFRGEAVYSAEDEKHFPHLTVGQTLEFAAACRTPSARVM
I  I  I  I  I  I
2 1 0  2 2 0  2 3 0  2 4 0  25 0  26 0
25 0  26 0  27 0  2 8 0  2 9 0  3 0 0  310
I I  I  I  I  I  I
NMSRDEFASYAASW MAIFGLSHTHNTKVGNDFVRGVSGGERKRVSIAEMALAMTPFAAW DNSSRGL
•  •  •  •  I   I  •  •  •  I  •  I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 * 1  I  I  •  •  •
GM ERKEFSHHIARW M AIFGLSHTVNAKVGDDYVRGVSGGERKRVSIAELGLSGAPW CW DNSTRGL
I  I  I  I  I  I  I
2 7 0  2 8 0  2 9 0  3 0 0  31 0  32 0  3 30
32 0  3 3 0  34 0  3 5 0  36 0  3 7 0  38 0
I  I  I  I  I  I  I
DSATALKFVQALRLSADLAGAAHAVAIYQASQSIYEVFDKVTVLYEGRMIFFGPTGTAKEYFERMGW
  I  •  •  *  I  I  I  •  I  • • I I . . . . . . . . . . . . . . . . . . . . . . . I  •  •  I  I  I  I  •  •  I  I . . . . . . . . . . . . . . . . . . . . . . . . . .
DSATALEFTKALRIASDVM GATQAVAIYQASQAIYDLFDKAW LYEGRQIYYGPANSAKKYFEDM GW
I  I  I  I  I  I  I
3 4 0  3 5 0  3 6 0  37 0  38 0  3 9 0  400
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3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  4 4 0  4 5 0
I I  I  I  I  I  I
VCPARQTTGDFLTSITNPLERKARAGM EDW PKTPKDFEIYW RQSPEYKTLLGEM TGVRDQHPTGND
« * ! * * #  # * # « * # » * # # I * * I  •  •  •  «  *  I  *  I  I * *  *  *  * { *  I I *  I  1 * 1  * 1 * *  *
YCPPRQTPGDFLTSITNPMERRVRDGFESKVPRTAHEFETYW RNSQQFKDMQAEIEQCEDEHPVGGP
I  I  I  I  I  I
4 1 0  4 2 0  4 3 0  4 4 0  45 0  4 6 0
4 6 0  4 7 0  4 8 0  4 90  5 0 0  510
I  I  I  I  I  I
EQ ASAELRARK ENSQ SR NSRAASPYILSIPM Q IK LNTK RA YQ RIW N DM SSTM STW G Q IV IALITG V
I  I  I I I  M i l  I  I  I I I  t i l l  I  I  I  I
ALGELREAHNQAQAKHVRPKSPYTITILM QVKLCTTRAYQRLW NDKASTISRVM AQLIM SLIIGSLY
I  I  I I  I  I  I
4 7 0  4 8 0  4 9 0  5 00  51 0  52 0  530
520  53 0  54 0  550  560  5 7 0  580
I  I  I  I  I  I  I
VFYDSPNTTAG FQ SK G G TLFYAV LLNALTA M SEITSLYSQ RPIV EK Q ASYA FYH PATEA IAG W SD V
I I  I I  I  I  I I I  -  - I  I I I  ni l  I
F N T P Q V T SS F F SK G SV L F F A IL L N A L L S ISE IN T S Q R P IV SK H V SY A L Y Y SC V E A F A G IV SD IP IK L
I  I  I  I  I  I  I
5 40 55 0  5 60  57 0  58 0  59 0  600
590  600 610  62 0  630  640  650
I  I  I  I  I  I  I
PVKFLLAVAFNVIMYFLANLRREPAQFFIYFLMSFTVMFVMSAVFRTMAAVTKNAAQAMGLAGVLML
I I  I  I  I  I  I  I  - I !  - I  1 * 1  !  I I  I  ni l  n •  I  i n
IT ST V FN L IIY FL G D L R R Q A D H FFIFFL FT FIT M L T M SA IFR T L A A A T K T ISQ A PA FA G V M V L A IV I
I  I  I  I  I  I  I
610  620  630 64 0  650  660  670
6 60  67 0  680  6 9 0  7 0 0  7 1 0
I I  I  I  I  I
ALW YTGYVLPVPSM HPW FEW IH YLNPIYYAFEAM IANEFHG RDFDCIAFVPSM Q IW TG DSFSCSSL
•  I  11 I  I  n I  I  I I  n i l  I  I  I I
YTGFTIQRSYMAPM DEW ISW INPVAYAFEAILVNEVHNQRYACALIVPPYGEGM NFQCPIAGAVPGE
I  I  I  I  I  I
6 80  690  7 0 0  71 0  7 2 0  73 0
7 20  7 3 0  7 4 0  7 5 0  76 0  7 7 0  780
I  I  I  I  I  I  I
GSVAGERM VSGDSYINFNYTYTYSHVW RNFGVLLAFLIGFM AIYFLASELNSSTTSTAEALVFRRGH
• • 1 * 1 * 1 1  I I I  •  •  I I  I  I  *  •  I  I  •
RSVSGDAW VESQYGYKYSHIW RNLGFIFAFQVFFYW YLTATQLNTASASTAEFLVFRRGNVPIYM L
I  I  I  I  I  I  I
7 4 0  7 5 0  7 6 0  77 0  7 8 0  7 9 0  800
79 0  800  810  820  830  8 4 0  850
I  I  I  I I  I  I
V PE Y M R PG Y T R PT D E E K A V T Q SD IK PSSPSPT N PIL PL PPQ R D IFT W K D ISY D IE IK G E PR R L L D D V
I  •  I  *  •  I  I  I I I  I  1 * 1  *  I  *
KQDDEENGKAAPPAAAAAAAAAAAAEANSKNEEDKTNVLPPQTDVFTW RNVTYDITIKGEDRRILDH
I  I  I  I  I  I  I
8 10  82 0  830  84 0  8 5 0  860  870
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8 60  870  880 89 0  90 0  910
I  I  I  I  I  I
SGWVK-PGTLTALMGVSGAGKTTLLDVLAHRTTMGVITGDMFVNGKGLDASFQRKTGYVQQQDLHLE
I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I  •  I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
VSGWVRPGTLTALMGVSGAGKTTLLDALAQRISFGVITGDMFVNGKPLDLSFQRKTGYCQQQDLHLE
I I  I  I  I  I
8 80  8 9 0  90 0  9 1 0  92 0  930
920  93 0  940  95 0  9 6 0  97 0  980
I  I  I  I  I  I  I
TATVRESLRFSALLRQPASVSIREKHDYVESVIEM LGM GDFCRACCGTPGEGLNVEQRKLLTIGVEL
*  I  # * * #  I  $ # « « *  I  # « # #  • • •  { * *  I I * *  * *  * *  *  *  *  *  *  • • • • • • • • • • • * • • • • • • •
TSTVREALRFSAM LRQPKSVSKQEKYEFVEDVIKMLNM EDFAEAW GNPGEGLNVEQRKLLTIGVEL
I  I  I  I  I  I  I
9 4 0  95 0  9 6 0  97 0  98 0  99 0  1 0 0 0
9 9 0  1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0  1 0 5 0
I I  I  I  I  I  I
PPSPK LLLFLDEPTSG LDSQSSW AICTFLRK LADSG QAVLCTIH QPSAILFQEFDQ LLFLAK GG K TV
I I  - I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AAKPQLLLFLDEPTSGLDSQSAW AIVTFLRKLAGHGQAVLSTIHQPSA
I  I  I  I  I
1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0  1 0 5 0
1 0 6 0  1 0 7 0  1 0 8 0  1 0 9 0  1 1 0 0  1 1 1 0
I I  I  I  I  I
YFGPIGPNSRTLLDYFESNGARKCDEAENPAEYMIEW W AEVNDHGTDW FDVW KGSKECQAVKEEIE  
1 1 2 0  1 1 3 0  1 1 4 0  1 1 5 0  1 1 6 0  1 1 7 0  1 1 8 0
I I  I  I  I  I  I
RIHEKKRGTAGAIEETDDGSTKSEFADAILVPAVCRHVRVFQQYW RM PEYIISKGALAIVAGLFIGF  
1 1 9 0  1 2 0 0  1 2 1 0  1 2 2 0  1 2 3 0  1 2 4 0  1 2 5 0
I  I  I  I  I  I  I
SFY D A K TSLA G LQ TLVFSLFM VCA LFA PLV NQ IM PLFITQ RSLYEVR ERPSK AIPG K LPD CNILVEI
1 2 6 0  1 2 7 0  1 2 8 0  1 2 9 0  1 3 0 0  1 3 1 0  13 2 0
I  I  I  I  I  I  I
PYQ VLM GILTFVCYYYPLSVPAK DQ TERALVLLFCIQFYVYASTFAHM CIAAM PNAETASPIVILLF  
1 3 3 0  1 3 4 0  1 3 5 0  1 3 6 0  1 3 7 0  1 3 8 0
I  I  I  I  I  I
SMCLTFCGVMQPPDALPGFW IFMYRVSPFTYWVAGMATTQVHGREWCGENELSIFDPPTNQTCGQY  
1 3 9 0  1 4 0 0  1 4 1 0  1 4 2 0  1 4 3 0  1 4 4 0  1 4 5 0
I  I  I  I  I  I  I
M ERYISVAGGQVLNPSATAGCEYCSLTVADEYLAASQIYW SDRW RNFGLIW VYIGFNIFVATAVYYL
1 4 6 0
I
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The protein encoding sequence of the pft2 gene characterised in this study spanned a 
further 3792bp and was interrupted by two putative introns. The first intron is 156bp 
in length and located at nucleotide positions 1710-1866 while the second intron is 
80bp and is found at nucleotide positions 2200-2280. The partial gene sequence 
appears to encode 1053 amino acids representing the bulk of a PDR-subfamily ABC 
transporter. This includes both NBDs and one of the MSDs. It would appear that 
Pft2 conforms to the NBD-MSD-NBD-MSD arrangement that is typical of these 
proteins and an inversion of the organisation observed in P-glycoprotein (Higgins, 
1992 ).
The protein displays highest homology with AtrA from Aspergillus nidulans (Del 
Sorbo, et al., 199) but also shows considerable homology to CD Rl (Prasad et al 
1995) and PDR5. As is common in ABC transporters this homology is most 
pronounced in the nucleotide-binding domain. The conservation of Walker A and 
Walker B boxes is most notable in the C-terminal domains, the region targeted in the 
degenerate PCR. The N-terminal NBDs of PDR-subfamily transporters are peculiar 
in that the normally conserved lysine residue is degenerated to a cysteine. This 
remains true in Pft2. The Walker B site in these proteins is only slightly conserved. 
The precise Walker B of Pft2 is not seen in any other ABC transporter but most of 
these proteins have largely exclusive sequences at this point. The ABC signature 
sequence in the N-terminal NBD tends to be semi-conserved but the corresponding 
motif in Pft2 is identical to that of AtrA. Similarly the C-terminal LNVEQ signature 
consensus can be degenerated but is conserved between AtrA and Pft2.
The membrane spanning domain of the partial gene sequence displays relatively little 
homology making the pft2 gene very distinct in this region. It is difficult to note any 
distinguishing features in this region as the importance of any given sequence is not 
well characterised. A conspicuous stretch of 12 consecutive alanine residues is 
observed at amino acid positions 818-829. The functional consequences of this long 
hydrophilic stretch of amino acids cannot be surmised without further biochemical 
investigation but its inclusion in a membrane spanning domain is interesting. It may 
represent an extracellular or intracellular loop between two helices. Alternatively it
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may provide a hydrophilic surface within the pore but this is hard to envisage if we 
accept the most popular model of 12 amphipathic helices.
It is unfortunate that the complete gene sequence of pft2 was not achieved in this 
study. Despite continued and varied approaches the final 3’ coding sequence proved 
recalcitrant to cloning. The missing DNA is expected to encode the C-terminal MSD. 
Assuming that no introns are present the complete sequence should be attained on the 
isolation of an approximate additional 600bp (if the homology with other transporters 
continues). The completion of this sequence is an ongoing concern. Despite the 
incomplete reading frame, the current data allows access to biochemical studies. For 
example, the over-expression and purification of soluble NBDs is now possible for 
Pft2 as both NBDs are present in the above sequence.
Ascribing any function to Pft2 on the basis of sequence homology is difficult. AtrA 
does not seem to be a drug transporter despite a number of investigations applying a 
wide range of drug substrates (Alan Andrade; Personal Communication). However 
this does not preclude such a role for Pft2. The sequence homology with AtrA lies in 
the NBD and the homology with proven drug transporters is almost as high in these 
domains. It is possible that the diversity of substrate tolerance in these transporters 
involves the MSDs. If this is the case then the novelty of the Pft2 MSD sequence 
prohibits any direct comparison with other proteins. When the full sequence is 
appreciated this gene should be used in complementation studies in S.cerevisiae  
mutants including strains that are hypersensitive to drugs. This is a preferable 
approach to knockout studies in P.brasiliensis as the organism is difficult to 
manipulate and the multi-nucleated nature of the cells means the construction of a 
complete knockout would be very difficult.
Pft2 could enhance the current understanding of fungal ABC transporter processes 
and potentially the phenomenon of multidrug resistance.
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Expression analysis of p f t l  and p f t 2  transcripts at mRNA  
lev e l.
Analysis of any particular genetic determinant can be performed at a number of levels 
within the biochemical compartments of the cell. The four main levels currently 
acknowledged are the genome, transcriptome, proteome and metabolome. Molecular 
biology concentrates extensively on the first two areas. The field of genomics has 
produced an enormous volume of information that is evident on examination of the 
literature base. Such data ranges from small gene fragments to analysis of entire 
genomes. The previous two chapters have demonstrated the successful application of 
genome level analysis in the case of P.brasiliensis.
In order to further the analysis of p ftl and pft2 investigations progressed to the level of 
the transcriptome, namely the RNA population of the cell. For the purposes of this 
study the questions addressed by transcript analysis would be fourfold. Firstly, the 
demonstration of a mRNA corresponding to the pft genes would demonstrate that these 
determinants are indeed expressed in this organism thus confirming the validity of the 
study. Secondly, it was necessary to confirm the position of the proposed introns in the 
genomic sequences discussed in Chapters 3 and 4 and to ensure that they are 
successfully spliced. Also, a comparative analysis of the P.brasiliensis mRNA 
populations purified from cultures grown under different conditions could provide some 
evidence of transcriptional regulation. Finally, in the case of p f t f  we investigate the 5’ 
boundary of the transcript, the transcriptional start site, and demonstrate a potential 
ambiguity in the conceptual translational start site for this and other fungal MDR-like 
ABC half transporters.
It should also be noted that successful isolation of intron free cDNA is central to 
construction of recombinant plasmids for heterologous protein expression. Many 
expression systems, especially those relying on prokaryotic technology, are unable to 
process introns in unspliced transcripts. Splicing is always inadvisable in expression 
systems as the process will hinder over expression. Therefore, without cDNA material, 
the analysis of genes cannot graduate from nucleic acid to protein level.
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5 .1  Introns and splicing in pftl.
Initially it was necessary to prepare RNA from total nucleic acids derived from 
P.brasiliensis. The total nucleic acids were prepared elsewhere by another investigator. 
The total RNA was prepared by the removal of DNA by DNase. It was decided that the 
mRNA would be isolated from the total RNA fraction in order to enhance the 
perfoiTnance of RT-PCR. The preparation of two mRNA pools was successfully 
performed using a polyA tail hybridisation/ magnetic separation procedure (see section 
2.3.10). Of the two pools of mRNA, one was derived from the yeast form of 
P.brasiliensis, treated with 5pg per ml of amphotericin B while the second was derived 
from the yeast form treated with Ipg per ml fluconazole. Growth in the presence of 
drugs was requested to allow further specific investigations described and discussed in 
this chapter. The yield of mRNA was assessed by spectrophotometry at 260nm and the 
yield was determined to be 965ng and 846ng per ml for the amphotericin B and 
fluconazole associated preparations respectively.
The expression and splicing of p ftl  was addressed by RT-PCR using oligonucleotides 
specific to the p ftl gene. The mRNA used for this reaction was that of the fluconazole 
treatment pool as it was expected that expression would be highest in this preparation, 
assuming that p ftl was associated with drug resistance
The XS62 reverse primer, responsible for first strand synthesis was designed to overlap 
the proposed translational stop site at nucleotide position 2626-2645 of the p ftl  
sequence (see Fig3.10). The forward primers, XT72 and XT74, correspond to the 
boundary of the 5’ p ftl  sequence possessed at this time and anneal at nucleotide 
positions 771-787 and 663-683 respectively. The isolation of the final 5’ sequence of 
the gene remained problematic at this stage. However, following the complete 
sequencing of p ftl  it was evident that these RT-PCRs did indeed span both of the 
putative introns in the genomic sequence.
As can be observed in Fig5.1, a good yield of cDNA amplicon was observed in the RT- 
PCR reactions that demonstrated that p ftl  was expressed at mRNA level and that 
splicing did occur. The amplification of the XT72/XS62 genomic fragment is used as 
an illustration of the decrease in transcript size. The cDNA amplicon generated by the 
XT72/XS62 RT-PCR reaction was cloned to pGEM-T Easy™ and completely 
sequenced in both directions (data not shown). The sequence observed was identical to 
that obtained for the genomic sequence, except the proposed introns were absent. The 
splicing had occurred at the exact sites proposed previously. In order to enhance the 
illustration of splicing, the product of the XT72/XS62 RT-PCR was gel extracted and
144
FigS . l  RT-PCR analysis of p f t l  transcripts to assess expression 
and splicing.
Lanel] XT74/XS62 RT-PCR
Lane2] XT72/XS62 RT-PCR
Lane3] XT72/XS62 genomic DNA PCR
Lane4] XT74/XS62 RT-PCR negative control
Lane5] XT72/XS62 RT-PCR negative control
Lane6] MDR1/MDR2 PCR (cDNA product)
Lane7] MDR1/MDR2 PCR (genomic product)
LaneS] MDR1/MDR2 PCR (negative control).
RT-PCR conditions'. 1 cycle] 
40 cycles]
1 cycle]
48^C for 45min 
94°C for 30s 
60"C for Imin 
68'^C for 2.5min 
68"C for 7min
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used in a PCR with the primers MDRl and MDR2 (see section 3.1). The region of the 
p ftl gene spanned by these primers contains a 77bp intron, thus the expected amplicons 
from an RT-PCR reaction would be 338bp while the genomic amplicon would run at 
415bp. The size difference shown for these amplicons better illustrates that splicing has 
occurred.
5 .2  RT-PCR expression analysis of p f t l  andp/^2 under conditions of 
drug treatment
An upregulation or complete induction could if observed for pftl and pft2 could provide 
an initial indication of the association of these genes with hydrophobic drug transport. 
The preparation of mRNAs from amphoterecin B and fluconazole treated populations 
could allow an initial assessment of this phenomenon. RT-PCR was again used. The 
p ftl RT-PCR, using primers XT72 and XS62 (see Fig5.1) would be employed to 
analyse transcriptional regulation.
As a positive control for the integrity of the RNAs and their competence as templates for 
RT-PCR, an additional reaction was performed for each RNA pool. This control 
targeted the hsp70 transcript of P.brasiliensis. The trancriptional profile of this gene 
had been investigated previously and had illustrated the constitutive expression of a 
completely spliced form of this mRNA in the yeast form. Two hsp70 oligonucleotides 
(HSPfwd and HSPrev) were designed to target a 3’ intron spanning sequence of the 
heat shock protein gene (Da Silva, et a l, 1999). A successful reaction on this template 
would result in a 250bp cDNA amplicon (or a 412bp amplicon if using a genomic DNA 
template). As a PCR positive control, and differential size reference, the XS72/62 PCR 
was performed on P.brasiliensis genomic DNA.
The results of this RT-PCR are presented in Fig5.2. The amplicon was isolated only 
under conditions of fluconazole treatment and not in the template from amphoterecin B 
treated cells. Fluconazole is a well known substrate for many fungal ABC drug 
transporters while amphoterecin B is not an MDR substrate (Bolhuis, et a l ,  1997). 
This dramatic and specific induction represents the first indication that a fungal MDR- 
like ABC half-transporter may be involved in resistance to a hydrophobic drug 
compound.
A similar RT-PCR was performed to analyse expression of pft2. In this case primers 
P2RTfwd and P2RTrev were used, targeting nucleotide positions 415-435 and 1983- 
2003 of the p ftl  gene respectively. This region is spans the first 152bp putative intron
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Fig5 .2 Azole dependant induction of p ftl expression.
Lanel] XT72/XS62 RT-PCR (Amphoterecin B mRNA pool)
Lane2] Hsp70Fwd/Hsp70Rev (Amphoterecin B mRNA pool)
Lane3] XT72/XS62 RT-PCR (Fluconazole mRNA pool)
Lane4] Hsp70Fwd/Hsp70Rev (Fluconazole mRNA pool)
Lane5] XT72/XS62 PCR (Genomic DNA)
RT-PCR conditions (Lanes 1-4); RT-PCR conditions applied were those optimal for XT72/XS62  
amplification and as noted in Fig5.1.
PCR conditions (Lane 5); The PCR on genomic DNA was performed under the same reaction 
conditionsas the RT-PCRs except the Afl Reverse Transcriptase was omitted. The PCR reaction was 
added to the thermocycler on termination o f the first strand synthesis step of the RT-PCRs.
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producing a 1588bp product from genomic DNA and a 1432bp cDNA from spliced 
mRNA. No specific regulation was observed in this case (Fig5.3) and indeed no 
particular difference can be observed in the intensity of yield from either RT-PCR, 
(identical template quantities being used in each case). It must be concluded therefore 
that the pft2 gene is not expressed in an azole specific manner. No hsp70 positive 
controls were employed in this experiment because the integrity of both RNA pools was 
demonstrated to be good in the previous p ftl  experiment.
5 .3  SMART^”^ RACE RT-PCR analysis of the 5’ terminus of the p f t l  
transcript
As previously mentioned in Chapter 3, the final completion of the p ftl  gene sequence 
proved problematic due to a truncation of the genomic open reading frame during library 
construction. In order to solve this problem both GenomeWalker™ SSP-PCR (see 
section 3.4) and 5’ SMART™ RACE RT-PCR would be used. It was decided to 
include 5' RACE RT-PCR as a strategy to complete the sequence because the apparent 
robust nature of the p ftl  mRNA observed to this point indicated it was a receptive target 
for molecular applications. The results for the 5’RACE experiment were superseded by 
those generated by the SSP-PCR with respect to extending the p ftl  sequence. 
However, the 5’ RACE data did provide a serendipitous discovery relating to an 
unexpected ambiguity between the expected and observed transcript length.
This particular 5’ RACE technique makes use of MMLV reverse trancriptase. This 
enzyme adds 3 to 5 C nucleotides to the 3’ end of the first cDNA strand in a non­
template directed manner (similar to the addition of a single A nucleotide to 3’ DNA 
amplicon termini by Taq polymerase). These 3 to 5 C nucleotides are used as a target 
for the annealing of a SMART™ adapter to the 3’ end of the transcript which can serve 
as a target for a forward facing primer (see Appendix II.). The addition of the C 
nucleotides by the MMLV RT requires successful termination of reverse strand 
synthesis and theoretically alleviates the risk of amplification from partial reverse 
strands.
The 5’ RACE RT-PCR was performed using a nested approach using two p ftl  specific 
primers (PT72 and PT7) and two adapter specific primers (API and AP2). The results 
of both the primary and secondary nested PCRs show successful and unambiguous 
products in both cases (fig 5.4a & b). It should be noted that the result presented here 
was achieved after extensive PCR optimisation with respect to template concentration.
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F ig5 .3 Induction of pft2 expression.
Lanel] RT-PCR (Amphoterecin B mRNA pool)
Lane2] RT-PCR (Fluconazole mRNA pool)
LaneS] PCR (Genomic DNA)
RT-PCR conditions: 1 cycle] 
40 cycles]
1 cycle]
48"C for 45min 
94"C for 30s 
65"C for Imin 
for 2min 
68"C for 7min
PCR conditions (Lane 3); As above but the first 48°C cycle was omitted. The PCR reaction was added 
to the thermocycler on termination o f the first strand synthesis step of the RT-PCRs.
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F ig 5 .4  5’ SMART™ RACE RT-PCR amplification of p ftl to determine the 5’ 
transcript boundary
a) PT72 primaiy PCR on P.brasiliensis cDNA
b )  PT7 secondary PCR on P.brasiliensis cDNA
PCR conditions are as noted in Chapter 2, section 2.4.6
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annealing temperature and MgCl^ concentration. The 5’ RACE RT-PCR reactions 
performed using alternative downstream reverse primers, which would have generated 
larger amplicons, did not seem to perform well and no single product could be 
generated, even in a nested strategy (data not shown).
Despite the difficulty in initial PCR optimisation, this 5’RACE RT-PCR was entirely 
reproducible under these optimal conditions. The primary (PT72/AP1) fragment was 
cloned to pGEM-T Easy™ and sequenced in both directions. The DNA was confirmed 
as originating from the p ftl  transcript. Inspection of the ends of the amplicon readily 
allowed the identification of the SMART™ adapter and the 5 C nucleotides that allowed 
annealing. However, translation of the coding sequence of the fragment revealed no 
new ATG start codon. Critical analysis of the sequence data and the sequencing of a 
number of clones from replicate PCRs continued to confirm the initial observed 
sequence as being correct. Application to RT-PCR of the primer Pftl pro (targeting the 
promoter of the p ftl  genomic sequence) in conjunction with the PT72 reverse failed to 
generate a product (data not shown).
The conclusion had to be that the p ftl mRNA in the fluconazole pool did not exhibit an 
ATG start codon in a position that would be consistent with the conceptual start codon 
of other such fungal half transporters. The actual start of the mRNA transcript shows 
that the RNA polymerase initiation site was 6bp downstream from the conceptual p ftl  
ATG as suggested by the GenomeWalker™ SSP-PCR. Translation from this transcript 
would implicate the ATG at nucleotide position 550 as the initiating codon (Fig5.5).
5 .4  Full length cDNA for p f t l
The recombinant expression of p ftl would require complete length cDNA transcripts to 
be generated for incorporation into an appropriate expression vector. Previous 
investigators have reported a difficulty in the generation of complete transcripts for ABC 
transporter genes and many have resorted to a protracted method of partial 
amplifications and fusion PCRs to piece together the necessary DNA.
In the case of p ftl there were two potential boundaries to the open reading frame, based 
on the comparative data from the genomic sequence versus the 5’RACE RT-PCR 
sequence. It was decided to amplify the cDNA relating to both sites. It is fortunate that 
the p ftl transcript in the fluconazole mRNA pool terminates just 6bp downstream from
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F ig 5 .5  A comparison of the ATG start sites of pftl based on the conceptual and
the experimental positions. The arrow marks the first codon (CTT) of 
the transcript demonstrated by 5 RACE. The initiating methionine based 
on the genomic DNA sequence is in red while the ATG suggested by 
5’RACE is in green.
Transcript start site
1 ATGGCACTTGCCGCCTTCACTCCACGAGCATCTTCACGTCGCATTGCTCAGTTTGGATCG 6 0
(1 )  M A L A A F T P R A S S R R I A Q F G S  ( 2 0 )
6 1  CGATCGCTTCCCTTATTTAACTATACCTCCTTCCATGCCCAGAGACCATCGCTTGATGCT 1 2 0
( 2 1 )  R S L P L F N Y T S F H A Q R P S L D A  ( 4 0 )
1 2 1  AGCGGTGGCTTAAGACGTCACCAGTCGAACGCCCCCATCGTAACCCAACGACCAGACATC 1 8 0
( 4 1 )  S G G L R R H Q S N A P I V T Q R P D I  ( 6 0 )
1 8 1  CTACGGCAGCCAGACATCCGAAAGTCATCTGCAACAAATATACATGTCACTATTTCATCT 2 4 0
( 6 1 )  L R Q P D I R K S S A T N I H V T I S S  ( 8 0 )
2 4 1  ATCGTGGGACCTGGTTGTCTTCAGCAGGTCCGATTCCTCTCCTCTACGACAGCACGGCGA 3 0 0
( 8 1 )  I V G P G C L Q Q V R F L S S T T A R R  ( 1 0 0 )
3 0 1  AAAGAAGCCAAACCGGAGCCCGCGAAAAAGCTGCGGAAGCCGCAGAAGCCGCAGACAGAG 3 6 0
( 1 0 1 )  K E A K P E P A K K L R K P Q K P Q T E  ( 1 2 0 )
3 6 1  CTAGAAAAGAAACAAGAAACCGCTCTAGAAGAGATACATAGAGGATTTGAGCGTACGGAG 4 2 0
( 1 2 1 )  L E K K Q E T A L E E I H R G F E R T E  ( 1 4 0 )
4 2 1  AAGGCATCACAAGCAGCGAAATTAAACCTTAGCGCAAGATTATCAAAGGATGCGGGCGGG 4 80
( 1 4 1 )  K A S Q A A K L N L S A R L S K D A G G  ( 1 6 0 )
4 8 1  AAGAGGCTCGGCTTTCGCGAGATATGGCGGTTATTGAAAATTGCCCGTCCAGAGGCCAAA 5 4 0
( 1 6 1 )  K R L G F R E I W R L L K I A R P E A K  ( 1 8 0 )
5 4 1  ATCCTGTCCATGGCGTTACTCTGCTTGCTCATCTCGTCATCTATCACCATGTCGATTCCG 6 0 0
( 1 8 1 )  I L S M A L L C L L I S S S I T M S I P  ( 2 0 0 )
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the genomic DNA conceptual start codon. A forward primer, including the conceptual 
ATG of the gene, would still anneal to this site as only a 6bp 5’ extension is required. 
This primer extension is a standard practice and is often used to introduce restriction 
sites to the termini of amplicons to facilitate downstream cloning.
Successful amplification of both cDNAs was evident (fig5.6). These products were 
cloned in pGEM-T Easy™ in case they were required for further experiments.
5 .5  D iscussion
The transcription of p ftl  and p ft l  is assured in P.brasiliensis, The presence of these 
transcripts argues against the possibility that the pft genes represent pseudogene 
sequences and suggests the loci can be functionally active in the yeast cells of this 
organism. It is also notable that the transcript is fully spliced. Of the small amount of 
information available on the regulatory process employed by P.brasiliensis, the 
retardation of the splicing process has been implicated. The expression of the Hsp70 
protein is specific to the yeast form of the organism. However, a hsp70 transcript can 
be detected in the mycelial form (Da Silva et al., 1999). This mycelial transcript 
remains unspliced thus preventing translation and protein synthesis. It is evident that 
this does not occur under conditions of yeast growth and drug treatment with respect to 
the p ftl  and p ftl  transcripts.
The analysis of mRNA populations in response to environmental stimuli is a common 
and productive technique. It has been employed to good effect in the case of molecular 
studies on the expression of fungal ABC transporters involved in drug transport often 
by northern blot. The air genes of A.nidulans (Del Sorbo, et a i, 1997), the pdr5 gene 
of S.cerevisae (Bissinger and Kuchler 1994) and the cdrl transcript of C.albicans 
(Prasad, et a i, 1995) have all been shown to increase in abundance in direct response to 
various cytotoxic drugs using northern blot analysis. Such induction has been shown 
to be specific, for instance the atrA gene is upregulated by the presence of imazalil but 
not particularly with cyclohexamide.
For the purposes of the p ftl  study, RT-PCR was substituted for Northern blot. This 
provided the added advantage of enhanced sensitivity and a requirement for less 
material, an important aspect considering the logistical difficulties experienced in 
acquiring P.brasiliensis nucleic acids from external sources. The choice of this
153
F i g 5 .6  RT-PCR generating cDNA amplicons from the conceptual and
experimental ATG positions of p ftl (see Fig 5.5).
Lane 1] ATG position 1
Lane 2] ATG position 1 (no template negative control) 
Lane 3] ATG position 550
Lane 4] ATG position 550 (no template negative control)
RT-PCR conditions; 1 cycle] 48"C for 45min
40 cycles] 94'^C for 30s
56"C for Imin 
for 3min
1 cycle] 68"C for 7min
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technique allowed additional benefits. For indicating complete induction of a gene, like 
that demonstrated for p ftl, northern blot is less conclusive. In a situation where low 
levels of transcript are present, their abundance may lie below the detection limit of the 
hybridisation procedures employed. Northern analysis can conclude that a transcript 
lies below the level of detection but not that it is necessaiily absent. In a PCR based 
technique it is theoretically possible to detect of a single copy thus enhancing specificity.
The differential transcription of p ft l ,  illustrating fluconazole dependant induction, 
serves as a preliminary indicator that this gene may be involved, in some way, with 
azole drug resistance. In keeping with the lack of biochemical characterisation, the 
dynamics of expression of the MDR-like fungal half transporters has remained 
unreported to this point. Further analysis of mRNAs from a more extensive range of 
growth conditions may provide further information regarding p ftl .  Unfortunately, the 
preparation of these mRNAs was not possible in this study due to the lack of facilities. 
It is very likely that other azoles, such as ketoconazole (the therapeutic drug of choice 
for PCM) could elicit a similar profile.
The expression of the transcript of p ftl  did not show an azole specific induction. 
Indeed, although this RT-PCR was not designed to be particularly quantitative, the yield 
of product between amphoterecin B and fluconazole reactions doesn’t suggest 
upregulation in the presence of the azole. However, this does not dispel the notion that 
Pft2 could be involved in drug transport. Many proteins involved in response to 
potentially damaging environmental stimuli are transcriptionally activated from stress 
response elements (STREs) (Katzmann, et al., 1996). It may be that the exposure of 
the organism to amphoterecin B is sufficient to trigger this response. Again, this data 
can only be considered preliminary and the opportunity to extend this aspect of study to 
a more extensive array of mRNA populations should be encouraged.
As a contemporary route of investigation to the GenomeWalker™ SSP-PCR we 
employed 5’ RACE RT-PCR, both techniques aiming to complete the 5’ sequence of 
p ftl .  Indeed the 5’RACE RT-PCR reactions have been used by a number of 
investigators to determine the definitive open reading frame for genes of interest. There 
are a number of cases where the completion of a 5’ sequence during initial gene cloning 
and characterisation has been achieved solely using 5’RACE RT-PCR and the results of 
those PCRs were considered definitive. Recent notable examples include the human 
homologue of the yeast PheRS tRNA synthetase subunit (Zhou, et al., 1999),the gene 
encoding rat homologue of the connective tissue growth factor (CTGF) (Xu, et al., 
2000), the nuclease of the fungus Syncephalastrum racemosum (Ho and Liao, 1999) 
and the cbhl and cbhll genes for cellulose utilisation by the straw mushroom Vovariella
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volvacea (Jia, et al., 1999). Scenarios which prompted the use of RACE RT-PCR in 
these investigations included the completion of ORFs for which an apparent partial 
sequence was possessed.
The definition of the dimensions of the p ftl  gene were extensively influenced by those 
of homologues. Those homologues have not been studied at transcript level and all data 
is therefore putative. The 5’ SMART™ RACE RT-PCR data poses a number of 
significant issues regarding the transcript boundaries of the fungal half-transporter 
genes. It should be noted that all definitions of the dimensions of these genes has been 
generated from DNA sequences rather than RNA. In essence the 5 ’ transcriptional start 
is often identified as the first ATG codon following an extended stretch of apparently 
non-coding DNA that exhibits stop codons in the appropriate reading frame. It remains 
possible that these conceptual start codons can be mis-identified. The theory relies of 
the fact that stop-codons will spontaneously arise in regions of non-coding DNA 
because the selective pressure required for sequence conservation is absent. However, 
the lack of selective pressure per se does not select for stop codons, it merely doesn’t 
select against them. The 5’ RACE data presented for p ftl  would suggest that, in this 
pool of mRNA at least, any protein arising from this transcript will begin at a later 
ATG. It is interesting that the region of conservation between these genes becomes 
apparent around the proposed alternative ATG rather than the conceptual one. It has to 
be acknowledge that some conservation remains upstream from this position but that 
may persist as an evolutionary artefact.
Recently, a similar observation was made for the C.albicans tpk2 gene, which encodes 
a protein kinase A involved in the regulation of dimorphism. The unconventional 
electrophoretic mobility of the Tpk2 protein prompted an investigation of the 5’ ends of 
the associated transcript to clarify the precise ATG used. It was found that the correct 
ATG was positioned 33bp upstream from the conceptual start codon which explained 
the apparent difference in the expected size of the protein. The proposed Tpk2 protein 
was 422 amino acids while the correct length is 411 (Sonneborn, et al., 2000). The 
potential error in p ftl  is even greater with the second candidate ATG positioned at 
position nucleotide 550 with respect to the conceptual start codon (a difference of 183 
amino acids).
A second hypothesis could lie with the use of alternative translational start sites for the 
same core protein under different growth conditions. Differential transcription, leading 
to the expression of different isoforms has been reported, particularly in higher 
organisms. Such differential transcription can arise from alternative transcriptional 
initiation sites or from differential splicing of pre-mRNAs. The murine Girkl transcript
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exists as five transcript isoforms each one proposed to encode for a channel with 
slightly differing function (Wei, et a l ,  1998). Likewise the Na,K-ATPase mRNA 
expressed in the rat myocardium imposes the possibility of two different transcriptional 
start sites and three different 3’ termini arising through 3 different poly-adenylation sites 
(Shao, et al. 1999). If Pftl is a multifunctional protein then this multifunction could 
originate from differential transcription and the exclusion of the first 183 amino acids 
provided by the rest of the 5’ sequence.
A final possibility is that this data indicates a negative regulation effect on the expression 
of Pftl. The origin of the transcript at position +6 in the p ftl  gene removes the 
conceptual ATG, but it would also remove the ribosome binding site associated with the 
gene. If a splicing event has occurred which removes this ribosome binding site, 
translation will effectively be blocked. It remains a possibility that a specific splicing 
event occurs within the p ftl transcript in order to prevent the progression to the 
translation process. This is a wasteful notion on the part of the organism. Not only 
does the organism exhibit a direct induction of p ftl in response to drug but it also 
successfully removes the introns towards the 3’end of the transcript. This is a lot of 
physiological effort to extend to a transcript with no intended function. However, 
P.brasiliensis persists in expressing unspliced forms of the hspltl transcript in the 
mycelial form, prohibiting protein expression, so the organism is not adverse to this 
apparently wasteful mechanism of post-transcriptional regulation (Da Silva, et a l ,  
1999).
The generation of a full length cDNA transcript, originating at either ATG, was 
achieved for p f t l . This success was in keeping with the excellent performance of this 
mRNA for other applications and would allow progression to recombinant protein 
expression.
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Over-expression of P ftl domains and the purification of the 
P ftl nucleotide-binding domain
The successful acquisition of the spliced cDNA of p ftl  allowed the introduction of this 
gene to a heterologous protein expression system. Any recombinant protein obtained 
would be purified and examined on biochemical investigation. A number of expression 
constructs were produced, allowing successful purification of the Pftl nucleotide- 
binding domain for biochemical studies.
Construction of expression systems was achieved in a 2 step process. Firstly 
expression cDNAs were amplified by RT-PCR and cloned to pGEM-T Easy™. The 
expression fragments were then excised from the pGEM-T Easy™ using BanM i and 
Xhol restriction enzymes. These enzymes acted at restriction sites at the termini of the 
expression fragment inserts. The sites were incorporated into the RT-PCR amplicons 
by inclusion of the appropriate sequence in the PCR primers. The restriction fragments 
were then cloned into the multiple cloning site of appropriately prepared pET21b vector. 
The scheme is presented in overview in Fig6.1.
It was decided to use the pET system of recombinant expression vectors, in particular 
pET2Ib. This vector allows the tightly regulated induction of cloned ORFs, to very 
high level. In addition, the plasmid affords the fusion of a hexa-histidine (His^) tag at 
the C-terminus of the protein. The His^ tag exhibits high affinity for the nickel anion 
allowing efficient and rapid purification of protein on a nickel-agarose matrix (ion- 
affinity chromatography). A number of E.coli strains have been generated in which the 
genome has been optimised to enhance the efficiency of the recombinant expression 
process. Many of these are available commercially and we used a derivative of BL21 
(DE3), Epicurian coli ® BL21 -CodonPlus™ (DE3)-RIL cells (Stratagene), the benefits 
of which will be explained below.
The recombinant over-expression and purification of membrane proteins is widely 
acknowledged to be a very difficult practice. Even homologous over-expression of 
E.coli membrane proteins in E.coli can often be difficult. In order to express 
recombinant EmrB, the membrane component of an E.coli transporter the inefficient 
practice of in vitro translation had to be employed (Lomovskaya & Lewis, 1992).
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Fig 6.1 Strategy for the construction of expression plasmids
The construction of pET21b expression systems was achieved in a two stage cloning 
procedure. The necessary coding cDNA was obtained by RT-PCR and A-T cloned to 
pGEM-T Easy™. BainHl and Xho\ digestion, at sites incorporated by the PCR 
primers, allowed the isolation of expression fragments for cloning into the 
corresponding sites in the MCS of pET21b.
Ampr
pGEM-T Easy™
A-T A-T
p ft l  DNAXhol BamHV
o
Xhol
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Successful over-expression of membrane proteins in prokaryotic systems is often the 
result of extensive optimisations that can take years to perfect.
It is true that the accumulation of pure membrane proteins is critical to the long-term 
evaluation of the mechanism of ABC transporters in terms of both biochemistry and 
structural biology. However, it is important that these difficulties should not retard the 
progression of research on ABC transporters. As an alternative avenue of introduction 
to the study of these proteins a number of researchers have reported successful 
expression of the nucleotide-binding domains of ABC transporters in the cytoplasmic 
fraction of the E.coli cell. These domains tend to exhibit greater solubility and are more 
accessible to current recombinant systems. Of particular note are the successful 
investigations of the substrate binding capacity and procès si vity of the murine mdrl N- 
teiminal NBD (Dayan et a i, 1996) and C-terminal NBD (Conseil et al., 1998). These 
two investigations illustrated not only the successful acquisition of a soluble NBD but 
also that these proteins could be successfully used to study the binding of ATP and 
other substrates. The functional and stmctural aspects of NBDs have been previously 
reviewed (Sharom et al., 1999) and are discussed in detail in Chapter 1.
This chapter reports the over-expression of the Pftl nucleotide-binding domain. The 
design of constmcts were based on the requirement for soluble, hydrophilic molecules, 
that could be readily purified and applied to downstream fluorescence based 
biochemical experiments. As in the aforementioned investigations, the production of a 
suitable soluble molecule was achieved by partially empirical means,
6 .1  Initial construction of a pET21b plasmid that would allow the 
over-expression of P ftl NBD
In order to generate the appropriate cDNA for expression it was first necessary to define 
the boundaries of the Pftl domains. In the absence of any stmctural information for 
this protein the junction was estimated on the basis of a Kyte-Doolittle hydropathy plot 
(Fig6.2a). As mentioned in Chapter 3 this plot is ambiguous in relation to the position 
of membrane spanning or associated regions. It was decided to define the nucleotide- 
binding domain as being the C-terminal portion of the protein. The junction of the 
MSD and NBD domains was estimated to be at the position where the flux in polarity of 
hydropathy was markedly reduced, as indicated in the figure. The NBD portion was 
estimated to span from amino acid at position 398 to the terminal amino acid of the 
protein at position 827.
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Fi g 6.2 a Kyte-Doolitle Hydropathy plot of the amino-acid sequence
of Pftl (generated using Genejockeyll).
Noted amino acid positions represent the boundaries of the expression constructs 
prepared from Pftl NBD.
1] PftlNBD N-terminus (amino acid number 398)
2 ] PftlNBDT and PftlNBDTW N-termini (amino acid number 516)
3] PftlNBDT C-terminus (amino acid number 634)
4] PftlNBDTW C-terminus (amino acid number 756)
5] PftlNBD C-terminus (amino-acid number 827)
F ig6.2h  Restriction enzyme analysis of pET21hNBD clones.
The BamWUXhol PftlNBD expression fragment was ligated at 16^C to 
appropriately prepared pET21b at 16®C, overnight and then transformed to 
Novablue competent cells.
Ten potential pET21bPftlNBD recombinants were analysed using BamUl and 
Xhol restriction digestion (37°C for 2h in Promega multi-core buffer). AH 
recombinant plasmids exhibit PftlNBD inserts.
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Generation of PftlNBD cDNA for expression was achieved using the primers 
PftlNBDfwd and PftlNBDrev. The forward and reverse primers were designed so as 
to introduce terminal BamHl and Xhol sites respectively. Downstream digestion of 
these sites with BamWl and Xhol (which do not cut the p ftl gene) would facilitate 
cloning into the MCS of pET21b. These primers were used in RT-PCR and the 
required cDNA insert was produced (data not shown). This PftlNBD was cloned into 
pGEM-T Easy™ (data not shown). The insert was released from this clone by 
digestion and ligated to appropriately cut pET21b. The clone pET21PftlNBD was 
consequently created (Fig6.2b).
6 .2  Over-expression from pET21PftlNBD
The pET21bPftlNBD expression plasmid was transformed into Epicurian coli (H) BL21- 
CodonPlus™ (DE3)-RIL cells. These cells are of the same phenotype as the BL21 
(DE3) cells commonly used for recombinant expression but an additional plasmid, 
based on a pACYC construct, is maintained on a chloramphenicol resistance marker 
within the cell. This plasmid promotes the expression of three recombinant tRNAs, 
argU, ileY and leuW, which although rare in E.coli, are optimal for the translation of a 
number of eukaryotic genes including Pftl.
Expression from the T7 promoter of pET21b is under the control of the lac operator and 
is induced by the non-utilisable lactose analogue IPTG. The PftlNBD expression clone 
was grown to an O.D.g^Q of 0.5 in 100ml of LB broth and induced by the addition of 
IPTG to a final concentration of ImM. Prior to induction and at Ih intervals thereafter, 
a 1ml sample was removed. The cells were pelleted by centrifugation and prepared for 
SDS-PAGE analysis.
The over-expression of the nucleotide-binding domain was rather modest. A very weak 
band, at the expected size of 48.4kDA, could be visualised in induced cultures but 
could not be observed in photographs of the gels. For this reason no SDS-PAGE gel is 
presented here. This result was very encouraging and demonstrated that this 
prokaryotic expression system was capable of expressing P.brasiliensis proteins. The 
small amount obtained was certainly less than would be hoped for and accumulation of 
large amounts of protein for characterisation would probably require large volumes of 
culture. Conversely, the lower level of expression may well mean the circumvention of 
insoluble protein, or inclusion bodies, and this system may afford access to a correctly 
folded functional molecule.
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Prior to purification it was necessary to confirm that the protein was indeed Hisg tagged 
and localised as a soluble molecule in the cytoplasm. To this end a western blot, using 
a mouse anti-HiSg antibody, was performed on the total cell protein of the 
pET21 PftlNBD clone. In addition, the soluble cytoplasmic, membrane and insoluble 
fractions of the cells were isolated. This blot (Fig6.3) confirmed that the C-terminal 
HiSg tag was present in the PftlNBD. However, the protein remained exclusive to the 
membrane fraction. The estimation of the domain junctions from the hydropathy plot 
was evidently erroneous and the PftlNBD persisted as a membrane protein. It was 
decided to re-assess the strategy for the expression of the Pftl nucleotide-binding 
domain in order to circumvent the need to purification of a hydrophobic protein. Such 
an endeavour is complicated by the need to optimise buffer detergent composition and 
by the relative poor performance of strains expressing these proteins. It was anticipated 
that the effort required to accumulate this protein would not be proportionate any 
additional benefit that may be passed to down-stream experiments.
6 .3  Construction of expression systems for Pftl nucleotide binding 
domain truncates.
In comparison with the size of the domains purified by other investigators, the 
PftlNBD was substantially larger. It was hoped that a larger NBD would allow more 
extensive investigation of substrate binding, assuming that the bindings sites for 
molecules other that ATP could be located at some distance from the nucleotide-binding 
fold. However, as a soluble cytoplasmic preparation would not be readily obtained 
from this system, it was decided to emulate the strategy used for the murine Mdrl C- 
terminal NBD (Conseil, et aL, 1998). The homology between this mouse NBD and 
that of Pftl readily allowed the comparative alignment of these sequences. The region 
of Pftl that corresponded to the previously expressed portion of the mouse protein was 
noted.
Unfortunately, despite the extensive homology between the two sequences, the single 
tryptophan residue possessed in this region by the Mdrl was substituted for serine in 
Pftl (Ser^^^). The analysis of M drl in the aforementioned work relied extensively on 
the variations in intrinsic fluorescence of this tryptophan as a reporter of conformational 
change in the protein. The exclusion of this tryptophan residue in our truncate would
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Fig 6.3 Western Blot of PftlNBD in total cell protein (TCP) and 
subcellular fractions of expressing cells.
Lane 1] TCP (Oh induction)
Lane 2] TCP (Ih induction)
Lane 3] TCP (2h induction)
Lane 4] TCP (3h induction)
Lane 5] TCP (4h induction)
Lane 6] Soluble cytoplasmic fraction (4h induction)
Lane 7] Membrane fraction (4h induction)
Lane 8] Insoluble fraction (4h induction)
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limit options on the type of fluorescent analysis that could be performed. The 
differential fluorescence of bound and unbound fluorescent substrate analogues would 
still be possible but any experiments based on protein tryptophan fluorescence would 
not.
The inclusion of a tryptophan molecule in the NBD of Pftl would require an extension 
of at least 39 amino-acids, the nearest tryptophan being positioned at amino acid 743. It 
was decided to make two further expression constructs. The construct 
pET21PftlNBDT would contain the region of DNA corresponding to the original 
region used by Consiel et al., (excluding any Pftl tryptophan), and would consist of 
amino acids Thr^*  ^ to Thr^ '^*. The second construct, pET21 PftlNBDTW, would also 
originate from T h ^ ^  but would have a further 122 amino acids at the C-terminus 
(terminating at VaP^®) thus including the native tryptophan, Trp^"^\ An additional 13 
amino acids following the tryptophan were included in the hope that the tryptophan 
would then be positioned in the correct place in the folded molecule.
The cDNAs were generated using the forward primer PftlNBDTfwd and either the 
reverse primer PftlNBDTrev or PftlNBDTWrev, the amplicon cloned to pGEM-T 
Easy™, excised and cloned into the BamHl and Xhol sites of pET21b. The resultant 
pET21b clones are shown in Fig6.4.
Over-expression from these clones, again in Epicurian coli ® BL21 -CodonPlus™ 
(DE3)-R1L cells, was performed as for earlier constructs. For the purposes of analysis 
samples were taken prior to induction and every hour for 3 hours following induction. 
The resultant SDS-PAGE gel can be seen in Fig6.5. A high concentration of the 
21.3kDa PftlNBDT and 28.0kDa PftlNBDTW is observed for each respective clone. 
This result is a sharp contrast to the relatively meagre quantities produced by the earlier 
construct and initially suggested that purification of large amounts of each protein 
would be possible. However, a common problem with over-expression to such high 
levels is the formation of insoluble masses of recombinant protein, or inclusion bodies. 
Protein in inclusion bodies is incorrectly folded and generally biologically inactive. A 
number of investigators have reported the restoration of biological activity on the careful 
refolding of inclusion bodies but any activity observed is often a small percentage of 
that which is observed from proteins purified directly from a soluble form. On 
examination of the sub-cellular localisation of the PftlNBDT and PftlNBDTW proteins 
it was found that they persisted almost exclusively in the insoluble form (Fig6 .6 ).
There are a number of strategies that can be employed to alleviate, wholly or partially, 
the formation of inclusion bodies. The biological mechanisms that induce inclusion
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Fig 6.4 Restriction enzyme analysis of pET21bNBD clones
The BatnHUXhol PftlNBDT and PftlNBDTW expression fragments were 
ligated at 16°C into appropriately prepared pET21b and transformed into 
Novablue competent cells.
Twelve potential pET21b recombinants (Lanes 1-6 are PftlNBDT, 7-12 are 
PftlNBDTW) were analysed using BamHl and Xhol restriction digestion {31^C 
for 2h). All recombinant plasmids exhibit PftlNBDT or PftlNBDTW inserts.
Chapter 6
2 3 4 5 6 7 8 9 10 11 12
5090bp
1018bp
Fig 6.4
166
F ig6.5  Time-course analysis of expression of PftlNBDT and 
PftlNBDTW
Lane 1] PftlNBDT (Oh induction)
Lane 2] PftlNBDT (Ih induction)
Lane 3] PftlNBDT (2h induction)
Lane 4] PftlNBDT (3h induction)
Lane 5] PftlNBDTW (Oh induction)
Lane 6 ] PftlNBDTW (Ih induction)
Lane 7] PftlNBDTW (2h induction)
Lane 8] PftlNBDTW (3h induction)
i] 21.3 kDa PftlNBDT
ii] 28.0 kDa PftlNBDTW
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Fig 6.6 Subcellular localisation of PftlNBDT and PftlNBDTW
Lane 1] PftlNBDT soluble fraction
Lane 2] PftlNBDT insoluble fraction
Lane 3] PftlNBDT membrane fraction
Lane 4] PftlNBDTW soluble fraction
Lane 5] PftlNBDTW insoluble fraction
Lane 6] PftlNBDTW membrane fraction
Lane 7] Epicurian coli ®BL21-CodonPlus™ (DE3)-RIL soluble fraction
Lane 8] Epicurian coli ® BL21 -CodonPlus™ (DE3)-RIL membrane fraction
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body formation are not well characterised but is generally appreciated that their 
formation occurs as a result of an incapacity in the E.coli foldases to process the 
heterologous or massively over-expressed molecules. Slowing the growth rate of the 
culture or the rate of expression of the protein can often increase the amount of soluble 
protein by reducing the stress on the foldase population of the cell. In the case of these 
Pftl proteins, conventional measures such as varying the induction point, lowering the 
culture temperature to 25®C, 20^C or 16°C or reducing the concentration of IPTG used 
to induce had no effect on the distribution of the protein within the cell (data not 
shown). However, on occasions where the majority of protein exists in an insoluble 
form there is often a smaller proportion of the protein folded in the correct manner and 
soluble in the cytoplasm. This was true for both PftlNBDT and PftlNBDTW.
6 .4  Denaturing purification of PftlNBDTW.
It was decided to concentrate purification efforts on PftlNBDTW. This protein would 
afford all the features of PftlNBDT with the additional advantage of the single 
tryptophan residue that may prove useful as a fluorescent reporter for biochemical 
studies. Ideally, biochemical studies are perfoimed using protein folded in a native 
conformation as isolated from the soluble cell fraction. In the case of PftlNBDTW, 
which manifested as massive amounts of inclusion bodies material, it appeared prudent 
to attempt purification of this insoluble protein. A successful purification would 
demonstrate the inclusion of a HiSg tag on the protein. Also, in the event that a 
reasonable amount of soluble PftlNBDTW could not be purified it may be important to 
resort to this insoluble material for a source of protein, which would be refolded prior 
to analysis.
In order to purify the protein, the inclusion body fraction of the cells were prepared 
from cell lysate by centrifugation. Generally, the insoluble pellet from IL of culture, 
which had been induced for 3h, was collected and prepared. These inclusion bodies 
were solubilised in 30ml of 8M urea, O.IM NaH2PO^, O.OIM TrisHCl, pH8.0, and 
applied to an NTA-agarose affinity column. This procedure of purification under 
denaturing conditions relies on a decreasing affinity of the Hisg tag for nickel as the 
buffer pH falls. The column was washed in excess volumes (4 x 80ml) of the 
aforementioned buffer at pH6.3. It is important to wash extensively when large 
concentrations of denatured proteins are involved to ensure that the proteins obsei'ved in 
elutions are indeed purified and not merely dilutions of the crude extract applied to the 
column. The protein content of each wash was assessed by spectrophotometric 
analysis of Ajgo during the procedure. Only when the Ajgo of the wash flow-through 
was less than 0.01  was the washing considered to be complete. In this case it was
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usually the fourth wash that achieved the satisfactory low level of contaminants. The 
bound protein was then eluted in 4 x 0.5ml of the above urea buffer at pH 4.5.
The result was the purification of a single band on SDS-PAGE that corresponded to 
PftlNBDTW (Fig6.7). It was noted that this procedure would supply large amounts of 
purified protein, but that protein would not be immediately useful for biochemical 
studies.
6 .5  Native purification of soluble PftlNBDTW
The soluble fraction of the cell was prepared by the removal of inclusion bodies by 
centrifugation and of membrane material by ultracentrifugation. This soluble fraction 
was applied to a column and purification was attempted under native conditions. 
Initially, the conditions used were those proposed by the Ni-NTA matrix manufacturer. 
Essentially, the manufacturer advises the use of buffers based on 50mM NaH^PO^ and 
300mM NaCl at pHS.O. Imidazole is included in each buffer at an appropriate 
concentration, competing with and eventually displaces the HiSg tag of the protein from 
the nickel ion. The advised concentrations of imidazole are lOmM for lysis buffer, 
20mM for wash buffers and 250mM for elution buffers.
Despite evident PftlNBDTW protein in the cytoplasmic fraction of the cells, 
purification was not achieved initially. Precipitation of the protein during the 
purification process was suspected to be the cause and conditions were varied in an 
attempt to retain the protein in soluble form. Variation in NaCl concentration (from zero 
to 5(X)mM) did not seem to have any particular affect. The inclusion of glycerol in the 
buffers did result in the purification of protein and titration of the glycerol concentration 
over a number of preparations suggested that 15% was optimal (data not shown). This 
observation supports the notion that precipitation had been the problem in previous 
preparations, as glycerol is known to decrease hydrophobic interactions between 
proteins.
Additional buffer optimisations were required to reduce the number of contaminant 
proteins associated with PftlNBDTW in the elutions. In particular an increase in the 
imidazole concentration of the wash buffer to 40mM allowed the production of 
PftlNBDTW of higher purity. Manipulation of the pH of buffers was not attempted as 
a pH of less than pH8.0 allows the action of metalloproteases. Despite the inclusion of 
protease inhibitors in all buffers, the action of metalloproteases would not be inhibited 
(EDTA is generally used to achieved this inhibition but its inclusion would chealate all 
nickel from the NT A matrix used in the purification procedure).
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Fig6.7 Purification of PftlNBDTW under denaturing conditions
Lane 1] Column flow-through
Lane 2] Wash number 1
Lane 3] Wash number 4
Lane 4] Elution number 1
Lane 5] Elution number 2
Buffer compositions and volumes
Lysis buffer; 8M Urea
O.lMNaH^PO,
lOmM TrisHCl pH8.0
IL pellet was resuspended in 30ml
Wash Buffer; As lysis buffer but with lOmM TrisHCl at pH6.3 
4 X 80ml washes
Elution Buffer; As lysis buffer but with lOmM TrisHCl at pH4.5 
4 X 0.5ml elutions
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The composition and volume of each buffer used is noted in Fig6 .8 , which shows a 
typical SDS-page gel of the native purification procedure.
Following purification and SDS-PAGE analysis, the elutions were generally combined 
and placed in 14kDa pore-size dialysis tubing. The protein was dialysed against 3000 
volumes of dialysis buffer (50mM NaPi pH8.0, 300mM NaCl, 15% glycerol plus 
protease inhibitors). Dialysis was permitted at 4°C for 36h and the complete removal of 
imidazole was assured by fluorimeter analysis. Imidazole is fluorescent and is excited 
at 380nm. It can thus be detected as a fluorescence peak if present in the protein 
preparation. The protein was then aliquoted into 200|il volumes in sterile cryotubes and 
snap frozen in an ethanol/dry ice bath. The frozen stocks were stored at -80‘^ C until 
required.
6 .6  D iscussion
Initial expression of the entire C-terminal of Pftl proved to be successful to a degree 
with a low level of expression of the 48.4kDa protein observed in the whole cell protein 
of the expressing cells. Unfortunately, the estimation of domain boundaries using a 
Kyte-Doolittle hydropathy plot of Pftl proved to be ineffective in denoting the 
beginning of the hydrophilic portion of this protein, and the PftlNBD remained 
associated with the membrane. This is perhaps of no surprise. No proven consensus 
is available which defines either the number of position of membrane associated regions 
in these proteins. Four transmembrane domains are proposed for AfuMDR2 (Tobin et 
al., 1997) while other attribute six TMs to MDLl and MDL2 (Bauer et al., 1999). 
Despite the problematic locale, western blot did demonstrate that this molecule could be 
expressed in the E.coli strain, which was encouraging for the further refinement of the 
expression systems.
Essentially a recombinant expression system was required which would supply a 
correctly folded, native molecule which would remain soluble while exhibiting the basic 
biochemical properties of a nucleotide-binding domain, essentially the ability to bind 
ATP and, perhaps, other ligands (the eventual ligand binding studies are discussed in 
Chapter 7). This had been achieved by other investigators, including the study of the 
modulation of ATP-binding by flavonoids in the murine Mdrl C-terminal NBD. By 
adopting the dimensions of this nucleotide binding domain, and a 52 amino-acid C- 
terminal extension of those dimensions, a further two expression systems were 
constructed. These were termed pET21bPftlNBDT and pET21 bPft 1NBDTW 
respectively (NBD Truncate and NBD Truncate W [tryptophan]). The dynamics of
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Fig 6.8 Purification of PftlNBDTW under native conditions
Lane 1] Soluble fraction of PftlNBDTW expressing cells (pre-purification)
Lane 2] Column flow-through
Lane 3] Wash number 1
Lane 4] Wash number 2
Lane 5] Wash number 3
Lane 6] Elution number 1
Lane 7] Elution number 2
Lane 8] Elution number 3
Lane 9] Elution number 4
Buffer compositions and volumes
Lysis buffer; 50mM NaH^PO^ pH8.0, 300mM NaCl, 
15% glycerol, lOmM imidazole.
3L cell pellet was resuspended in 40ml
Wash buffer; 50mM NaHjPO^ pH8.0, 300mM NaCl, 
15% glycerol, 40mM imidazole.
Each wash was applied at a volume of 50ml
Elution buffer; 50mM NaH^PO^ pH8.0, 300mM NaCl,
15% glycerol, 250mM imidazole.
Each elution was applied at a volume of 0.5 ml
All buffers also contained EDTA-free protease inhibitors.
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expression in these systems was in extreme contrast to those observed for the original 
PftlNBD construct, with the recombinant protein representing an estimated 80% of the 
total cell protein. Excellent yield of PftlNBDT and PftlNBDTW could be observed 
after only Ih induction. As is often the case with such high level expression of 
heterologous proteins, the product was isolated, to a very great extent in inclusion 
bodies, thus rendering it inaccessible to direct biochemical analysis. Unfortunately, all 
of the common techniques used to minimise inclusion body formation, such as 
manipulation of temperature and induction conditions, proved ineffective in this 
situation.
Previous work by others had suggested that the amount of soluble NBD obtained was 
inversely proportional to the size of the molecule expressed. However, for these two 
NBD constructs of P ftl, the expression performance of both constructs was rather 
similar in terms of both total yield and the yield of soluble protein. It was decided to 
continue the work only on PftlNBDTW. This larger protein possessed all of the 
features of PftlNBDT and included a native tryptophan towards the C-terminus.
Denaturing purification of the inclusion bodies demonstrated that the PftlNBDTW was 
successfully His^ tagged and very high yields (hundreds of milligrams) could be 
prepared from 1 litre of culture. This was a re-assuring observation because it meant 
that large amounts of protein was readily available should refolding experiments be 
required to provide material for further investigation. This was reinforced by the 
relative ease of purification which required no optimisation of recommended 
purification protocols.
As with many cases of inclusion body formation a relatively small yet notable yield of 
protein could be found in the cytoplasmic fraction that represented a native and soluble 
form. While this yield was dwarfed by that of the inclusion body material, it was 
decided to pursue this small amount for the biochemical studies rather than go through 
what could be laborious and potentially ineffective refolding experiments. Refolding 
was dismissed for three main reasons. Firstly, as the molecule was a truncated form of 
a larger protein there was a chance that sub-optimal refolding conditions could result in 
an aberrant conformation that was not akin to that of the conformation of the domain in 
the full-sized molecule. Secondly, it would be very difficult to ascertain if the 
behaviour of the molecule in future experiments would be due to a true biochemical 
characteristic or an artefact of refolding. This is particularly true in this case where the 
“activity” is not a measurable enzymic activity but a measure only of ligand binding, 
where true processive function is not demonstrated. Finally, as the amount of restored 
biological activity would probably be partial (relative to material from a native source) it
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may be difficult to attribute any numerical data to observations without first knowing 
the proportion of protein yield that had attained the correct conformation. This is 
impossible without well characterised, active, native protein as a reference.
The native purification of PftlNBDTW proved difficult at the outset and the suitability 
of the standard purification protocol was not observed as it was for the denaturing 
purification. Despite visible evidence of the PftlNBDTW in the soluble fraction and 
it’s retention of the column (as demonstrated by it’s absence from the initial column 
flow-through) the protein did not appear on elution, even when imidazole 
concentrations were elevated to 500mM. It was suspected that this was probably due to 
aggregation or precipitation, perhaps exacerbated by the fact that the molecule in 
question was a truncate and some exposed faces of the protein may normally be 
stabilised by interactions with portions of Pftl which were omitted in this construct? 
The addition of glycerol to 15% proved effective in stabilising the protein and a purified 
28.0 kDa protein was observed by SDS-PAGE. This protein remained stable during 
dialysis and cryostorage. The protein was then used in a number of biochemical 
experiments reported in Chapter 7.
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Ligand binding studies for P ftlN B D T W .
In order to attribute a function to Pftl a number of options for investigation were 
considered. Initially, and perhaps most logically, the recombinant expression of the 
entire Pftl protein in a drug sensitive mutant of S.cerevisiae could be attempted. This 
could provide a direct answer to the question of whether or not Pftl is involved in 
multidrug resistance. This option was developed, to a point, and is discussed briefly at 
the close of this chapter. However, in designing experiments to answer some of the 
basic questions we had to acknowledge that there were scenarios that could preclude a 
successful result from such a direct approach.
Firstly, many of the modular components of bacterial ABC transporters are expressed 
separately and form a dimeric or oligomeric complex. The bacterial maltose transporter 
is also an oligomeric complex of MalFGK^ (Mourez, et al. 1998). Similarly, the 
histidine permease of Salmonella typhimurium is arranged as HisQMP^ (Pei-Qi and 
Ames 1998). The Lactococcus lactis, LmrA is perhaps a good example of an ABC 
half-transporter which is functional as a homodimer (Van Veen, et a l  1998). 
However, it has to be noted that dimer complexes in eukaryotic ABC transporters are 
most often heterodimers. The best characterised must be the Tapl/Tap2 heterodimer 
complex involved in MHCI antigen presentation in mammalian cells (Abele and Tampe 
1999). Also a heterodimeric ABC transporter has been described in S. cerevisiae which 
displays considerable structural homology to the human adrenoleukodystrophy 
transporter complex (Shiani and Valle 1996). The real possibility that Pftl may 
represent a component of a hetero-oligomeric complex meant that straight forward 
heterologous complementation might not provide a phenotype.
It was also decided that the association of Pftl with drug transport was, in fact, an 
assumption and the potential that the protein may have no affinity for drug must be 
addressed. This notion is partly supported by the fact that the S.cerevisiae AD 1-8 
mutant (a gift from Prof. A. Goffeau) used for the complementation assays retains 
copies of both m dll and mdl2 but continues to exhibit a high sensitivity to selected 
drugs. If these half-transporters are involved in drug resistance then why do the Mdll 
and Mdl2 proteins not result in a persistent Mdr phenotype in this mutant strain. 
However, it must be noted that the PDRl and PDR3 transcription factors involved in 
the Pdr network (Balzi and Goffeau 1995) are inactive in this strain and the 
transcriptional control of the two ABC transporter genes in relation to these factors has
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not been addressed. It is possible that the expression of Mdll and Mdl2 is averted due 
to this deletion.
In addition to the direct question of phenotype (Is Pftl a drug transporter?), a more 
subtle biochemical approach was employed. Essentially the issues that we aimed to 
address related to the competence of the purified native PftlNBDTW (see chapter 6 ) to 
bind substrates. Substrate binding would be confirmed by a demonstration of 
conformational change (measuring valuation of intrinsic tryptophan fluorescence) or by 
fluorescence resonance energy transfer (FRET) (the transfer of fluorescence energy 
from the excited tiyptophan to a bound fluorescent substrate). In this way we could 
implicate biochemical function at a protein level even if a phenotype could not be 
demonstrated at the level of the organism.
7 .1  Fluorescence based analysis of ATP binding to PftlNBDTW.
In order to demonstrate that the PftlNBDTW retained an affinity for ATP, a stopped- 
flow device was employed. This device allows the rapid mixing of both substrate and 
protein in a small chamber and the resultant changes in fluorescence to be measured 
repeatedly over a very short time base. Thus a transient profile of progressive 
fluorescence change can be plotted.
For the purposes of these experiments a fluorescent ATP analogue, MANT-ATP, was 
used. The MANT-group on this molecule can be useful in two ways. This additional 
group is an efficient receptor of the fluorescence energy generated by tryptophan 
molecules and is thus a good candidate for FRET based analyses. Additionally, 
binding of MANT-ATP can result in a tryptophan independent increase in MANT 
fluorescence which occurs as result of the shielding of the MANT group from the 
aqueous environment by internalisation within the protein structure. Either phenomena 
would illustrate ATP binding.
The stopped flow was programmed in the following way. An input beam, at an 
excitation wavelength of 280nm was applied to the mixing chamber, via two 
monochromators. Measurements of tryptophan fluorescence were recorded over a 10 
second logarithmic time base. These measurements were made on the basis of changes 
in light detection by a photomultiplier tube (PMT). Essentially, the emission light 
derived from tryptophan or MANT fluorescence passes from the chamber through
176
Chapter 7
an appropriate filter (320nm for Trp fluorescence, 420nm for MANT-ATP) to the 
photomultiplier (PM) tube. The gathered emission light causes an alteration in the 
voltage of the PM tube and this variation in PM volts (PMV) is displayed over the 
selected timebase. An increase in PMV denotes an increase in fluorescence while a 
PMV decrease reflects a fluorescence decrease.
Eight replicate traces were generated for each form of fluorescence (tryptophan or 
MANT). This allowed averaging at each data point and a mean PMV trace to be 
plotted. For each individual trace a solution of 25pM MANT-ATP in buffer was mixed 
with an equal volume of protein (at 400jag per ml). The MANT-ATP solution was 
prepared in the same buffer that was used to dialyse the protein of that preparation. It is 
the mean trace that is presented for each experiment. It is notable that the 
reproducibility between each trace was very good and the variation at any data point 
was minimal.
The analysis of a change in tryptophan fluorescence was the first to be examined. 
While FRET requires both ligand and tryptophan to be in relative close contact, the 
observation of tryptophan fluorescence is independant of the location of ligand binding. 
The degree of tryptophan fluorescence is directly related to the extent to which the 
tryptophan residue is accessible to bombardment by water molecules. The collision of 
water with the fluorescent aromatic group dissipates fluorescent energy and thus 
reduces the observed output of light at 320nm. Thus an increase in tryptophan 
fluorescence relates to a protein conformational change that results in the internalisation 
and shielding of the amino-acid. Conversely, a decrease in fluorescence would indicate 
a conformational change which exposes the tryptophan to the quenching aqueous 
environment.
The trace presented in Fig7.1 is the mean trace of the change in the tryptophan 
fluorescence of PftlNBDTW when the protein was mixed with MANT-ATP. An 
increasing signal is observed indicating a conformational change and suggestive of 
internalisation of the tryptophan. The reaction is rapid, occurring over approximately 
0.07sec. The trace was fitted to a double expontential equation using the Applied 
Photophysics software. The initial rapid phase had an amplitude of 0.127V. The PMT 
was zeroed to a 4V signal so the percentage fluorescence change can be calculated as 
0.127/4 X 100. This defines a fluorescence change of 3.175%. The conformational 
change appears biphasic with a rapid increase in fluorescence from 0  to 0 .0 2  sec 
followed by a change of slower rate.
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F igT .l Analysis of PftlNBDTW tryptophan fluorescence on 
binding of MANT-ATP
Sample Resei*voir A; 25 pM MANT-ATP
50mM NaH^PO, pH8.0 
300mM NaCl 
15% glycerol
Sample resei-voir B; PftlNBDTW (400pg ml'^)
50mM NaH^PO^ pH8.0 
300mM NaCl 
15% glycerol
Input light at 285nm. Output light filtered at 320nm
lOOpl volumes from each sample reservoir were rapidly mixed in a stopped flow
appaiatus and fluorescence output measured over a 10s timebase.
This trace represents the averaging of points from 8 individual traces.
X Axis Time (Seconds)
Y Axis PMT Voltage signal
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The amplitude of the second expontential (0.051V) gives a further fluorecence increase 
of 1.275%. This increase in fluorescence signal was not observed in control 
experiments where the PftlNBDTW or the MANT-ATP were mixed with reaction 
buffer alone. Thus we can conclude that the protein does indeed exhibit affinity for 
ATP (or at least an ATP analogue). Also this initial experiment demonstrated that the 
C-terminal tiyptophan was an effective reporter for confoiTnational change.
The filter for emission light was replaced and the experiment was repeated, this time 
analysing emission from the MANT-ATP. Again an increase in fluorescence was 
observed (Fig?.2). The major fluoresence changes appear to occur over approximately 
0.8 seconds. The data has been fitted using a double exponential equation revealing a 
biphasic configuration. The first rapid increase in fluoresence has an amplitude of 
0.107V representing a 2.67% increase in fluoresence. This occurs over 0.02 seconds. 
The second slower exponential has an amplitude of 0.054V allowing for a further 
1.35% increase. This result consolidates the conclusion that conformational change is 
occurring as a consequence of ligand binding. The increase in output can be attributed 
to binding of MANT-ATP in such a way that the MANT group was internalised into the 
protein structure, thus shielding it from the aqueous environment, or as a result of 
fluorescence energy transfer from the tryptophan. It is not possible on the strength of 
this data to dissect which of these two mechanisms is responsible or indeed if both are 
at work. If FRET is involved then the signal of tryptophan fluorescence of Fig7.1 may 
under-estimate the true output from the tryptophan when the MANT-ATP is bound, 
because some of this energy would have been donated to the MANT group.
These experiments were repeated in the presence of lOmM MgCl^, ATP binding is 
usually observed to be greatly enhanced by the presence of the Mg^^ ion. In the case of 
PftlNBDTW the traces with and without lOmM MgCl^ proved to be identical 
suggesting no involvement of magnesium in this case (data not shown).
7 .2  Steady state binding studies for azole binding to PftlNBDTW.
The successful binding of the MANT-ATP to PftlNBDTW implied that the protein was 
correctly folded and performed the basic function of binding nucleotide. We now 
wished to examine interactions with a drug ligand. A number of NBDs for ABC 
transporters display an affinity for the substrates that they transport. These substrates 
have been shown to modulate the affinity of the NBD for ATP and thus act as 
modulators on the process of energising the transport of solute (Conseil, et al. 1998).
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F ig7 .2  Analysis of MANT-ATP fluorescence on binding to
PftlNBDTW
Sample Reseiwoir A; 25 |iM MANT-ATP
50mM NaH^PO^ pH8.0 
300mM NaCl 
15% glycerol
Sample reservoir B; PftlNBDTW (400|xg ml'*)
50mM NaH^PO^ pH8.0 
300mM NaCl 
15% glycerol
Input light at 285nm. Output light filtered at 420nm
lOOpl volumes from each sample reservoir were rapidly mixed in a stopped flow
apparatus and fluorescence output measured over a 10s timebase.
This trace represents the averaging of points from 8 individual traces.
X Axis Time (Seconds)
Y Axis PMT Voltage signal
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The upregulation of p ftl expression in direct response to an azole stimulus was the only 
evidence pointing towards any phenotype afforded by this protein. Therefore 
interaction of azoles with the nucleotide binding domain was an appropriate avenue to 
follow. It was decided to use ketoconazole, the therapeutic drug of choice for 
paracoccidiodiomycosis. If Pftl has evolved a drug binding capacity it would have 
done so in the presence of ketoconazole rather than any other azole.
The intention was to use fluorimetery to measure the steady-state change in tryptophan 
fluorescence in response to the drug. This technique has proved useful for 
characterisation of a wide range of kinetic systems. A lamp supplies input light at a 
required wavelength, in this case 285nm, via a series of chromating mirrors. The input 
light enters a quartz cuvette containing the test substances and excitation of tryptophan 
is achieved. The emission light is then measured at right angles to the input light, 
assuring that the measured light is indeed emission based and not merely transmitted 
light from the input source (as used in spectrophotometry).
For the experiments described below (in section 7.2 and 7.3), carefully designed 
conditions were employed in order to ascertain whether the observed changes in 
emission output had been influenced by inner-filter effect. The inner-filer effect can 
occur if a non-protein ligand or other substance tends to absorb light at 285nm. This 
reduces the amount of light available for excitation of the tryptophan and the degree of 
tryptophan fluorescence would appear artificially low. To this end a second quartz 
cuvette was placed directly in front of the cuvette housing the protein. All substances 
used for these experiments were applied to the front cuvette; buffer plus ketoconazole, 
buffer plus ATP, buffer plus ketoconazole and ATP (at all concentrations used in 
experiments) and buffer alone. It was noted that a significant and concentration 
dependant inner filter effect could be observed with ATP. The degree of inner filter 
effect was noted and all values presented in the following data have been corrected 
accordingly. Also all observations were carried out with the front cuvette in place 
(filled with buffer) to eliminate any variation in input light transmission which may have 
occurred from the use of two parallel cuvettes.
The intention was to monitor the flux in tryptophan fluorescence on addition of drug. 
However, on execution of the experiment, the serendipitous discovery that 
ketoconazole was highly receptive to FRET superseded the direct tryptophan based 
approach. To the test cuvette was added PftlNBDTW and ketoconazole to a final 
concentration of lOOpM. Ketoconazole exhibits a basal level of fluorescence on 
excitation at 280nm, emitting at 340nm. This fluorescence is markedly elevated in the 
presence of protein, indicating binding of the azole to PftlNBDTW (Fig7.3).
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Fig7.3 FRET transfer from PftlNBDTW to ketoconazole
X Axis Wavelength (nm)
Y Axis Arbitrary fluorescence units
Peak at 280nm and 200 Absorbance units 
Peak at 390nm and 200 Absorbance units 
Peak at 280nm and 950 Absorbance units
PftlNBDTW  alone 
Ketoconazole alone 
PftlNBDTW  plus Ketoconazole
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Tryptophan to ketoconazole FRET results in the removal of all evidence of tryptophan 
fluorescence, presumably through a high efficiency of energy transfer. This indicates 
that ketoconazole does bind to the NBD and that the location of this binding site is very 
local to the tryptophan. The increase in the fluorescence of ketoconazole on the 
inclusion of protein is much greater than the observed decrease in fluorescence of the 
tryptophan. It is possible that the extent of ketoconazole fluorescence is enhanced by a 
FRET independent increase in azole fluorescence that may occur if the bound drug is 
buried within the protein.
On the basis of this effect, the concentration dependant affinity of binding could be 
investigated. Ketoconazole was applied to the fluorimeter cuvette at increasing 
concentrations (0 to 60 pM), thus titrating the drug against protein. Each concentration 
was measured in triplicate (from three replicate titrations) and the arbitrary fluorescence 
units attained by the ketoconazole FRET peak were noted. Fig7.4 shows a plot of the 
azole titration. Each point represents the mean value for replicate observations but no 
error bars are included because the reproducibility of data was almost exact (fluctuation 
occurred only in the second decimal place of the fluorescence unit).
A non-linear regression analysis was performed using Sigmaplot™. This process 
applies the data to the following equation;
AF/F„= (AFMAx/[PftlNBDTW])/F„ . {(K, + [PftlNBDTW] + [Ketoconazole])W(Kj + 
[PftlNBDTW] + [ketoconazole]^ - 4 ([PFTlNBDTW][Ketoconazole] ))/2
Where F is the fluorescence.
Using this equation a value of 0.959pM was calculated.
7 .3  ATP alters the binding of ketoconazole on PftlNBDTW.
The experiments on the murine NBD discussed earlier (Conseil, et al. 1998) focus on 
the kinetics of ATP binding and the role of flavonoid ligands in the modulation of the 
rate of ATP binding. For Pftl investigations involving ATP and ketoconazole were 
pursued but from a slightly different perspective. It was decided to focus on the effect 
of the presence of ATP on the affinity for ketoconazole rather than the presence of 
ketoconazole on ATP binding. ATP was applied to the fluorimetery experiments at a
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Fig 7.4 Titration of ketoconazole against PftlNBDTW
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constant concentration of lOpM, pre-incubated at 20°C with the protein for lOmin prior 
to measurements. The titrations with ketoconazole were repeated, again in triplicate.
The results of this titration can be observed in Fig7.5. Increased levels of FRET are 
observed. Using the equation described above a value of 0.858pM was calculated. 
This suggests that a slightly higher affinity for the azole was observed on the addition 
of ATP. Also this increase in fluorescence output is consistent with the internalisation 
of the drug supporting this hypothesis of tighter binding.
7 .4  Heterologous complementation of a drug sensitive phenotype in 
S.cerevisiae  by Pftl.
As mentioned in the opening section of this chapter, the direct way to demonstrate a 
drug transporter phenotype with Pftl was heterologous complementation. The potential 
pitfalls of this approach were also discussed. These experiments were introduced but 
were not followed up to a conclusive level. This section serves to mention the status of 
this approach and the few observations made so far.
The construction of expression systems for Pftl in S.cerevisiae was achieved in 
pYES2-TOPO“His. Two cDNAs were amplified, allowing expression from each of the 
alternate ATG codons implicated in Pftl transcription (data not shown). These cDNAs 
were T-A cloned to the pYES2 vector. As A-T cloning is not directional, the orientation 
of the inserts were confirmed by PCR using the forward Pftl primer and the reverse T3 
sequencing primer of the pYES2 vector. Correct clones were identified for both 
constructs. These constructs were transformed to S.cerevisiae A D l-8  .
7 .5  D iscussion
The purified PftlNBDTW proved to be very useful in the initial demonstration of Pftl 
ligand affinity. The integrity and correct folding of the PftlNBDTW was demonstrated 
by the competence of the recombinant protein to bind ATP. This was demonstrate from 
both protein (tryptophan fluorescence) and ligand (MANT-ATP fluorescence) 
perspectives. Stopped-flow analysis showed a rapid increase in fluorescence for both 
protein and ligand over a short time base, indicating that the binding of ATP results in a 
rapid conformational change in the NBD. The ability of the NBD to bind ATP was
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Fig 7.5 Titration of ketoconazole against PftlNBDTW in the presence of
lOmM ATP
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expected as it had been successfully detected by various means by other investigators 
using similar constructs (Dayan, et al. 1996; Conseil, et al. 1998).
Until these investigations, no biochemical analysis had been performed on the Mdr-like 
half-transporters of fungi that had been proposed to be involved in drug resistance. The 
experiments above do not prove that Pftl is a drug transporter either. They do give 
conclusive proof that Pftl exhibits an affinity for ketoconazole (K^=0.959|iM). In 
addition these data suggest that ATP may improve ketoconazole binding providing 
another example of ATP co-operativity in ligand binding (Kj=0.858pM).
It is important to note that the binding of a substrate to the NBD does not indicate that 
this substrate will be transported by the protein. Indeed, in other well characterised 
transport systems where the solute binds to the NBD we find that this precise molecule 
is not transported but merely served to positively modulate function to facilitate the 
transport of another. The NBD of bacterial arsenite transporter complex (ArsA) has the 
capacity to bind both arsenite and antimonite ions. The binding of these ions to the 
NBD is not a precursor to their transport but a precursor to the transport of another 
identical ion. Secondly, if some current models are to be believed (eg. the hydrophobic 
vacuum cleaner model (Bolhuis, e ta l ,  1997)) the extrusion of hydrophobic substances 
occurs by their direct removal from the lipid bilayer during passage. It is initially 
difficult to see how the molecule to be transported could bind with such high affinity to 
the soluble portion of the NBD if this is true.
While there is no experimental evidence to support the following hypothesis, it remains 
an interesting notion. The high affinity demonstrated for ketoconazole would mean that 
the drug would bind to the PftlNBD when the intracellular concentration of the drug is 
low. The binding of the ketoconazole to the NBD could serve to allosterically activate 
the membrane portion of Pftl and enhance the removal of drug molecules passing 
thi'ough the plasma membrane. This environmental sensing mechanism could convey a 
mechanism of selective activity on the ABC transporter so that, in the absence of the 
azole, the passage of other hydrophobic molecules through the bilayer is not affected. 
The considerable homology between the PftlNBDTW and the coiTesponding regions of 
other proteins could mean that this is a widespread phenomenon.
While the heterologous complementation assay for drug transport by Pftl were not 
conclusive it is not possible to state that Pftl one does not act as a drug transporter. 
There are a considerable number of technical difficulties to be addressed which may 
have influenced the result and the data briefly described above can only be described as 
preliminary. For example, it would be prudent to continue this line of research and
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make conclusions about MICs for yeast cells in which Pftl expression is confirmed and 
quantified. If a transport system is observed then it may be possible to study the 
subcellular localisation of transport, e.g. whether the transport occurs at the cell 
membrane directly or whether transport of solute results in sequestration into the vesicle 
transport system and the intracellulai* concentration of drug is reduced by exocytosis. 
While it was hoped that such investigations would form part of our characterisation of 
Pftl, it was found that to advance this aspect to a conclusive degree was beyond the 
timescale of this thesis. However, the molecular infrastructure for such experiments is 
now in place and it is hoped that this avenue will be advanced in the short term.
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Chapter 8 
Final D iscussion
In the present climate of complete genome sequencing, the practice of searching for, 
cloning and sequencing individual genes might be considered less valid. This is true of 
course for those involved in the study of organisms where a genome sequencing project 
is underway and will shortly be complete. However, a number of important 
microorganisms, including P.brasiliensis, have not yet been afforded a genome 
sequencing program. This oversight does not mean that molecular investigations of 
such organisms are not valid. Indeed the opposite should be considered true. As drug 
discovery in the 2 1 st century tends towards rational drug design rather than the high 
throughput screening of naturally occurring substances, it is important that science 
provides a contemporary literature base for all organisms of clinical importance. To this 
end the search for potentially important determinants must continue until all genomes 
have been sequenced. With the necessity for entry level molecular characterisation in 
mind, the subject of this thesis was conceived and developed. At the time of writing 
there are a total of 13 P.brasiliensis genes available on the NCBI database. Fewer were 
available at the outset of the research. This total is rather small when you consider the 
3000 ORFs identified in S.cerevisiae (Decottignies and Goffeau, 1999).
ATP-binding cassette transporters are among the most ubiquitous of proteins found in 
nature and the superfamily is now known to be responsible for a number of essential 
and important physiological functions. In microorganisms these functions include 
solute uptake (Hung, et al., 1998), virulence factor export (Young and Holland, 1999) 
and multi-drug resistance (Higgins, 1992). ABC transporters have been identified as 
candidates for drug targets in both the infectious and physiological disease context and 
this feasibility is reflected in the intense global interest in the field. With the exception 
of the two genes identified by this study no ABC transporters are known for 
P.brasiliensis. The universal nature of these proteins would tend to assure that they 
would be present.
The isolation of the p ftl  and p ftl  gene fragments by PCR confirmed the effectiveness 
of the degenerate oligonucleotide primers for initial gene identification. This technique 
has since been used to good effect in other projects within our lab to discover a number 
of genes, including loci potentially involved in the thermal dimorphism of P.brasiliensis 
(unpublished data). Each set of degenerate primers were designed to be specific for the 
subclass of ABC transporters concerned; MDRl and MDR2 targeting P-glycoprotein
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(mdr-) like genes while PDRl and PDR2 were intended for PDR-like genes. While 
others had found that the application of the MDR primers could lead to the amplification 
of regions from more than one gene, only a single product was observed in our 
experiments. In retrospect the gene corresponding to this amplicon was the exception 
to the rule in that Tobin et a i isolated a full-sized ABC transporter from both of the 
Aspergillus ssp. they addressed The half transporter, afuM DRl, was found in 
A.fumigatus alone (Tobin et al., 1997). In P.brasiliensis we could find no evidence of 
a second gene, full-sized or otherwise, using this technique. The tendency of our 
degenerate PCR experiments to identify only one gene per primer set carried on in the 
application of the PDR primers. This primer set should have amplified DNA from 
coding regions from a number of similar ABC transporters within the genomes of both 
S.cerevisiae (pdr5, pdrlO, p d r ll ,  etc.) and C.albicans {cdrl, cdr2, cdr3). But, in our 
experiments, only one Jr-like amplicon was generated, even over a range of PCR 
conditions. While we have addressed both of the major classes of ABC transporters it 
is most likely that p ftl and p ft l  do not represent a complete inventory of P.brasiliensis 
ABC transporters. It is possible that the degeneracies chosen for these primers sets, as 
well as the PCR conditions in the initial stages of amplification have selected for the 
preferential amplification of these fragments in each PCR. However, experiments that 
altered the degeneracies of the MDR primers and the initial conditions used in this PCR 
had no effect on the amplicon generated. The p ftl  fragment prevailed even when 
primer mismatch was required for oligo annealing.
Identification of further ABC transporters in P.brasiliensis remains a valid avenue of 
research. The findings of this study may allow access to this endeavour. The NBDs of 
both genes show considerable homology to most recognised ABC transporter genes of 
other fungi. This conservation would allow their employment as heterologous probes 
for further library screening. The procedures employed for homologous probing of 
libraries in the search for a lambda clone harbouring the p ftl  and p ft l  genes could be 
easily adapted to allow heterologous probing. A second option is to approach the issue 
from the level of phenotype rather than genotype. The construction of an expression 
library in a yeast vector system could allow screening for typical ABC-transporter 
mediated phenotypes in an appropriate yeast strain. For example, the drug 
hypersensitive S.cerevisiae strain ADI-8' would be a good host for such expression 
plasmids if MDR was the phenotype in question. An added advantage of this approach 
is that a functional protein is assured. No truncation of the gene has occurred that 
would necessitate the additional demanding PCRs required in this study. Also, no 
genes would be isolated which represented a single component of an oligomeric 
complex, although it does not follow that this is a good thing. However, it is always 
encouraging to know that you have a complete experimental system when designing
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future experiments. Unfortunately, the expression Ubraiy approach requires a 
reasonable quantity of total cDNA to allow library construction. For logistical reasons 
this material was not available during the course of this study.
It is important that the identification of further ABC transporters is carried out within a 
framework of directed research. The work reported in this thesis demonstrates the 
existence of such genes in P.brasiliensis. In order to avoid a “stamp collecting” 
exercise further investigations should be motivated from the point of view of 
phenotypic investigation. This makes the second approach, using yeast expression 
libraries, the most appropriate.
Work at the mRNA level was more extensive than originally intended, primarily 
because of the need for the 5’RACE RT-PCR in the case of p ftl .  The results for this 
PCR were rather confusing at first and this prompted a considerable amount of 
repetition and optimisation. The observed result, indicating a shorter transcript that 
expected, persisted throughout and it had to be concluded that this was the mRNA 
species present. This highlights a fundamental issue in the characterisation of genes 
based on the ORFs observed on DNA sequencing. It is common practice to define the 
5’ boundary of a gene based on the “first ATG after a stop” philosophy. The prolific 
post-transcriptional modification and alternative transcriptional start sites observed in 
higher eukaryotes should seiwe as a warning that the true boundaries of a gene aie not 
those depicted by the DNA sequence but those exhibited by the transcript on arrival at 
the ribosome. While this thesis yields to conventional wisdom and sets the first ATG 
of the genome at nucleotide positions 1-3 of p ft l ,  it is just as possible that the ATG at 
position 550-552 is a more likely start codon for this is the one that has been identified 
experimentally.
Other mRNA experiments, such as the RT-PCRs examining transcriptional regulation, 
resulted in the bias for p ftl  displayed in this thesis. The genetic and biochemical 
characterisation of Pdr5 and Pdr5-like proteins has been carried out to great extent by a 
number of excellent researchers and the pursuit of data for Pft2 would probably involve 
a repetition of their experiments and merely reinforce paradigms already firmly in place. 
Half-transporters remained uninvestigated to any notable degree and we had already 
uncovered ambiguity between our observations and accepted wisdom. The apparent 
neglect of these smaller proteins permits easier access to original research thus Pftl was 
given priority.
The generation of a Pftl cDNA allowed progression to recombinant protein expression, 
and thus the potential for downstream biochemistry was realised. The procedures
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employed to obtain protein were standard. As a consequence of the limited number of 
genes sequenced for P.brasiliensis, the recombinant expression of proteins from this 
organism is not reported frequently in the literature. Cisaplipino et al. (1996) 
successfully expressed the C-terminal portion of the major P.brasiliensis diagnostic 
antigen gp43. This was then transferred to nitro-cellulose rather than purified and 
reacted with anti-gp43 sera with a view to preliminary epitope mapping. To our 
knowledge the recombinant expression and purification of PftlNBDTW represents the 
first isolation of protein, derived from this organism, for biochemical analysis.
While the expression and purification procedures employed gave satisfactory results 
there is now scope for further optimisation. The aggressive induction of the pET 
system is perhaps not the ideal in this case. From the large amount of inclusion bodies 
observed for both PftlNBDT and PftlNBDTW, it is apparent that protein folding 
remains a problem in the E.coli system. Alternative vector systems could be 
considered. For example a higher level of transcriptional control is afforded by 
expression vectors like pBAD (Invitrogen) in which the degree of indication can be 
controlled and optimised by the empirical titration of arabinose to the expression culture 
(pBAD vectors express from a promoter induced by arabinose rather than IPTG). 
These alternative strategies may allow a higher yield of soluble protein from 
PftlNBDTW expressing cultures.
The allocation of function to Pftl proved to be rather illusive at first. The problems 
associated may be the reason for the lack of published information on these proteins.
At the time of investigation the fascinating data regarding mitochondrial peptide 
transport by Mdll (Young et al., 2001) was unavailable. The discoverer of the mdl 
half-transporters of S.cerevisiae reported that these genes have been supplied to a 
number of other investigators who were keen to include them in there own research 
technologies, but these endeavours have never come to fruition in the literature (Paul 
Dean, personal communication). Most of the approaches were based on heterologous 
complementation in yeasts of various genotypes, an approach that was not particularly 
effective in this study. In light of the very recent data, the possibility that Pftl is 
involved in mitochondrial processes must now be addressed. It will be interesting to 
see how the binding of ketoconazole fits in with this activity. Drug binding by Pftl 
may represent a totally unrelated process giving the protein a pleiotropic role. The 
investigation that ascribed function to Mdll reported that the protein was found in 
isolated mitochondria. Other components of the cell, including the cell membrane, were 
not investigated as mitochondrial function was the initial focus of the study. The 
truncation of the p ftl  mRNA observed in 5'RACE may be involved in a process of 
pleiotropy as the exclusion of the 5' end of the transcript might remove any
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mitochondrial localisation signal and allow a different Pftl isoform to progress to the 
cytoplasmic membrane. Alternatively Pftl may sequester azole drugs into vesicles 
during intracellular transport and reduce the free concentration in the cytoplasm. Or 
perhaps Pftl does not transport azoles at all but is modulated by them by interactions at 
the NBD. All these possibilities will require further investigation and promise an 
interesting insight to the processes of these proteins.
The alternative approach of detailed biochemical characterisation at the level of the 
protein has proved more appropriate in the case of Pftl. The experiments reported in 
Chapter 7 demonstrate that the expression of domains homologous to those 
successfully employed in the study of mammalian proteins are also effective in fungal 
research. While the binding of ATP to PftlNBDTW is of no great surprise the results 
concerning ketoconazole are remarkable. The fact that this ABC transporter has an 
affinity for this drug does not confirm that it is a substrate for translocation but does 
suggest that it could be. Alternatively this affinity may afford some allosteric control of 
activity as discussed in the previous chapter.
A detailed study of PftlNBDTW mechanism is now possible. The dissection of 
binding kinetics for other ABC transporter nucleotide-binding domains, such as ArsA, 
illustrate the depth of information that can be gathered from comprehensive 
experimentation. The competence of the NBD for interactions with other azole drugs 
and hydrophobic compounds should be a priority. The potential that the NBD was 
processive and could hydrolyse ATP was not addressed in this study for technical 
reasons. The optimised purification system for PftlNBDTW was based on phosphate 
buffers which prohibits direct analysis of phosphate ion release as a consequence of 
ATP hydrolysis. An alternative purification procedure was attempted, based on MOPs 
buffers, but no protein was obtained in this way. It may be possible to purify the 
protein in phosphate buffer and dialyse into MOPs or another phosphate free buffer for 
this analysis.
Despite no demonstration of a transport process per se this thesis reports strong 
evidence for the involvement of Pftl in the physiological response of P.brasiliensis to 
ketoconazole. This is an important observation as ketoconazole is the therapeutic drug 
of choice for paracoccidiodiomycosis and these findings may have significant 
ramifications for the clinical efficacy of this drug. Other hydrophobic ligands may also 
prove to have a high affinity for this protein. One of the complicating clinical issues 
associated with the MDR phenotype is the competence of ABC transporters for a wide 
range of molecules that appear structurally unrelated. Recently the Cdrl protein of 
C.albicans proven to be a mediator of clinical azole resistance (Sanglard, et a i ,  1995)
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was shown to transport the female hormone oestrogen (Krishnamurthy, et a l ,  1998).
A similar scenario in P.brasiliensis could have a deleterious impact. It has been 
demonstrated that the morphological transition of this organism, which is required for 
progression to the disease state, is inhibited in females due to such hormones. If the 
organism is developing a mechanism that will circumvent the intracellular accumulation 
of this hormone then the protection afforded to females may be alleviated, increasing the 
susceptible population.
In summary, the results in this thesis reveal the existence of two genetic determinants in 
P.brasiliensis that appear to encode ABC transporters. One of these determinants, 
termed p ftl ,  has been completely sequenced to reveal a 2627bp open reading frame 
coding for 827 amino acids and interrupted by two introns of 68 and 77bp. The gene 
exhibits highest sequence homology to afuMDRl o f A.fumigatus (Tobin, et a i ,  1997). 
The second gene, p ft l  was partially sequenced. The portion sequenced amount to 
3792bp coding 1053 amino acids covering the bulk of the gene (as estimated on 
comparison with the nearest homologue AtrA (Del Sorbo, et a l, 1997)). Both of these 
genes were found to be expressed loci in P.brasiliensis, with a total induction of p ftl  in 
response to fluconazole. The p ft l  transcript showed no notable up-regulation in the 
presence or absence of this MDR substrate. Analysis of the 5’ region of the p ftl 
transcript reveals a shorter than expected transcript, implicating the ATG at position 550 
as the true start codon.
Recombinant expression of various C-terminal portions of the Pftl nucleotide-binding 
domain was achieved in the pET21b vector. The largest of these constructs expressed 
PftlNBD, a 48.5kDa protein. On analysis of the subcellular localisation the protein 
was found to be exclusively localised to the membrane fraction of the cell. Smaller 
truncates of the NBD were expressed and the tropism for the membrane was averted. 
Unfortunately the extensive over-expression of these proteins resulted in the 
predominate formation of inclusion bodies. Despite a number of attempts to manipulate 
the dynamics of expression and increase the proportion of the protein in the native 
soluble form, a comparatively small amount of protein could be observed in the 
cytoplasmic fraction. Even so, the purification of one of these truncated nucleotide- 
binding domains, the 28.0kDa PftlNBDTW, was successfully achieved under native 
conditions using an empirically optimised protocol. Following dialysis this protein was 
applied to biochemical characterisation using tryptophan fluorescence based techniques. 
Transient analysis of MANT-ATP binding, for the perspective of both tryptophan 
fluorescence and MANT- fluorescence illustrated that the PftlNBDTW exhibits an 
affinity for ATP. The highly efficient fluorescence energy transfer from the excited 
tryptophan of the protein to ketoconazole allowed the measurement of the binding
194
Chapter 8
kinetics of this drug to PftlNBDTW. A titration of the drug over a range of 
concentrations allowed the evaluation of value that was measured at 0.959|xM which
increased to 0.858 pM on the addition of lOmM ATP.
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